{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.2-dev",
    "document_metadata": {
      "name": "TAU and Interaction Partners",
      "version": "1.2.5",
      "description": "TAU Interactions Section of NESTOR",
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved",
      "authors": "Kristian Kolpeja",
      "licenses": "CC BY 4.0",
      "contact": "cthoyt"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/90e1cb9e5e882703380c9db8d4915ac6f3cba137/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {
      "MouseStrain": [
        "K3 model with hyperphoshorylated tau resembling FTD"
      ],
      "TauIsoform": [
        "Isoform F (441 aa)"
      ],
      "Method": [
        "Chromatin Immunoprecipitation",
        "Chromatography",
        "Chromatography, Affinity",
        "Chromatography, FPLC",
        "Chromatography, Gel filtration",
        "Chromatography, Ni-NTA-Sepharose",
        "Chymotrypsin Assay",
        "Co-Immunoprecipitation",
        "Comet Assay",
        "Confocal Microscopy",
        "Confocal Microscopy, Laser Scanning",
        "Deglycosylation Assay",
        "Degradation Assay, 20S Proteasomal",
        "Dephosphorylation Assay",
        "Dephosphorylation Assay, Colorimetric",
        "Dot Blot",
        "Dot blot",
        "ELISA",
        "Electron Microscopy",
        "Electron Microscopy, Immunological",
        "Enhanced Chemioluminescence visualization (ECL)",
        "F-actin depolymerization assay",
        "Immunoaffinity Chromatography",
        "Immunoblotting",
        "Immunocytochemistry",
        "Immunofluorescence",
        "Immunofluorescence Imaging",
        "Immunohistochemistry",
        "Immunoprecipitation",
        "Imunofluorescence",
        "In vitro actin-bundling assay",
        "LDH Assay",
        "Mass Spectrometry",
        "Microtubule Co-Sedimentation Assay",
        "Microtubule Sedimentation Assay",
        "Microtubule polzmerization Assay",
        "Microtubule-binding Assay",
        "Non-denaturing Fast Halo Assay",
        "Phosphorylation Assay",
        "Protease-coupled Assay",
        "Pull-down Assay",
        "Pull-down Assay, GFP",
        "Pull-down Assay, GST",
        "Pull-down Assay, His-tagged",
        "Pull-down assay, GST",
        "Pull-down assay, His-tagged",
        "RNA Interference, shRNA",
        "RNA Interference, siRNA",
        "RP HPLC",
        "RT-PCR",
        "SDS-PAGE",
        "Scanning electron microscopy (SEM)",
        "Surface Plasmon Resonance",
        "Tandem Affinity Purification, TAP",
        "Transmission electron microscopy (TEM)",
        "Ubiquitination Assay",
        "Western Blot",
        "Yeast Two-Hybrid Assay"
      ],
      "GOCC": [
        "axon cytoplasm",
        "membrane raft",
        "neuron projection"
      ],
      "Cell_Line": [
        "CG-4",
        "COS7",
        "HCN2A"
      ]
    },
    "path": "tau/nestor/tau_interaction_partners.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "2-bromohexadecanoic acid",
      "id": "1028fce5b555766254a32e0ae25fd8a281b290a7958c60dfebd45463ea42ee666a22960a9682ca2ff02fde55b964c6985725860fc4f5e223ec6f55e34edf2067"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "calcium(2+)",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "double-stranded DNA",
      "id": "188c53b14dfd8785575621c034b0d0924a0b65a8af4f6583df1fd3fc3f14165c78e3f00992798fecb1f075c5c1b1f4f56fcfb666d62ea8ad892a90a95b516e02"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "phosphate(3-)",
      "id": "8766b90e9eefbc5a7e02d2527e3fd48dea0a2fc6185218c99162adf376fc5cf7add59b057bf54498d274ae89e4e2277691d1df45bff72f174af3a8ed19abb21e"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "transfer RNA",
      "id": "50dc535d2561a6c243628aa7ea6069b51a5192c1bd4493dd241c2405499b32299e03bc8c23fc46e52693260e603948882a1826e9909f4f82339c0e493cffd0ac"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "zinc(2+)",
      "id": "94b0a4e4ea78da28e3f49e25ef431d498faa0597cfb5df72a4dd991157c2f6bc3e054c807617cc70ee1304f5d5f5142c4115acb575de09b30f40f464b96c2d97"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "juglone",
      "id": "6f8cb1a25e35d466c02c96b6eef1d4d935b6cba5488b234e9bb5f2438848730931574eaf24c668c5b58a9cef203e7465bc097400e17022a2c706d3d2bd551dda"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "tanespimycin",
      "id": "409d39722f4d5c9457a215c12a920d2bf82d03e7f143571a2ce44293d3b8a741f96f61f35a43f0580f6588e3a11c62fc1888fcdc048311e8b3180dc20f703944"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "amyloid-beta derived diffusible ligands",
      "id": "bb1bf00d89b855bbc846286bc0389eba22194342acf023f66bc324ceacf0ba483cee9dc67d56822bb7efa028804229cb820f4c45346b8131ec4cc58b8ff7f06a"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "microtubule-binding region",
      "id": "284e708151d3cdbad19b4883cd8b646d2cc4aca4e6b25b4267105e4c9dfe435cae86b0db038162e48956fb2de06ded489d92170df9e0c06d0d16a3b3376903c6"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "Neurodegeneration",
      "id": "52fac4ee7f9b3b0fbfcb98add48ce6b5926d97ec8d5b2d7be5e26abd9856e9a5fb4751523d7874eb2444348b726fedf3c0e18a99cf5383b69f3380c3be2f91ff"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Cell Membrane",
      "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "Microtubules",
      "id": "423b251fc00ca8300e6cffacc8328a41dc26c7935969fd1bbcffa31f767128c32deebfe0aa07def102c24e674932310fff1d766b7db765c8f47dfc23de220438"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "Wnt signaling pathway",
      "id": "bb7db3c69b4ba4b1b094d58c8bc59fac8c0b58b50dafdb59d4a6ed1e5b8cd8689f56bcfb6c0d6c9c12035693d75345e4fb5c95ab311a8673bd4fed15585c67c8"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "inflammatory response",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "microtubule polymerization",
      "id": "96a7816f8b02933054d24cccfe2f73fb8beb845049ee361c408761f17dbfda8aa44e9e83f8ee54cf90d9984d0676e2208acff137deee1e66e4c3c9bac2f35dcd"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neurofibrillary tangle assembly",
      "id": "ddb806442eeaf16c4573d02545b21939cd739066593dc5fde6d82f5d5b7bad5b274420d38fb8d36b39d6ab68d6de55b663d56fca339fd516217d141e702e5815"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neuron apoptotic process",
      "id": "b9dabb1ef70e6265bcd2b24c2109961235bb35268bf9525a7ce468bd3244274273d156fc8c743c001d71896f7e3fc4dd9cf8a2e06ecf33e2f55fba778d2fa6d7"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neuron projection development",
      "id": "a4a789d35e8057526e04bafad4ccdb25a365a70101ab2ca873fc63a4ff8c0335429d22b292ebf9c39512bab7b2e66a74e77f23e36abc3c091b76aab6dcd3b331"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "vesicle-mediated transport",
      "id": "fd2e854e392487bbfc5f7809c44b14cc1873eeda5f18f54c7d5a63a1ea206b6bf71b8248e51997c3c0b84a2bca3c9afca41a8f6d7f00b66f49e3ada62d55ff8e"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "myelination",
      "id": "a1624dace0d43cc577c74c8bb7c6ec9c506fffb56accf61b056fd6f8c87651df1b29b73efe5b082445383b869cbd6175365f9385ba9f0e17368a4c51c109fbba"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Hot Temperature",
      "id": "e2fdd0bcaae16da3a0744518cfdb3cdfe63c64465dbbb8fc6a28da0848b132099b6951f0b0745f864bef44ef0e19d0975a512ea5fab410826271489dc20df5b5"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "MESH",
      "name": "Oxidative Stress",
      "id": "32bd3ab5e8a3a26be3209856c88741f0f0e2dff98d2587599a6a21b0f4793c5d8feb1194ea2166cf3cece076e7095530b116270e6655bc8feb35a437fda42cf6"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "Lewy body",
      "id": "0d911be37b882d9cbb9bdc5353e88be5ad1c5a3901011851c05d4fe64736c7f7a2aa3a78ecf13250680dc847bcd862c5c6ea422e955531d8d188486a157c0c76"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "filamentous actin",
      "id": "98934728511be71546a4951fdd9499b480b537fdff6fd0200467db38b82c1e26e09f23752a3170ed1ec9dc72e172624ebbab04ebeed002d77e606af519e2dc58"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "kinesin complex",
      "id": "ba50358a38cb1fec35ba62560fd3f8ae910ed04fb0ad573d4de450d2550d46c28db20fbcb6c0055ba95686228615f1b57c597a023fa07b6257d27a2fb17900bc"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "neurofibrillary tangle",
      "id": "83563b0bf7b4e8223bab3bc7bfc5d3f34eef173b06c17dc9313fe7f786eebd3eda569f012c7293bdcece2a95a9c825fee6f7643ff2c31525f6806be2449fbdcb"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "neuron projection",
      "id": "7b7a536beb8bc972ab5a7469f26c26009606a9d6772015ee5018c50b9f432ba704805661362e9d4d77fadfc2dd17184826ec229986922f3c359ece4430b64f54"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "plasma membrane",
      "id": "b60aac76fcf9cc0da340377a60711f69f7a35b27e5bc519a67d5f5c016621da73eca5757196fdb41891b6c732eaeebd6dbf43b5b4c4cd474f835652c7ea5daca"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "polysomal ribosome",
      "id": "00ae19a20683f78821370f1d49efa7415e5d636bef575aa3578a685a88ab41e415698041635a162b820698f3fad6b194831110822bff879236051b0cc38dd902"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "proteasome complex",
      "id": "5deb6bcfdcfa66f95c4979205b8144cf23a26c8da492c2d4b71750a7f8e440a3d40a37452d67ccbdccfba2bd5cea7bf1bbba3d66e18875bae3fd8abd8d3d68f4"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "axon",
      "id": "7308516a8780d50c14c3e1022732825363d997dbf3d2f9c30bf1976f3b1cd2f2953381b216c757ce80ae33f5fc295dde5d40e9e28e178a0105df0b72734c1feb"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "microtubule",
      "id": "4f9896462896b7433e0b33a04c48c7e3d61950f58f888a42e867fb6af605ed0b6fa2622c669ae341fc894aa676013ee8b1b5bc3617132016c5ede97d67e6c631"
    },
    {
      "function": "Complex",
      "namespace": "GO",
      "name": "neurofilament",
      "id": "282cb9663b452890a2dffac0596d833bdb930eb8f366dca1b66cddd3210864f547c94171bad3c0e97bab5bc17cd2cac3203e2af20e9a3e485ca42b5e4cb2600d"
    },
    {
      "function": "Complex",
      "namespace": "SCOMP",
      "name": "PP2A Complex",
      "id": "9f885b3b8a86839fe446f19dd8d0fcf1c02222fabf5b9e5304a8478ab0d7a5241d718fc25c01c70579de6f8c502a1e87d0fd72839448e4dbcaa4d1ba29520bb7"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "calcium(2+)",
          "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
        },
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "CALM",
          "id": "0ec9c189d22b2217d25b75629353f6f5d5b5e486d3b82cabea08668b2b248dc760ea36e76bb0e8b98c980e00a33d7f59c47bb98d6d602291bca5c9b70ee7a5fa"
        }
      ],
      "id": "fa537daaad0bf13364c61e6b32b826602a30645c0c22f10ff9e0f6eecac7cd5e9e238dedcead376cb77069122a8036ee784cfbfdf1bba933c3b59b9f1d8539ff"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "calcium(2+)",
          "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
        },
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "CALM",
          "id": "0ec9c189d22b2217d25b75629353f6f5d5b5e486d3b82cabea08668b2b248dc760ea36e76bb0e8b98c980e00a33d7f59c47bb98d6d602291bca5c9b70ee7a5fa"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "36f9a4a2b7acef54965c8018edd762a2cb0f0455cd95917a18934b6adbfc74356040f6136e4638ed8b6f09f0954701be080cba2a1bbabec3abcb635a1a239e33"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "double-stranded DNA",
          "id": "188c53b14dfd8785575621c034b0d0924a0b65a8af4f6583df1fd3fc3f14165c78e3f00992798fecb1f075c5c1b1f4f56fcfb666d62ea8ad892a90a95b516e02"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "dcb9e9e2f180c0c2d0c2721c550d310b1380f1e06b5be26ea4c7e79b2c84189c12ff817b1840c8b1849abea998e319a1d3015adc11bc5fefb9fac8957f9ed789"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Cell Membrane",
          "id": "01ec7ffbcb8c9179057e9b0566861267a0a59f1b56f279101da5015908500b307bc7b168ef6d6540548d8fe99dd18a44e972e1682631a179a440ad4e5f662b4a"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "ANXA2",
          "id": "a99211fb2cd197e6d36aaf8602c20247b772f6c083bc7813f78679080be7063a4113aa2283a9f9907e857a492bd5805e7dd8ebd24fa7f649bb0fe34f859fab8a"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "3400bbad6a179a3a74bbdcf402eab2074318f0b083d47dd154e67ccf412089986d579d94297cb0dc848808256ccf218ff2d27e02cce6980f318efcc0bcdb39a6"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "Microtubules",
          "id": "423b251fc00ca8300e6cffacc8328a41dc26c7935969fd1bbcffa31f767128c32deebfe0aa07def102c24e674932310fff1d766b7db765c8f47dfc23de220438"
        },
        {
          "function": "Protein",
          "namespace": "INTERPRO",
          "name": "Dynein associated protein",
          "id": "370ead0ab50a12bf23c5e451e1fdf2b5e2ea06194650b5b24960ace1c1f7ea01e44be2581c3b04a249a8149a5175cb7bbd88412487a7a2f440792ff3a3854a20"
        }
      ],
      "id": "f8bbb8a0ff6d037782ffd1a69317a1f91899a512bdab1d1f5838a5f1ae0125dc6f8f0f72da2766dff4b79f0b69b02da4fe55776a76e187321fb297f8c355a926"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Complex",
          "namespace": "GO",
          "name": "filamentous actin",
          "id": "98934728511be71546a4951fdd9499b480b537fdff6fd0200467db38b82c1e26e09f23752a3170ed1ec9dc72e172624ebbab04ebeed002d77e606af519e2dc58"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "66c05010830f476c430ec93d8b4227551f002bde6c4f7f95c9e65162ec1deb2d25f85168c3e5eb50b21d983c1aeab6cea41d16c40369f2925b586a9c5d37a767"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Complex",
          "namespace": "GO",
          "name": "microtubule",
          "id": "4f9896462896b7433e0b33a04c48c7e3d61950f58f888a42e867fb6af605ed0b6fa2622c669ae341fc894aa676013ee8b1b5bc3617132016c5ede97d67e6c631"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "c5b5bf376bc800ad53983bcf39746751ed98a31cb96d04c033c61f645c370bfe65c908cf63a4cc081ae799d94022f3d99f01073683a5c3cfdcda827ed6c173ee"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Complex",
          "namespace": "GO",
          "name": "microtubule",
          "id": "4f9896462896b7433e0b33a04c48c7e3d61950f58f888a42e867fb6af605ed0b6fa2622c669ae341fc894aa676013ee8b1b5bc3617132016c5ede97d67e6c631"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PPP2CA",
          "id": "6baa9d09125d1244431e7a8a8d8788f573889554982a8abcbd5c5d85b5f5c28771ff34971f8ab09e92bd0d7517b229ff34958f0f1278cc23410b7141982490a1"
        }
      ],
      "id": "b793b60c91bdaa07f9ba92a56ce806cf1ed607e15bd036db0c017edc7f39ed67dc7319ea36348af189e797a780e42000f3da5b74bfc25923aeaea0cd6f4af5a6"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "Cytoplasmic_dynein",
          "id": "882bfc0597397f0d7c8b85524cc945eb474c718abe598435b3f3f6ebbd292f646e2e4e3a4b0b046a36f1881592af790fced97c4ce3b692272cb021003696b87d"
        },
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Snca",
          "id": "632e5cdd1e08579897495c066b1c49c745827e51b2a38d4bb113c9657cac6bfeb2334f843bbbedbb3f4acde1943e018ccb57947c1e1095a38fffedae0985348d"
        }
      ],
      "id": "d74bc9a4de24cb183dc40dbb85ec52bc521c7f937a5088845082a6a9c00bf09f04dc2e46acfaa3ada8b0c3828edba0f49608442dd9b58171de45ad9e374238d7"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "FPLX",
          "name": "CALM",
          "id": "0ec9c189d22b2217d25b75629353f6f5d5b5e486d3b82cabea08668b2b248dc760ea36e76bb0e8b98c980e00a33d7f59c47bb98d6d602291bca5c9b70ee7a5fa"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "a8b34766c7e660329a8516fda8a54241e2acb7127551cc73676a4930a0410bb620cde39e0e1d88c25ae89e6dc1839d405eaf043bb1f26fb5231b1ccee2b53901"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "AHSA1",
          "id": "11a853fc14b77522314fab2709c38add5e956dac10acc0070da97ad317b2909a68d9795388464aa588c7e7ef51c9bb0190a3f168750c1e687b6ce1707eb4f9a0"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "952674720e9805d4e95dcb66d51b9b6080b3947879b2191f7978dfcacdeedcfdbb85240205e5099d233165079b66020ba430409e61599d6b1007bea8bb5e0e77"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "BAG1",
          "id": "16010efedd909e1809b9f15337bfa512d6188fbd0ac9c2f9787342600e90ab4411f71aafe35e04dae02318d3e8bb384c0d1e32135c2e04d40712b9a3e54f3c80"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "STUB1",
          "id": "7edf63ec4c2eaacc63944e79144be59c6ded86334f97e772d1e6ccbca7065106451bd7861e8acfbda8051ed22ecf6451dd68a33a35fc2d3b91083a48b53e1c68"
        }
      ],
      "id": "f69334929b6da0fdef7a7433a4d3a2ef608d4e6e4902d18ca0dc7630439898deb8c31ffdbfae913bb6a846d963250fac4bae04a494aef8cf7cc73ddef0b056d8"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "CDC37",
          "id": "926e7052adcda63d68ea1ea2a8c703a4652ea6ab6b281e9462ad243171de9ee72dadad40e0ca15c988cffc2580dcf4a9a0383eaea52c091eed2e0a4b395359e9"
        },
        {
          "function": "Protein",
          "namespace": "SFAM",
          "name": "HSP90 Family",
          "id": "1f08351a0a73246a35f18a54510f3ebd89b3f520d4eec714a258af4f7f36fc70c6770bef120aada195dcbafd014997c657135019603821d6789109936410f4ce"
        }
      ],
      "id": "c5237032b950ce214729c36e05d59371d049761caff63b8d460ba3b52318b47e9d61a6eb45421145f5585a5822f6060bd578c712da14c5d88eaf30f9273e605e"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "DCTN1",
          "id": "6ed0e0b37b870c5380696b3ba3ad9829ca680296d8e3a40aa72a25cd4d006971b47979b938fbbf7d209112fc5661604085baa314081fd3b1376be5b948b7a7c4"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "80aaba45cc458c4f8bd8f19398a4b58d8bf74dcc3af0c27e641868c9e9e3cbac32f60149f53715124f3899f0ddcab049f3c056cb7e079c5791adb73a22afa757"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP4",
          "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
        },
        {
          "function": "Protein",
          "namespace": "SFAM",
          "name": "HSP90 Family",
          "id": "1f08351a0a73246a35f18a54510f3ebd89b3f520d4eec714a258af4f7f36fc70c6770bef120aada195dcbafd014997c657135019603821d6789109936410f4ce"
        }
      ],
      "id": "4a720dc5d8de49a7cae806da4edba6dedb01355d9a257f096f5786564fa757195900b44d17cb04d4ae9e4601455bef83b3b61d921c5905d2f629f7cd28a9d56a"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FKBP5",
          "id": "235130a6aad5392b8d93ce87ee8c3548278ee308274731183499ce12dda8591cebd72053e22806a7c74a50cea9078cc291520f2bb9b1af2eb56e3880dd8d73ab"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "0cbb5bcb442e40c827a60f8abf6de23136cb949d36cbd17e555971637850cdebad7c9a43cfd6cd46c0f63bba2d80eb49b5a6c59882c6d04f4f6ed172810d772f"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "FYN",
          "id": "ecffd0427f2e321c9ed5143ca2510464c2fef5432457c332ee991bda79dbdd12ace6375208ee66760cc5b9b7990248651b41a370f16eb9459d2b8682cb0da86b"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "01d824ca10de347035229275725e6b2849ef7fadbbdf5484b8648e951a01eed70e1d6bcb3831ff41da4179ac44cbcf3cb218e3de3165d47b68b7ca0968403bc3"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GRB2",
          "id": "f94af8faaaccda960957759a32709642d7b4d818e8c8ba3ed97d7ba05833b4af9c016e3eb270995a8fbcd1fa75f839418fc6a71673178efd3786e4f881a3df32"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "e8a55a0b8924f769f8705953053f3b82c29afa309dd39d48c6b739f70e8751502e2079db909c35757247fcccdfb2e98eb6d15ce29c4907a38b60dead19fbddf2"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GSK3B",
          "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "3de72453f41eab956eeaec32644399b0ac3bf48184c74662afabdfe208cb5acacda021fc07869fcf50eff781d6e8b8f2f1957fdcb68798030c864311a5cefa17"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "GSK3B",
          "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "YWHAZ",
          "id": "e34d659c6722333f4f7db72f276727f6aaadd83e08eaa6e3f32cdc113b6a73bb927f8f66b88eda74697be02655279bb1b7ced720d1a34e97156cde5ae615974a"
        }
      ],
      "id": "0aa8fac882a5c64f3ed1999021b6224f86af045215f94e81c2ab95819278da736eefd7b17b712c92802acf608ce518b741ce9dce702c3cf7de9f90fa792d3c00"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "HSPB1",
          "id": "96c2e5e8f77aed7e051078529a022b3f2749abfafa85556c562ca52d96ef14965065c600e95bd3a593a68254aee443067dbb3631852f09acc84313fc5cf9015d"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            }
          ],
          "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
        }
      ],
      "id": "0dbf63e3e52f2ab58f824482fa547c06c9e37dd0d8d72fce69a98e25f37e63efa0b245717c980408abf57eac33086e93711fc910f58f5e21b1cbe13d8199f6e5"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PIK3R1",
          "id": "6736b1202cc0649ef0ea06f06b85b3ff637ede613f094e79ed09fe970a863e9daf79ec723946d9f64058dd50b9b15fec66ef3e9e9d95d6858ec6827707c6bedb"
        }
      ],
      "id": "5b05448d3ee2f267894aaaeb5f22de44b5f33c3545050823e9cc2bf1f198aa0be82bae52eebe73483a3cc2c1d0ede7be8a064d4fc7b03f326e19f39e81111d64"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PLCG1",
          "id": "1512790a6177cbcb3e1fa3670ab32a1e96cb66ceb251a6717153f95adb12b12bc42d7a8b96a468e6b27fb7365da5f4c302ebb64b5bb611fec1d9c50a25d334f1"
        }
      ],
      "id": "e94b8effda5f001ccda9e6fd0e94f81c9f53e825547d63bfa24bab36dea74b21c237356269fa3ba0422ed78873f879e46e8318f3611fa1b776fe51b14dbc213c"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PTGES3",
          "id": "743fd8f60493bef225875a48d1e2b407ba42f50f44599aad5c556c443395a0f89e397754ace47bfc9433603285bf7499f4ddf8a568b10821a3c260f508c7d69a"
        }
      ],
      "id": "24df141b0d66e7aacd8900c21ceff34294f4a416f0f19d233711352330f9425e35e23340f67fd8c97836b532b83860cf010f89ee75ea3d37ce2eb38ce6323355"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "S100B",
          "id": "f7c74d78e50e9084bbd32771955eff3c412004927980d769d1edc2fba3b569af908e85437a88a7eed468bdc0b56c2c60a4bc2559ff565f010a15f1040abfc855"
        }
      ],
      "id": "869729bcba32e4310da371c45b2e50659918e46aca9b49a0879ace3dee051367b32758284266fc2b3cbbc38ddc5b580e0c9f20cb37dedc989faee662d45efaee"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "SRC",
          "id": "89cf6fe86000d59fa342b801d809a06408db3c65a224250ba500634f4976a061da0e71d6f72c101186d9032a0624af6fc3b50e209815858d6bdb51831883be6a"
        }
      ],
      "id": "f3708001443325b8f2b3e28a7a1fb909966b0d56c11fc0d44384d3c31d32e05b54996063cd65a6f15d2ea7f81e02b4582fd890f18094608d8ca17bde6a9d7190"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "SFAM",
          "name": "HSP90 Family",
          "id": "1f08351a0a73246a35f18a54510f3ebd89b3f520d4eec714a258af4f7f36fc70c6770bef120aada195dcbafd014997c657135019603821d6789109936410f4ce"
        }
      ],
      "id": "6ed2cf62aff900a9e65c077dde438ad60c6a91fd7edf8cd9b3306e9e762d6bf95bbd30e5ad7a23af7c5656f08ac78127a166e6a205b88fdb8dd2a1aaa482d7e0"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            }
          ],
          "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "STUB1",
          "id": "7edf63ec4c2eaacc63944e79144be59c6ded86334f97e772d1e6ccbca7065106451bd7861e8acfbda8051ed22ecf6451dd68a33a35fc2d3b91083a48b53e1c68"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "UBE2D2",
          "id": "6f612ba174bda858d8de19ad46bd8fd67a1f46f4b2d01f726a7b677b2b1e94d41d6b121d551928994ab861e4efd1232ce7990a80fba180b8f9f983660e088b9f"
        }
      ],
      "id": "e2052877bf958e048b04586c8dc61edf8fab71c96c6fe1eb37756acfc571668d319c3d5b4e52ed277ec78548e2f783c5d0f561434a52c436bd3e43b239c9ba54"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              },
              "code": "Thr",
              "pos": 231
            }
          ],
          "id": "fd67fbe5c0c0911e8bffaf415eb40748a781d8776f2e2cdf8a3f4f97f0f2f312aaa680c7b670dc27b11d220f0079b4d5e41cbcf095a568bc644b6e9eaefc50b3"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "PIN1",
          "variants": [
            {
              "kind": "frag",
              "start": 5,
              "stop": 39
            }
          ],
          "id": "9481742935d1ff7ea36a2ef53093e28f4e6467e76ea1686f49d9818b07f5a9079b440cf8369a630cb5a7f1925404d070008f8fb7014836be4e6c97ae832f0204"
        }
      ],
      "id": "b7460e54d180a99b740a79d33f69b5ceedd06ac8d8ea5c3029e7fc35d865905eb0ec08b73b1b56c9db3497146bea24e49d831194643d4540e778728c2338ca85"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Fkbp4",
          "id": "4357441d5c81146af2f5cc5df57e680c37951261efdcdf741e5a0970e0f5b74886b9c5b69d247ca2aab45895f0c9287c9693ddccc70423b2511bd7a452cf6b73"
        },
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Mapt",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            }
          ],
          "id": "3b0967909beeb3e40181b42fd6d8b686507dc30354899f69d27bf9a7ea2017d23c8c8eacece7f76cec5a6edf1718c6a64dcbe256459eaf7543b8049d477f0c96"
        }
      ],
      "id": "35eb6489edbcc743c87a53ee07bff5592ba947d7a7d267c20aaf498a34d392e5399ba784499da544532787649c6c83dee3f849a2a17e77cc564912b4c57fbc50"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Klc1",
          "id": "e24e2f0e3060e908ee154c18d2f616dd7dd4a2c310937a7202504fb714607afcbdd50f5e2438e297264b4d6d64a4650425a582c1793c73ecfc135acc74cffe58"
        },
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Mapt",
          "id": "d7ee72cc866dbe8148a83717b5c56b67f46b715c1c11fac47257b38efabf4f3947f73dc4a227db3e8e7a2039b162b0b1b1bbb0d7605e6e651f1dba7fedfc3bd4"
        }
      ],
      "id": "f46814f2d2cdda18218034a159f972976b9b88dac6bc55bc45d45afc68582143a2ee6e8cf260c46b937baa6350232d9893212e3d152731acc1902d6357bf9952"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Klc2",
          "id": "9eaa622d3a4c75cc6c45165a2685f5f42252f45f8fe3191106ab811fa579b101563f859a579e27605ec49e1cbfae62f59181cdd6d5d32e09e46d495f9240e61a"
        },
        {
          "function": "Protein",
          "namespace": "RGD",
          "name": "Mapt",
          "id": "d7ee72cc866dbe8148a83717b5c56b67f46b715c1c11fac47257b38efabf4f3947f73dc4a227db3e8e7a2039b162b0b1b1bbb0d7605e6e651f1dba7fedfc3bd4"
        }
      ],
      "id": "5d889235ed4aa1b51856511e6c502714334f8286f50d0f93edcd7d96b4acf995e4700f17c21409a9f598a3227ee410673b232f0df56138f1a1d4139e67d8705e"
    },
    {
      "function": "Composite",
      "members": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "SNCA",
          "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3"
        }
      ],
      "id": "e7ab164de499563b8a91b267ed7713d55cfe773200a10f6f33d1db3642cdc429c9cfe59de9aa56bc56ba736092658342c76171fcffb0ca2706d079ddedadaadf"
    },
    {
      "function": "Gene",
      "namespace": "DBSNP",
      "name": "rs104893877",
      "id": "f098eac718765a903046054cf932ec4f93ab73f7daebffe77734d95d78128e4b018ba53aff4ffb42f14857e94261e7262bc20b25c34ae717ce86064eccd157b5"
    },
    {
      "function": "Gene",
      "namespace": "DBSNP",
      "name": "rs63750424",
      "id": "67678857b17241b484255bcdf70c15858ecc4d4c80a51da3b1fff6e72d50e8489bc80b27424736f214f2224ad0c4412b4baa04f5313b0f49c081324f1ecc80cf"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "Cytoplasmic_dynein",
      "id": "882bfc0597397f0d7c8b85524cc945eb474c718abe598435b3f3f6ebbd292f646e2e4e3a4b0b046a36f1881592af790fced97c4ce3b692272cb021003696b87d"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "CALM",
      "id": "0ec9c189d22b2217d25b75629353f6f5d5b5e486d3b82cabea08668b2b248dc760ea36e76bb0e8b98c980e00a33d7f59c47bb98d6d602291bca5c9b70ee7a5fa"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "JNK",
      "id": "a9ed6db257ad5286099b1c787f20b6023ae9588e34100f98373865a084224f3815988fd9eafd8a85f974c668ef8c48bad8bee8de58c6e414fc8b084d8d066d6d"
    },
    {
      "function": "Protein",
      "namespace": "FPLX",
      "name": "Ubiquitin",
      "id": "718b9f707565a371c7d1223e4a8fe26dd963ecffba7d4ca9bdaacb3b6b1a9846dc629674a6720d37c0ad27129fef976d82613e096660153bfbc1407d8bba493b"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "Tau isoform F (441 aa)",
      "id": "6f77e66c8e6368b067f47a9e99af43c53de45b1decba4c781f56e3d00bc2250510977965c81031b9b64a3e71da16a521a52f27bb16fd9846d5816bd36abd9ee7"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "Tau isoform F (441 aa)",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Arg406Tyr"
        }
      ],
      "id": "f658f180734bcebfd95936cc38072fb065f290034e692f0a25217c0214f5be7152d9afcc3dc30fe4a43bcc507d22d084431e3be5ac6ff254d45eb4151e465f94"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "Tau isoform F (441 aa)",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Val337Met"
        }
      ],
      "id": "8809442793d8185d660463072352c2ecaf507c8953f4726eab9e8a1e80120045bf5b9abaac9b8882d1f314c45764a77767a19e2e39e06b3bf50f77270f3f40b8"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "VQIVYK motif",
      "id": "d24410c0e1f7134ec904e57582699c3206010f0f52b68cbe7c0703edf4c6ef1628720acd2447aa7e65fa67801ba3140fdaea3a4b1e60d7e5ada7a737c830869e"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "microtubule-binding region",
      "id": "99043577ba012bab6beaa261af4af0794f0bbf7ec841805dcdc7c837d54ed8ba6ee159ed8f3749148f589a7f75faa8a15068d82c4ead932464ee78fd704732b9"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "tubulin-binding repeat 2",
      "id": "03ab3f7416f5c92ed862db8ac2122c116ec3f1e1c6b2dffb2fcc1c3ea7ed3ae4479e1d37350995c75c001558f62453782d6f60e3776ea8769debb8a601aa7059"
    },
    {
      "function": "Protein",
      "namespace": "HBP",
      "name": "tubulin-binding repeat 4",
      "id": "1498e07780888f3c7b76873f3ebfad3a0371e52a239450c0a4255feaec6cd69c1635b7f65869fc1e0b78723e1a39f6ebd77437e17588aeeb222536a85681ef03"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AGER",
      "id": "7e397a005d17551ff46539ab6c2a5709d61f6e6a34c53dd914d2390a36fe3641cb438c1f1e5a08095695db19ea9e931449ec027bd08e3cdfafaf5acad2a74f4d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AHSA1",
      "id": "11a853fc14b77522314fab2709c38add5e956dac10acc0070da97ad317b2909a68d9795388464aa588c7e7ef51c9bb0190a3f168750c1e687b6ce1707eb4f9a0"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "AKT1",
      "id": "459b49bb1c745041814dfc37f0d89c3d0c3db4d952402fc2ca8e986e90bb84483919e9c4a520236e0b44f7438c90f068ea34f28822e46ae58e9515fc87c89569"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "ANXA2",
      "id": "a99211fb2cd197e6d36aaf8602c20247b772f6c083bc7813f78679080be7063a4113aa2283a9f9907e857a492bd5805e7dd8ebd24fa7f649bb0fe34f859fab8a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "BAG1",
      "id": "16010efedd909e1809b9f15337bfa512d6188fbd0ac9c2f9787342600e90ab4411f71aafe35e04dae02318d3e8bb384c0d1e32135c2e04d40712b9a3e54f3c80"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDC37",
      "id": "926e7052adcda63d68ea1ea2a8c703a4652ea6ab6b281e9462ad243171de9ee72dadad40e0ca15c988cffc2580dcf4a9a0383eaea52c091eed2e0a4b395359e9"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDK1",
      "id": "747cb5f5befdf836f554988dc78f239aa22c459cac15530f612c81e574e698015ce984fbf7e925106a70e03f362c9e1b812b74790a36fcc7124b05ad1e08c8b7"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "CDK5",
      "id": "a85beb5b2b9417fabbbcc2135b9533cb0766b38688caf02242632843ae455bad332fb625d6e8296ff77b40e841485a56854fc14e300552425d596e8a8e70fd3f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DCTN1",
      "id": "6ed0e0b37b870c5380696b3ba3ad9829ca680296d8e3a40aa72a25cd4d006971b47979b938fbbf7d209112fc5661604085baa314081fd3b1376be5b948b7a7c4"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "DKK1",
      "id": "43353c695c37d05100ccc4d88cfc994417614c34fe111df6314c9f4143abc3ea6c90a9bf584c4c8e811efaaa5fc268e61dbdc6ca23c67cba998a28632f6400b7"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP4",
      "id": "4b4d04660cce588fae0beec1c7476117f842e4de7495fb38ca6e84a1c0e432492353d48a26d4db9d75072c260d5bbc589bc6dd97ae31fc7b65151d4655878cb1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP4",
      "variants": [
        {
          "kind": "frag",
          "start": 270,
          "stop": 386
        }
      ],
      "id": "143190e932cb7a67de813effae3c4d5c1e0edde55a779ecdb495cc433cb3288c3cd697509cf6efa68db56c7f80b02453cae3308ce747d2eca249da89914f9f7f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FKBP5",
      "id": "235130a6aad5392b8d93ce87ee8c3548278ee308274731183499ce12dda8591cebd72053e22806a7c74a50cea9078cc291520f2bb9b1af2eb56e3880dd8d73ab"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "FYN",
      "id": "ecffd0427f2e321c9ed5143ca2510464c2fef5432457c332ee991bda79dbdd12ace6375208ee66760cc5b9b7990248651b41a370f16eb9459d2b8682cb0da86b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GRB2",
      "id": "f94af8faaaccda960957759a32709642d7b4d818e8c8ba3ed97d7ba05833b4af9c016e3eb270995a8fbcd1fa75f839418fc6a71673178efd3786e4f881a3df32"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GRB2",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 57
        }
      ],
      "id": "7a00f983aea8f9a564e15d2ace242922a40f8e6a15d8670787197fa23125ca9a481a4c11cf6243893c223ecbd4826b05965dc4ce57be1eb3b5b2d3a930d93978"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "GSK3B",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPA8",
      "id": "adbb7eb799b12cc7b0d44de87e8712515e7d06740dfc632ca77e4c00a3741a8efeb9259665e8deac8c5fe2184cbce4b0a228311a757c8571b706689f43aec19c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "HSPB1",
      "id": "96c2e5e8f77aed7e051078529a022b3f2749abfafa85556c562ca52d96ef14965065c600e95bd3a593a68254aee443067dbb3631852f09acc84313fc5cf9015d"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "KIF5B",
      "id": "525c368e691902009580e8256c18ca29c19cc4f85deb0ca9fa6fbc0f1ef86c557229ed93124bf248a42755a658674d1d55241ef0b2be0a5484a438f1fa84c089"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "KLC1",
      "id": "3a1941213c9c71520d8ece5a64c05b23fbfca33093442b4915e8f3eb4f0523ccc18d7f8c449a65b177973996c6280600732ca5b0bcbe91bd4275a141eeba18a2"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPK8IP1",
      "id": "a073766ac0227f5390160cba6eec4f0b7ab48434dc97665d1a35003c3572d56c84a91d8841abc77e5613071f9129661a27f2a80919141379d20e8436c0631163"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 244
        }
      ],
      "id": "ae10b72a8ed7afb39abe9ffc5b560f6e0b11ba9d150cfb0763217d46bef0233d6d5126067a7c9e791451c6fef921834342d5cf47d6d001e73e40b4c5eb6aaf68"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "frag",
          "start": 223,
          "stop": 226
        }
      ],
      "id": "9817614bea0a4a76d9e2dfa8c65c49239bfb00287091b6cb1b034399d8703bb2030533bc5745505ac82f213efe41028729f669232fb36e5030fa2cd2cbea970b"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "frag",
          "start": 237,
          "stop": 367
        }
      ],
      "id": "02330752c3a0c2af80ebbc3c436f8e595591808377ad8a6d9270af151018a588c5655efebf5d973c25dc589b54b453238359e08468163bf87f8be6c10a54cead"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "HBP",
            "name": "hyperphosphorylation"
          }
        }
      ],
      "id": "ede67fb639f29861d91976fefa16d8279b53ae13a659f35d70ed12e01bf3f339ffcf701fc54c7c4e908fee9902c02aac3e0022dcae5a7afa217ed2d4dba133b0"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 199
        }
      ],
      "id": "a145df05055e4436ddc08a7d9e576954162015f2fd2fa4cdbb4e673261fe4932313e7e8984a94c3d8624252ea9edb21bb2b1a15071d766a2ce5e919d17a2735c"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 202
        }
      ],
      "id": "49b56446b699c749fbb01c4560254bbf621f44bd52a02cb74e212fb0ef1b9b1616a31cfe6ca06023fee3689ef552a3e8fe71211987ebad4180c2d78535f4ad7a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 262
        }
      ],
      "id": "c20d653a77090fa48337a73d9915475bcb411eb52f7e239d287da66a8d92ac32ac84146976f90af86f112ccd6fb631b1dea88f465bf333cf545de4f9a44d07ef"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 356
        }
      ],
      "id": "48317023adebba2bdbc3547d0f7ee43578ecb436211b91ef867ec4d820c385520ab83ed151305262f74205eb47f03ee242509a03e3210e94a0ea5a87589d4241"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 396
        }
      ],
      "id": "233ebce30d7505cee42acc956f9d268e5b725e14853bd56fab3b87a93a4e0c8141a6fdec062d10e9c4924f6e13a61184600872c2f5080656e3ca27227eb4cb93"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Ser",
          "pos": 404
        }
      ],
      "id": "a448f901ddc919f32d50fa5284355b4eb4ed52e9ebf8705052086706d728d8ebef0cc66616b7fbfda3aeffd49db6e41134fb39996aa9b996a73bce331de95767"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Thr",
          "pos": 205
        }
      ],
      "id": "24f81ecd30f95a3f531b41b720220bf9d7658f3707c73433cb4f0aa57bc57aafa73ff95df5991871c0528b3a9de6d2ff36d46cd5b85e906f33d54e6b47bce815"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Thr",
          "pos": 212
        }
      ],
      "id": "d10f7602e71867be5adc0f8e0dc989e83163432837ca2c5869ab7d763dad95b87dc4ebcacb9c440ac7c30a31e1b7f42adbacd9bac529384743ab44360f7dc34e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          },
          "code": "Thr",
          "pos": 231
        }
      ],
      "id": "fd67fbe5c0c0911e8bffaf415eb40748a781d8776f2e2cdf8a3f4f97f0f2f312aaa680c7b670dc27b11d220f0079b4d5e41cbcf095a568bc644b6e9eaefc50b3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MAPT",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ub"
          }
        }
      ],
      "id": "b82dd479625165a1698c7d2d4c226eda11a649423410a6c490322188f1626aa059f6c0ab1052a838dd260fb3b0cde95fa88b8b559dbf59e85e7ad83f6a623350"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "MARK2",
      "id": "32e9705a2cfe2236e89f96b1de2674ed6b928f961ba06a2ee26a04d2758841c562de68ad629751e3068693935cde11d4c376ccf85a83ede814fd5b8c2721eeca"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PIK3R1",
      "id": "6736b1202cc0649ef0ea06f06b85b3ff637ede613f094e79ed09fe970a863e9daf79ec723946d9f64058dd50b9b15fec66ef3e9e9d95d6858ec6827707c6bedb"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PIK3R1",
      "variants": [
        {
          "kind": "frag",
          "start": 3,
          "stop": 79
        }
      ],
      "id": "b376acde12efe3256c7856cd0363b23e34a77853061f51483909edcc15dd5d89e0420a0166b22606badd6c05730ae04ca3c6c991c6db3e1742dace837f9f1ac5"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PIN1",
      "id": "a4b6cab238e3cf3e494c884c3b540f12c39b1604b07e59f53693996e4bc2658cc64c2c01ccfa634d6236037a0b85aec593bdb9b7667a3f19d8d33e93614f39c8"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PIN1",
      "variants": [
        {
          "kind": "frag",
          "start": 5,
          "stop": 39
        }
      ],
      "id": "9481742935d1ff7ea36a2ef53093e28f4e6467e76ea1686f49d9818b07f5a9079b440cf8369a630cb5a7f1925404d070008f8fb7014836be4e6c97ae832f0204"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PIN1",
      "variants": [
        {
          "kind": "hgvs",
          "identifier": "p.Tyr23Ala"
        }
      ],
      "id": "bc571d0abb11e1b73919451d58a5a3675ac7f32e60e4c19fbba561f01189306b9ea67635603a5275efd565383e69284dd527c825718ccaa0f31d612d5792cb4e"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PLCG1",
      "id": "1512790a6177cbcb3e1fa3670ab32a1e96cb66ceb251a6717153f95adb12b12bc42d7a8b96a468e6b27fb7365da5f4c302ebb64b5bb611fec1d9c50a25d334f1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PLCG1",
      "variants": [
        {
          "kind": "frag",
          "start": 790,
          "stop": 851
        }
      ],
      "id": "35159c3b9c8531b7e4e4716ae7ea783783529505223b5ce5b5423ff06c643bb87867add33042e265fef911204c9579fa67357f24a022db0cd74b9b025a7d5c63"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PPP2CA",
      "id": "6baa9d09125d1244431e7a8a8d8788f573889554982a8abcbd5c5d85b5f5c28771ff34971f8ab09e92bd0d7517b229ff34958f0f1278cc23410b7141982490a1"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "PTGES3",
      "id": "743fd8f60493bef225875a48d1e2b407ba42f50f44599aad5c556c443395a0f89e397754ace47bfc9433603285bf7499f4ddf8a568b10821a3c260f508c7d69a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "S100B",
      "id": "f7c74d78e50e9084bbd32771955eff3c412004927980d769d1edc2fba3b569af908e85437a88a7eed468bdc0b56c2c60a4bc2559ff565f010a15f1040abfc855"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SNCA",
      "id": "4345441d1f420dc0d830377737dba9467f21b1637ed3472a697534ce698f2566b780dd52cda47c96b782242b1bcfa70e9a6147fb3bb251d1f3e1e2a0bb7038f3"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SRC",
      "id": "89cf6fe86000d59fa342b801d809a06408db3c65a224250ba500634f4976a061da0e71d6f72c101186d9032a0624af6fc3b50e209815858d6bdb51831883be6a"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "SRC",
      "variants": [
        {
          "kind": "frag",
          "start": 84,
          "stop": 145
        }
      ],
      "id": "3736ec7273400bb921c2ab2367b4de117424b6bea553665909940e2c1804bee3c98e764e6a3ed91c2c590f8f8e9dd78f8273814aca2e38adf5b03200ffa66731"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "STUB1",
      "id": "7edf63ec4c2eaacc63944e79144be59c6ded86334f97e772d1e6ccbca7065106451bd7861e8acfbda8051ed22ecf6451dd68a33a35fc2d3b91083a48b53e1c68"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "UBE2D2",
      "id": "6f612ba174bda858d8de19ad46bd8fd67a1f46f4b2d01f726a7b677b2b1e94d41d6b121d551928994ab861e4efd1232ce7990a80fba180b8f9f983660e088b9f"
    },
    {
      "function": "Protein",
      "namespace": "HGNC",
      "name": "YWHAZ",
      "id": "e34d659c6722333f4f7db72f276727f6aaadd83e08eaa6e3f32cdc113b6a73bb927f8f66b88eda74697be02655279bb1b7ced720d1a34e97156cde5ae615974a"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "Dynein associated protein",
      "id": "370ead0ab50a12bf23c5e451e1fdf2b5e2ea06194650b5b24960ace1c1f7ea01e44be2581c3b04a249a8149a5175cb7bbd88412487a7a2f440792ff3a3854a20"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "GRB2, N-terminal SH3 domain",
      "id": "378a86584f1e3461094bc566d0b1c6eef77420e3005ea15577f313ff2d345035e2a311613590fc02704f9b256928605a641ce623e8658c1360a0f0a8a8342595"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "Heat shock protein 70 family",
      "id": "107f046963afb832d368b07bf920547caf81b030a2eacf8f0f4310d55600ca0f51950ad7489bd0d901c5df6076168ad4ec18432ce6724da28dc451cf74ce618c"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "Heat shock protein 70kD, C-terminal domain superfamily",
      "id": "16e9e48cda1de4ea94a03dc84386395a73e344c5d623442f6baf1f4a6508891e67f0051b5f58a1dedf2960086db0e2ffe37ab7c7eef9d8f9e0edf58f468e1703"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "Kinesin motor domain",
      "id": "97b9ef9b7308f03d8600bba4feb3fc89a58704ced9238f4780ead5e09455e68463285775fb11344b0c7a272d196b86ccacd0ecc176707627115bf3c721e52e6c"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "MAP2/Tau projection",
      "id": "115223264f85ca3aef98a34b4f7fa26c291ada3889afbf815fa89cac6eccb6045720e2d1a7005edc6b0d7221ad0328f6bfce6f3bf6116903608028012a53f49d"
    },
    {
      "function": "Protein",
      "namespace": "INTERPRO",
      "name": "SH3 domain",
      "id": "90b857227034f64ce1066fc20cf2bb0a5620046faab1c67a6fe2c03b8c711f7e3f209d248befe00fd1b0596ac9ecc2b2dd4b7f2925ac219ac8aef8f6c3172b5a"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Fyn",
      "id": "aee9e0d0ed2a634d63bf65e63187c6ecc9a3cd6d4baafa17be87b87d465e0077de34c9b969fbe2b92a789df5fce999229369754ed1bda1b65308c1b8aee8119c"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Fyn",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Palm"
          }
        }
      ],
      "id": "be7badd6961cb6d7447b8e33e3140aa0c1a34a0a45999f53a6831ba3c7902da1f4ae00c70446e3624655e3866842f0a32fa93b5cef5d71b2353d689a72417d30"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Klc1",
      "id": "fcdd393b35287d6f661f1bdd08b2e7e63d194c72ea94fa9d91d6a36b66df565982ccfda10f1dd5001ba3cf0d658714f294ca7403d9c70958716250feeaed7359"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapk8ip1",
      "id": "8e9be575941a012ad60919cfad1d80ad1a71c6cdf8cc29e49bdbabbc08f5eafb1ef30aae1ff3db87bb75bc5a827d33a315d58aa0080e801de4104f532cb92f31"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapt",
      "id": "7d94454106658b1e4190b417a419f7ccbab4b525157cd679cbb4da8a006b08c3819b0a360b692358b3f80ea2648890248be2aa7c97e1d59962dc6aa097560f2d"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Mapt",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "866eb2548d3ebb8c575db22b2dbbed794da750619a04d31b30c8ffbd59b1562d89d2191f4ea30cc09874d9d44f251a203918593f4cc4e29a12eb1d52d0f58bd4"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Fkbp4",
      "id": "4357441d5c81146af2f5cc5df57e680c37951261efdcdf741e5a0970e0f5b74886b9c5b69d247ca2aab45895f0c9287c9693ddccc70423b2511bd7a452cf6b73"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Klc1",
      "id": "e24e2f0e3060e908ee154c18d2f616dd7dd4a2c310937a7202504fb714607afcbdd50f5e2438e297264b4d6d64a4650425a582c1793c73ecfc135acc74cffe58"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Klc2",
      "id": "9eaa622d3a4c75cc6c45165a2685f5f42252f45f8fe3191106ab811fa579b101563f859a579e27605ec49e1cbfae62f59181cdd6d5d32e09e46d495f9240e61a"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Mapt",
      "id": "d7ee72cc866dbe8148a83717b5c56b67f46b715c1c11fac47257b38efabf4f3947f73dc4a227db3e8e7a2039b162b0b1b1bbb0d7605e6e651f1dba7fedfc3bd4"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Mapt",
      "variants": [
        {
          "kind": "pmod",
          "identifier": {
            "namespace": "bel",
            "name": "Ph"
          }
        }
      ],
      "id": "3b0967909beeb3e40181b42fd6d8b686507dc30354899f69d27bf9a7ea2017d23c8c8eacece7f76cec5a6edf1718c6a64dcbe256459eaf7543b8049d477f0c96"
    },
    {
      "function": "Protein",
      "namespace": "RGD",
      "name": "Snca",
      "id": "632e5cdd1e08579897495c066b1c49c745827e51b2a38d4bb113c9657cac6bfeb2334f843bbbedbb3f4acde1943e018ccb57947c1e1095a38fffedae0985348d"
    },
    {
      "function": "Protein",
      "namespace": "SFAM",
      "name": "CAMK2 Family",
      "id": "6272e7f1cdbe0dd7facc750301230f73b0438a4330e89404e5b9b025ee8ae4eb28917f5738057014e93a09941c41bdec68e7ad3ab0dbc7b8754409a90fd48e7a"
    },
    {
      "function": "Protein",
      "namespace": "SFAM",
      "name": "HSP90 Family",
      "id": "1f08351a0a73246a35f18a54510f3ebd89b3f520d4eec714a258af4f7f36fc70c6770bef120aada195dcbafd014997c657135019603821d6789109936410f4ce"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Frontotemporal Dementia",
      "id": "65b349369f9bedd1a6220b3923747475397a886cb45f96f65e9aad66d695cfd560911459bd006d087e0ee4cbf06d8829549b3e32854fe68093e2b5834049d726"
    },
    {
      "function": "Reaction",
      "reactants": [
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "variants": [
            {
              "kind": "pmod",
              "identifier": {
                "namespace": "bel",
                "name": "Ph"
              }
            }
          ],
          "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e"
        }
      ],
      "products": [
        {
          "function": "Abundance",
          "namespace": "CHEBI",
          "name": "phosphate(3-)",
          "id": "8766b90e9eefbc5a7e02d2527e3fd48dea0a2fc6185218c99162adf376fc5cf7add59b057bf54498d274ae89e4e2277691d1df45bff72f174af3a8ed19abb21e"
        },
        {
          "function": "Protein",
          "namespace": "HGNC",
          "name": "MAPT",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1"
        }
      ],
      "id": "109c8d27b2935c6380f7bf04bf181a906b06fbfbbc647d137df4991b95a94c614c7cb0ca66976458f8b227b34d31992b4fd3945058d9d77184a3a55507aac521"
    }
  ],
  "links": [
    {
      "line": 98,
      "relation": "directlyIncreases",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        },
        "GOCC": {
          "axon cytoplasm": true
        }
      },
      "source": 103,
      "target": 32,
      "key": "b43aad16bc179e45491fec14239cfda7a5593007df7e45ed9d1eeb77aa629ed6e924d1b6faaaa26b01c6bdaede8101e5e9c21f1967e440ba80eaa2e0f19acef9"
    },
    {
      "line": 135,
      "relation": "association",
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "citation": {
        "type": "PubMed",
        "reference": "6543144",
        "name": "Biochemistry",
        "title": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "volume": "23",
        "pages": "6023-31",
        "date": "1984-12-04",
        "first": "Aamodt EJ",
        "last": "Williams RC Jr",
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ]
      },
      "source": 103,
      "target": 32,
      "key": "045d1bb2e3de3488cb887daec65a07ba0a819c194eea9ea89b3b1e73db247ef65ff854dfe70666ad4db6d5262c280ddcddddc73f1589bde0166fe8c70c98a291"
    },
    {
      "line": 281,
      "relation": "association",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 103,
      "target": 32,
      "key": "b9c91fc23486e12c461e709afc405de6d138ec980f82769024ec675f4a754c35731991ba0d8a2ef52d07f22f6b498eb5917dad835aae1d10b283e20278a96a7a"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 106,
      "key": "d21cccee16a6dc90e21bc3bc9fa29a3540c4a983d9ab495672052b2e2641404851ec4ddd907cd49b983598ddafeff15bb89c6b052ba27fd8c7bf00f7535c7cc4"
    },
    {
      "line": 103,
      "relation": "positiveCorrelation",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "source": 103,
      "target": 31,
      "key": "9457d849e4b1af06f90da6978ee448a94e380c9e96c2f9a0345b14ee1d8bb32214088efe5a248016a4bf8caae436aa14eabde8556181e23710117cc9f768a6b5"
    },
    {
      "line": 104,
      "relation": "positiveCorrelation",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "source": 103,
      "target": 27,
      "key": "db101e4a3c56e10ff4be0258a357afe7e3ed41b8d9927e0cb5f2ba315b477af8364a0caab52b73d852ffe2d1fb754d98c4575448c57d04607502913c621aeefe"
    },
    {
      "line": 119,
      "relation": "directlyIncreases",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 103,
      "target": 24,
      "key": "8feda0777585234d11feceb5cf47e080b8b7b5190804ef040ef36ab81fb4dbb474690c6dc7ae7df101cf3d5f6e16daeba7b63e51fcf84e84b97555c6951eebd3"
    },
    {
      "line": 120,
      "relation": "increases",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 103,
      "target": 40,
      "key": "50fd02e7b846170092ab169373454878c341cec92d5cbf77ae83d3679cbaf228907cdf51d6c6dd430e9f7520d7077d2bdad7b6751b1f4f8b9380efeb6c0d2e75"
    },
    {
      "line": 134,
      "relation": "association",
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "citation": {
        "type": "PubMed",
        "reference": "6543144",
        "name": "Biochemistry",
        "title": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "volume": "23",
        "pages": "6023-31",
        "date": "1984-12-04",
        "first": "Aamodt EJ",
        "last": "Williams RC Jr",
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ]
      },
      "source": 103,
      "target": 33,
      "key": "036545c6b869002856ba51674265034fbd80bef1c04e01e76bfa70cbc02083fbe831b0fa5dc93c2f1b2d6fd3548d1ad7e7721aad2c87b5f3ff1a609ec9dfc67a"
    },
    {
      "line": 144,
      "relation": "association",
      "evidence": "This antibody binds only to tau and localizes along microtubules in axons, somata, dendrites, and astrocytes and on ribosomes (polysomes) without phosphatase pretreatment.",
      "citation": {
        "type": "PubMed",
        "reference": "2446784",
        "name": "Cell motility and the cytoskeleton",
        "title": "Phosphorylation determines two distinct species of Tau in the central nervous system.",
        "volume": "8",
        "pages": "210-26",
        "date": "1987-01-01",
        "first": "Papasozomenos SC",
        "last": "Binder LI",
        "authors": [
          "Binder LI",
          "Papasozomenos SC"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoblotting": true,
          "Immunohistochemistry": true
        }
      },
      "source": 103,
      "target": 29,
      "key": "582cbbbf0a8b0f741cfff3dcea4133de6ecc893e767b30b0a7b9584f0d81a77795d2489177e5de5fd5bf1eba77b04b05f2267a13ec8e7abb3aadf8ccb947f143"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 104,
      "key": "47f3ceb26cfb847c75a77d9613407a563bf96597720c9ff4fefeacab9946cc70ffc9ffb6ffc4b60868bf61d16af119437ffb0a413fcf7011b08261b535c5838c"
    },
    {
      "line": 160,
      "relation": "positiveCorrelation",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 103,
      "target": 53,
      "key": "ae4183dbc5aac4db6669dc5648e62bb18359c755a261254e6b03d5db99e4aad90ee7840e84b150a8ad6997d16e7f6060148b9e32748d6fbd9e3389c1835d538e"
    },
    {
      "line": 172,
      "relation": "association",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true,
          "oligodendrocyte": true
        }
      },
      "source": 103,
      "target": 94,
      "key": "00b21db990a196906a45b4ee77df5082ede79e8f5a7599ae24a980c7e57847e2c0675c0b4d2017ccf0576e3836586bc9fd160af19201d0e94120e124dab297a1"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 108,
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 105,
      "key": "ab8f6b0ee06d70bffa7fdd64d27d5fa88a0b9059669a7d4f6f508d01489ec2ab285bbf9341ad9ed1ee95783450df9ad3d3b19a68fa062bcb913b0ecbb93c91ef"
    },
    {
      "line": 187,
      "relation": "increases",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 103,
      "target": 51,
      "key": "9f87f1ecbe7d28a28464d95075113c664a8fa736f9ed6f2950094b759532a5d195d55640afbdddfe9b38607cd8d6cca4fa4ee6d50754714c16d724d8a7e716f9"
    },
    {
      "line": 190,
      "relation": "association",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 103,
      "target": 20,
      "key": "09f07cd2f4994596a3547a74cbeb0ede6802c9fbbb6c09575bf769f319f4ba0415ae312652cffe219e0ed8e69bdcf0409251a25332ac000790ba4acc814e99a9"
    },
    {
      "line": 202,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 132,
      "key": "c2e16352a3f6bab58d19ecc70c695b1af3e15ca8d1be056ac9d83462d10a74f9f49ff910423767271dbc90d313ac71a68afdaa76a8c5bd31e1bcafdf18979b71"
    },
    {
      "line": 206,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 60,
      "key": "62f6b26374fd532dc9eda03a7371bef3ae01f8798f1e9c9f8d798866b0a61684d0fe6b96f2b617d666eaac11ec51235230d7466325774005b558708f7be7b386"
    },
    {
      "line": 207,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 126,
      "key": "71070f28675be1be78585a4dbbd47c7c17882133ece40b414139d0abd3ade6d3b75155bae030ad6e65ca8c4b10f4adc5b72d6f20c4eb629b21bc7ff0d315c17c"
    },
    {
      "line": 210,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 57,
      "key": "44f63a09a9d199c1f66271c863a864db487bd17515a05e0ce8d02b6ee6252b197984eb13b5b8eedabd895f72da163469ec0c26cb84eb89160a35d373209990af"
    },
    {
      "line": 212,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 96,
      "key": "7e54175d21cdecbdf54fe2a218290177af7549edf71d1d1334c2abbaa341137070b5806578fea2f5ed16d371fbafbbe583d9a417c36a6703c289cccc10100a29"
    },
    {
      "line": 213,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 52,
      "key": "e7076bb5938b37fec3c76dc09f20a4b201b6033267969699f7038829aedca0c02aaeb990aecffae84c3565cc1398098d6005a47ed32e22d6b5808c530a179006"
    },
    {
      "line": 217,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 121,
      "key": "06ad64c1eacc39a664ccdfded4c3f67cd9af8878560cdaeb7c9aa2ef31553b299b9f624bf913e65c41476f4a773f420b265a77168d5d5c02af55436bc2c77e80"
    },
    {
      "line": 220,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 103,
      "target": 56,
      "key": "c7349f1e5c8a3bd0cbec7dc2571fd57dfc2c320d0e74dbac3ff9ed378e4db0044737a367e9f6547eafb21ccada4e1eeaf288ec19a471d41da2d29ee1c97ac9b4"
    },
    {
      "line": 282,
      "relation": "increases",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 103,
      "target": 41,
      "key": "979c7e73636fd8d3bddde1f34f59fec14cb984a77d937a35c613e4f1cd175f47b0b4a3ede16d658834e2b24869ab6456ae094c20ba6e2d1160471a3c48a06bcd"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 118,
      "key": "233175822018f00d5bba682b71d9619e69b1ffcbc798ef965753963c52979fe53377c90e3fec2a692a31e92e3e0183cf12a6286f7e77474e51b0e10554f3d71b"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 110,
      "key": "57f6dfc4cb18d002fb185a5f8ddb26897f5c0e93f59d9f1ee55374a026a04da6c975e40dd70e3f890ef9f9793c8b77bf916ea47533ecfee045a95797915ad8ba"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 115,
      "key": "1db8f17343211693622cb88d2cde2cdb16e928f591973bfefdad7cd961f5833254d55f34dfca66cd04cf34c2ac98ccc894b662b9d10420aa749361cc7d7f8677"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 113,
      "key": "09505215df0db1264915198df6f54ea647eb376b6ede05f22846b2d289a2907fa049769b8eb45a919e706a2eb7c7a96704537753eeb5e7c30a012888cd5296de"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 114,
      "key": "50403cc7ef5ce4172930d644a5740cda8918061439e7d529c0f888ba1b049a77a5339ec7d3482657b832429d9e62714c7fafa0d13366824ad8debfc61eaefc20"
    },
    {
      "line": 422,
      "relation": "isA",
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 103,
      "target": 46,
      "key": "fc6163c1a1f4b32b36a69b25d9bcaadceae0f856fa35dd909114fd603724ba6b6a0b18a119b59feabfa927aa14d31d4e9cb3e7fa2f32f773fe5e97a010741341"
    },
    {
      "line": 427,
      "relation": "positiveCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 103,
      "target": 85,
      "key": "899c61bc9ac280b86a0710b126b6f502a3e1b51b7649bc1a6a82231813c652b9601a7346e659414dfdc0b890c2d5b1be873e465632767d4c782277918991bccf"
    },
    {
      "line": 457,
      "relation": "isA",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 103,
      "target": 48,
      "key": "e447a235064bdf300c71d10cef3d4472e36873a57443cf19335943a156bb3c59896352b373a32c0f8712a154c962c594718ddfe39685aab8d7cf3642a279384d"
    },
    {
      "line": 467,
      "relation": "increases",
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 103,
      "target": 136,
      "key": "0a8ece80cd4111beb7fbc1c85027d2699220abc08c4d553cc45cc753b7c13cf6d54cc20f307cde275b83439fa045fabfdfd5b7e431ed6fe1a763de0a4a5354d1"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 117,
      "key": "43f3a05a562aea7d640aaac845125159fcfbdd06303b001b5cf1eec04af58dabda000353c3cf4551bae1aea91c8b1be6e3f2669e44287e4a25d0655b1d33aab4"
    },
    {
      "line": 530,
      "relation": "negativeCorrelation",
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 103,
      "target": 117,
      "key": "a51a3166dae2e16694ae0594ccde7e823e13988ceab561642f6f81dbe77f9aa71f0794fd7ca258dd3e13dbffc10eee6225a2ed588fd23eaca7f37c266d10133a"
    },
    {
      "line": 588,
      "relation": "isA",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 103,
      "target": 50,
      "key": "9c5e8499717a9bc4240e88162590940a0d50446d57aaff3913b5ae6ce1eadd99d64c3d311632e7820bf84b87ecd3a06941e77c8dcb3c6ebfed206521fe18f73c"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 109,
      "key": "3dd217dbf24e05387967c81e77bc580eae4bb79dbbaa0ec812338e6abafcc6f5c8365a7efe2732b7e571e9e3cec08e53f75be35fb922dff737ec143c8103218b"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 111,
      "key": "7c4dab41f0b789fe1a52f61758835723c3b320276f1f4dd19c15f5910c60497a112c4ec2b291ad3da3ffec9bbc530290dd67b167ac4d3ad55e2338982297e705"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 112,
      "key": "1ea70b1fdc71c02106277625f2caa4a966e913c03fe8ad751981023e6b74cc994370be7baa25ecf05138e10d08c4f2af7320c3a733cae82b6b055734105d1821"
    },
    {
      "line": 644,
      "relation": "negativeCorrelation",
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 Î¼M 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "subject": {
        "modifier": "Degradation"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 103,
      "target": 156,
      "key": "8fb90e59ab23233cc09877c02c764b70ddf4c1d7e15856e80d0082c54fe1bfc1a3846f2d03257ce493de0ee2b51d50dc0ce73f842a50f52e51bafce5e96ebe96"
    },
    {
      "line": 674,
      "relation": "isA",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "source": 103,
      "target": 44,
      "key": "c46620727e4ffb05d165aad06930f0b53a86416f09217231a64349c0801dbf5ca3c8c263725e0cb2d73f123ea86be4c019049ff2a721340243ca398be5cadf5a"
    },
    {
      "line": 677,
      "relation": "negativeCorrelation",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 103,
      "target": 36,
      "key": "8b6f17c3bd037e4bea8705b72e0547ed5a4bdd5c758ba13a66b81cfd0d28e20bfcf737b9f6d2bfeaad2cb1bc7c348546f3fd55f3624dcea7e42f6b3a8d84dfe3"
    },
    {
      "line": 678,
      "relation": "increases",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 103,
      "target": 15,
      "key": "b1eee9f5efe01ecddb4147134b8e08c9ff6172061c477ce9a9c7fdd83c9a115179e880358ab3ef4482217839d9f43285f0424b3185257e8a3512423f9d53e71a"
    },
    {
      "line": 693,
      "relation": "association",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "source": 103,
      "target": 129,
      "key": "e7b133eadd9c5184b34922075443672a76899ab834c34db474e27a47af1df224ac809696b632503f57fedf34c2694eba1e2fc5f90b279d454f725ed4611c8739"
    },
    {
      "line": 696,
      "relation": "isA",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "source": 103,
      "target": 59,
      "key": "01d2cf5826e79f11c3d9d590d0cd5886eb32280cbb851990f45db57c1a29846e8f3c6d88471e2bc52e59246266ff16e662fddc059b7674c608be63271429a009"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 107,
      "key": "9fbd9218812f1cd82827e2d73f3b6af04acbe1f408aaedcdc53c6fc17a36272c67cdcc254874f5473ba4443fa19971fe4877420e735c04f4f7353480d8e1f8b2"
    },
    {
      "line": 764,
      "relation": "association",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 103,
      "target": 135,
      "key": "e1c99703ff732f25b94ccf97a54c286ab216453028d131ce1a10262a0384c1be214c996fc664639429bccc574bf3be4268fd528e4b858f59986927fa583eeb14"
    },
    {
      "line": 767,
      "relation": "isA",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 103,
      "target": 54,
      "key": "ce7c44bdeb0008e1a2b239838fd8ddb9a5c36e183e135aef055fd0b8a231f32401760c681d4169659e5a64c29a76539bcd78a2fa78981562301f809d396f231c"
    },
    {
      "relation": "hasVariant",
      "source": 103,
      "target": 116,
      "key": "5dfb58d8aaec19dca766f910c5daa3183e4e9eada1060622d91815a34356c7e7c82c726922e016bfea5b95401a58e39fdb92eeec41d0717970c206adc5276ab5"
    },
    {
      "line": 809,
      "relation": "association",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 103,
      "target": 84,
      "key": "f318e3aded5af2526e561cb4584d2f82fdfaeb01e09506c80ba0de63ecdffbf127f1750cdbcc58ecd544078fb0f2dbb649af89e8e7b091f597e37ffc614fa55c"
    },
    {
      "line": 812,
      "relation": "isA",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 103,
      "target": 38,
      "key": "3b2d3f746e796e3b3c32984a165744b2afa00940a00c34ab82a06de292e64582860c91189c671a99fce65d1b9b9bdaf9954b1aab5316dda35e25e7ee48f6f489"
    },
    {
      "line": 853,
      "relation": "association",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 103,
      "target": 2,
      "key": "24abd7f6c9f96c377206f97c9b23447c9be59fcfe2c6251d34ca3e9d63afb636202f9beedb1620d9aa0bc1c6d7bf235df5d86d02d2d7afb17917fda41242e277"
    },
    {
      "line": 854,
      "relation": "isA",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 103,
      "target": 37,
      "key": "b85d19417c276a1b5f5ce810a409add8f7654b7e7fe46569def5312e72ec419c47b1d8bcd056dab13fd9f53635b4d50369bcae3f9bb8b2d79d1c24ad88e4985b"
    },
    {
      "line": 858,
      "relation": "negativeCorrelation",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 103,
      "target": 21,
      "key": "7c3f26e4f6cb21e6ddc6ea1a6e122eb40b77ef7bbc0fbaa9f6cf96d735a0927427399c1e8cfe175d7a791ca1cd61bf079754a5d16c508b4016b89fe03dff9b2e"
    },
    {
      "line": 135,
      "relation": "association",
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "citation": {
        "type": "PubMed",
        "reference": "6543144",
        "name": "Biochemistry",
        "title": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "volume": "23",
        "pages": "6023-31",
        "date": "1984-12-04",
        "first": "Aamodt EJ",
        "last": "Williams RC Jr",
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ]
      },
      "source": 32,
      "target": 103,
      "key": "069fc9653dfc601e5233a2fbda643263d37fa34363b340a197c07ae4ef7d8118dcb472b24538c9bdad184a4ca62ba341ff7bcd98e96127f24e495dc06290fa37"
    },
    {
      "line": 281,
      "relation": "association",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 32,
      "target": 103,
      "key": "f0065273d87a042ec6a1f9e6d0289469a75c43fe351b3ba31bfa253b0f7218779824d772871f4c4e9a777e68bad453b7fa928c4d48b5e4280160c26d4b03fb3d"
    },
    {
      "line": 248,
      "relation": "association",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 32,
      "target": 100,
      "key": "00435c747d7fce16a414fcb3f9e0676d46dca3959822dfef148cc5a8da8ee1ac6d8788b2ad819fd025307dc792d9ee0fb6aa5a53e52bb08b8d25bb2effd8b794"
    },
    {
      "line": 273,
      "relation": "positiveCorrelation",
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 32,
      "target": 78,
      "key": "95fb8f60e80fd8fad61988d639a028b41a0e4be84f37380cd5ad6fd36d24b2e409cce54605f6e8c36e5c6a4b53c285ad06a44fa5e3e4039126ce96ac3adae537"
    },
    {
      "line": 278,
      "relation": "association",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 32,
      "target": 127,
      "key": "5d101974e8c33c79528a6fc61e46ce830ffea1564d1a15f847f3bf34545ddc5f2cb677dc62d354d290a52ccc87317da2ee2d0111239bc8aecf3e879addcceabe"
    },
    {
      "line": 286,
      "relation": "directlyDecreases",
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 32,
      "target": 34,
      "key": "68c1984959d6794d870872c1de634097df05b26c1a245aa80ef47a6d81a90466d7f080c4c5a9f7ba0eeebe457e781bd5c716e947132329b40e78fcd81f3938bb"
    },
    {
      "line": 307,
      "relation": "negativeCorrelation",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 32,
      "target": 98,
      "key": "097f9941ed9d58d95214a769c495de87b4039530b124050c99a2403a8a9361b57b089ada9c345fe5df074c526076fe76b573bae7608c06866f3e9bdb93d8b7d3"
    },
    {
      "line": 309,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 32,
      "target": 138,
      "key": "9a8538ee3c65248f9c5efcfc2a92c8eab032989bba89dd3e9fb93515429e3754ae3b06cbdc8aa2d7cd012b7bd663acac75cb30324bfd45394bdca8eecd35ee0e"
    },
    {
      "line": 551,
      "relation": "positiveCorrelation",
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "source": 32,
      "target": 15,
      "key": "dede11a5f8705ad29eedc68b8bd082df5d28178e6a60f8921b48ed901863190663c68200d1ef72219cf3b57fafd580e191f97eb9fde16591eaf4a22d8f4b0464"
    },
    {
      "line": 99,
      "relation": "directlyIncreases",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        },
        "GOCC": {
          "axon cytoplasm": true
        }
      },
      "source": 106,
      "target": 32,
      "key": "393389f7a10453276f1102e04b2f36d9167e1af04fa168066909307e1e3472a90b826638d02906a1d3b0ac3a7bb378f53d6c9abf9f96dbf3a70e60d29f683db8"
    },
    {
      "line": 100,
      "relation": "partOf",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        },
        "GOCC": {
          "axon cytoplasm": true
        }
      },
      "source": 106,
      "target": 103,
      "key": "e6e27132bb241c061eee75b0363a6c23afc1d593e91ca4192153c4e804864479b7ba239111fad2e27136a6278ad87f805b4fbb6e287012207b8c44ed2170b1ce"
    },
    {
      "line": 101,
      "relation": "equivalentTo",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        },
        "GOCC": {
          "axon cytoplasm": true
        }
      },
      "source": 106,
      "target": 9,
      "key": "fad9b4fe6715648e30ea96465d49af942f981bac1edd6add0df0e36b6779acf819e4de8ad90d7daac953d8f5d8852c06baaf5d36491c05b032fc7ec34dceebcc"
    },
    {
      "line": 101,
      "relation": "equivalentTo",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        },
        "GOCC": {
          "axon cytoplasm": true
        }
      },
      "source": 9,
      "target": 106,
      "key": "762de31e34871da10e873c829cb09238e14539cde060e88beea4d41a375ee82960a4ef767bc37d3d8741bd0735d9ecc8861fbdab956eb80ff956caf709a2b879"
    },
    {
      "line": 103,
      "relation": "positiveCorrelation",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "source": 31,
      "target": 103,
      "key": "913fb4e68de4f1aae2407bc3fb18e7a22cd85b61ab1fc7f7d7f8e19d9ecb0715249dc486feb81ee36a69ef4462b423488a876d6f9bd177e8ed6f4291b09451a6"
    },
    {
      "line": 104,
      "relation": "positiveCorrelation",
      "evidence": "Tau protein plays a role in the extension and maintenance of neuronal processes through a direct association with microtubules. It is found in the axonal microtubules of mature neurons (Binder et al ., 1985) and in the axonlike elongated neurite processes synthesized by differentiating neurons in culture. To address this issue, three different tau protein fragments were synthesized in vitro: (a) the tau protein repeat domain (residues 237 to 367); (b) the amino terminal half of tau protein (residues 1-237) ; and (c) the carboxy terminal nonrepeat domain of tau protein (residues 358 to 430). From these results, we conclude the repeat domain contributes most of the binding energy for microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "1918161",
        "name": "The Journal of cell biology",
        "title": "Tau protein binds to microtubules through a flexible array of distributed weak sites.",
        "volume": "115",
        "pages": "717-30",
        "date": "1991-11-01",
        "first": "Butner KA",
        "last": "Kirschner MW",
        "authors": [
          "Butner KA",
          "Kirschner MW"
        ]
      },
      "annotations": {
        "Method": {
          "Microtubule-binding Assay": true
        }
      },
      "source": 27,
      "target": 103,
      "key": "079085eeb75dcb201c2868f1e98ffcb65586ff13f9b2abce1e229a5a7c793c472636429d5d5f803cee09a34217a80b5e43fadadfa16dd1adda9e830c20a996c5"
    },
    {
      "line": 121,
      "relation": "increases",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 24,
      "target": 40,
      "key": "0a9ad16c337aa401b891877c3f504c201c2613abb3d2ce7c59569b77fa774ad219c9cac942cd66f114f74e96da176c0fdf03c7916fecfc15ba6bea71cf17a58a"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 24,
      "key": "9d6c0d2d59d41c1a8c300fdc86af1a09dc46b9c76265d34fd2e0a4173b06df2bd42bb7fb9996dd449d747bc1728b31dd9ba53fee940f32e53a5de03076baa107"
    },
    {
      "relation": "hasComponent",
      "source": 40,
      "target": 103,
      "key": "69b47debe5dc7374414751dbf003562cf3514bd8aac929d30b5cf593141babd6212ee7512d691018d5e7c95d767d0da6f84fb2e00d2dbd8dbcf317461fc48663"
    },
    {
      "line": 123,
      "relation": "positiveCorrelation",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 40,
      "target": 10,
      "key": "4e7c3e0ffe445ecf7a664ff6f7f8e0fb3cb22b7c69b7e25de7523fad0b5101c20728bea65ba981f46643eca7bd19c66df1e9313811ef3723f049c3c2615bd50f"
    },
    {
      "line": 122,
      "relation": "increases",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 76,
      "target": 10,
      "key": "5570ad092cce20fb028b45874b6d914183d2a02108fcc87a716b9d26650d2af53caf1e381bf537cb33d895ced7d175f70188c10493688326b0fcf96790985baf"
    },
    {
      "relation": "hasVariant",
      "source": 74,
      "target": 76,
      "key": "3edbbb41869174ff1484400737423fbba8e27580a1aa8422dfaa2c15497754633f1af7262daef1219f58562fb8202db30e9132c5d998ac67286a615ccdc72c43"
    },
    {
      "relation": "hasVariant",
      "source": 74,
      "target": 75,
      "key": "3a78408fb0fe9e294fe7e8451024809104153037d878e457f185eaee7325e14da159a71d1141a6b5fd37c7fcafd37282d5db36385b605ae32d5d1f7e47232879"
    },
    {
      "line": 123,
      "relation": "positiveCorrelation",
      "evidence": "These results are consistent with previous in vitro studies and indicate that tau induces actin-filament bundling in vitro and F-actin accumulation in vivo, most likely through a direct interaction with F-actin.For genetic analysis, we selected a line of tauV337M-expressing flies that has a moderate rough eye and is a good substrate for genetic modification. Coexpressing an actin transgene (UASâAct5CâEGFP;GMRâ GAL4 driver) markedly enhanced tauV337M-induced toxicity.",
      "citation": {
        "type": "PubMed",
        "reference": "17187063",
        "name": "Nature cell biology",
        "title": "Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.",
        "volume": "9",
        "pages": "139-48",
        "date": "2007-02-01",
        "first": "Fulga TA",
        "last": "Feany MB",
        "authors": [
          "Elson-Schwab I",
          "Feany MB",
          "Fulga TA",
          "Hyman BT",
          "Khurana V",
          "Spires TL",
          "Steinhilb ML"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Transmission electron microscopy (TEM)": true,
          "Immunocytochemistry": true,
          "Confocal Microscopy": true,
          "F-actin depolymerization assay": true,
          "Scanning electron microscopy (SEM)": true,
          "In vitro actin-bundling assay": true
        },
        "Species": {
          "10090": true,
          "7215": true
        }
      },
      "source": 10,
      "target": 40,
      "key": "7a58df9adf9df420ed370f28852817ac59527f7994c5c069550ba5364126585696223e21f5ed9fabfa50855090b15fa998f6612cafadcad3cdeb14adb2f8181d"
    },
    {
      "line": 134,
      "relation": "association",
      "evidence": "The resulting MAP-decorated neurofilaments formed a viscous complex with microtubules, showing that some component of the MAPs mediated the association between the two filamentous organelles.",
      "citation": {
        "type": "PubMed",
        "reference": "6543144",
        "name": "Biochemistry",
        "title": "Microtubule-associated proteins connect microtubules and neurofilaments in vitro.",
        "volume": "23",
        "pages": "6023-31",
        "date": "1984-12-04",
        "first": "Aamodt EJ",
        "last": "Williams RC Jr",
        "authors": [
          "Aamodt EJ",
          "Williams RC Jr"
        ]
      },
      "source": 33,
      "target": 103,
      "key": "6e1a2b687bd6307026b4f88521abfefba94109c76d951622c5f67c784c08fa01b84a23c744ece93d80a37292ad3c50098a75a39485f5a07b1a99c662bd3f7ff6"
    },
    {
      "line": 144,
      "relation": "association",
      "evidence": "This antibody binds only to tau and localizes along microtubules in axons, somata, dendrites, and astrocytes and on ribosomes (polysomes) without phosphatase pretreatment.",
      "citation": {
        "type": "PubMed",
        "reference": "2446784",
        "name": "Cell motility and the cytoskeleton",
        "title": "Phosphorylation determines two distinct species of Tau in the central nervous system.",
        "volume": "8",
        "pages": "210-26",
        "date": "1987-01-01",
        "first": "Papasozomenos SC",
        "last": "Binder LI",
        "authors": [
          "Binder LI",
          "Papasozomenos SC"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoblotting": true,
          "Immunohistochemistry": true
        }
      },
      "source": 29,
      "target": 103,
      "key": "053dfe616748ab9c2b636b6f8ca4c61f3a841b9f64499965812e21fd8d1ef8e4014ddac3ba5295fbc57ab1ce72f8c248eb9709d419a5f6dfcca92f0c2597d5ae"
    },
    {
      "line": 157,
      "relation": "directlyIncreases",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 97,
      "target": 104,
      "key": "b719bb7f013551ccd64150409e67cd70005461d799439f06764d390618db3327f07e3abdbcf5f1f255fb83abbbb0f6f70adfeda8b12b896ddea4ae4cbe810dfc"
    },
    {
      "line": 159,
      "relation": "positiveCorrelation",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 97,
      "target": 53,
      "key": "b55cfad3d17d1c2ce5c81fc55f00dae52c18186a64173e2190a38f726ca72e98546dd051fb071d1e9260ecc1e871ef75c41fdd046a3a3f151c6b219a49cf8ad1"
    },
    {
      "line": 389,
      "relation": "directlyIncreases",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 110,
      "key": "f004b7af61c3d9d8a7e51d1430fe7bd0c87540aa3a377cc2c8ad4d27ab75c61bc1dd1c762e4591c4d1c7c761bc6b5b75304795463b591f9ab0e13875f0807c47"
    },
    {
      "line": 390,
      "relation": "directlyIncreases",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 115,
      "key": "a8c9ea63fcc79d3d15e6184a339fc378bab85833f660044bbcecdf6a3a9b9b450ac658f8f291ad105dc68aa95ccdd504ff6d08cb0328ad98021801ae958a59d6"
    },
    {
      "line": 391,
      "relation": "directlyIncreases",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 113,
      "key": "f728708da34cdf66ea55e0f5e0b084924ad2225a8efbba0a27f58a0e7245ad6886fb6716d7ba2ddc79f05e0bf9a18e906972b695566cbaf9a79a98f4e0ec674c"
    },
    {
      "line": 392,
      "relation": "directlyIncreases",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 114,
      "key": "bda30db0d802c4bb03dc1a4a096dc9e7e77c3042ab0c6aebf7610fb1bec533b2c4c77b1f255c0ee2229e435b434e32f56f7c8827c73e5512802199d5a4ed9411"
    },
    {
      "line": 707,
      "relation": "negativeCorrelation",
      "evidence": "In general, GSK-3Î² phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3Î² activity.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 97,
      "target": 13,
      "key": "13927f8d7a79a8ce5ed353f8ede6eeba4ce24a53484b1d2c9e503d5a2ef9759cdb67e80e69fa01c7e3729469310d46451d24dae428d42f3098e75ff78046e90d"
    },
    {
      "line": 715,
      "relation": "increases",
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3Î² activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to AÎ², and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 97,
      "target": 107,
      "key": "c4d164c1244482d856634287eb1aae835bf2d4a5e0237636d816a9209e88222ad5b19773f4fbc1e001ffbda5b7c41384477948d0b1d555a83372c293db264247"
    },
    {
      "line": 765,
      "relation": "association",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 135,
      "key": "86de2e365c220fa1a61f0e53c192226812b98790f9d0abca43210959736594b60a2aead609cc233717f1f98289b4b78e8641fdf1dcca89c23ab5206245aaff45"
    },
    {
      "line": 766,
      "relation": "isA",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 97,
      "target": 54,
      "key": "0d4dd3836298b089631eba18394e8d15d5ec19f3e32be0c9732b3dae1cc21a4da871d2c7f057facb163a7a9141f19f77a392121f45c3e64993e888e646520e0a"
    },
    {
      "line": 776,
      "relation": "increases",
      "evidence": "In cells that were co-transfected with fixed amounts of FLAG-tau and HA-GSK3Beta but different amounts of Xpress-14-3-3zeta, FLAG-tau phosphorylation increased progressively with the increase in the amount of Xpress-14-3-3zeta (lanes 7â9). This increase was evident not only by an increased immunoreactivity against all tau phosphorylation-sensitive antibodies tested but also by a retarded mobility of FLAG-tau on the SDS gel, a characteristic feature of hyperphosphorylated tau (2, 3). Thus, 14-3-3zeta profoundly stimulated GSK3Beta-catalyzed tau phosphorylation in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 97,
      "target": 108,
      "key": "f666629f81f1dda4951393102291dd016edb42b8ced34480c283bd7df656f72495e7cea6523405101ed63f77f5e0c07f3fa4c26294902c1d527ac89866461fb5"
    },
    {
      "line": 158,
      "relation": "partOf",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 104,
      "target": 103,
      "key": "bcd368c6db41760b03ea927009fc6d4b7498c7e1db4a0569f8d14cd87411379cac259e2f98fcbef708cabf3e203eba86733d0936013e4878a8562afa43f28cd7"
    },
    {
      "relation": "hasComponent",
      "source": 53,
      "target": 97,
      "key": "995c30a34106e1d20eb5fad8c15154fc7e0104c66ecc953c3f3308fdd670d21e28aff4f91bc2744e126fb856f3be4f71ded5dee1ef91d13b8a2638ee2b2ce954"
    },
    {
      "line": 159,
      "relation": "positiveCorrelation",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 53,
      "target": 97,
      "key": "049fbdaa40f0eee1b1848d4b87c31eff7c9d82fa118ee4a48170b8dd8b310183df289895181645ed9b2be557b0ed39e7daacd764aa733194a7fd1b6fde498a0e"
    },
    {
      "relation": "hasComponent",
      "source": 53,
      "target": 103,
      "key": "bca667d1ddd894a64e5dbb97758510ee46e847ce1d38ebe8775c58c58f53c34c8948d0347a9759097846836a0fe8ad62dfaa9e73359c93fb188eb7822b968591"
    },
    {
      "line": 160,
      "relation": "positiveCorrelation",
      "evidence": "GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1â244) containing the N-terminal projection domain, R-tau-(245â369) containing the microtubule-binding region, and R-tau-(245â441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1â244) (Fig. 5C) but not R-tau-(245â369) (Fig. 5D) and R-tau-(245â441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "11812770",
        "name": "The Journal of biological chemistry",
        "title": "Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.",
        "volume": "277",
        "pages": "11933-40",
        "date": "2002-04-05",
        "first": "Sun W",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Neufield KD",
          "Paudel HK",
          "Qureshi HY",
          "Sobue K",
          "Sun W"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Immunoaffinity Chromatography": true,
          "Microtubule Sedimentation Assay": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay": true
        }
      },
      "source": 53,
      "target": 103,
      "key": "e0db5e7039e97b5d05b5294e1f26cb2bf014082b47ffa9eb43a8a29f640fc5e03227d47b139ccd4824c911d83622377116c3a7bb5b1cb48d14bf802907845cde"
    },
    {
      "line": 172,
      "relation": "association",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true,
          "oligodendrocyte": true
        }
      },
      "source": 94,
      "target": 103,
      "key": "64d7c51640470e0c00f5bd2c5da036a423b3b50f63c08d79e1e03de0db8439f0670427d46e24b2e24e219dd9d759649e45d3b384c808e10f7d1e80433236427b"
    },
    {
      "line": 174,
      "relation": "increases",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 94,
      "target": 108,
      "key": "a9d9712bf31a3a685380bca34acd0ba34a11825ccd662ae1f4866c278c044b20858545ab6b08dbab6f621e84a121e4f7ae0be077c9a4885af27e00acef562dbf"
    },
    {
      "line": 175,
      "relation": "association",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 94,
      "target": 105,
      "key": "0ae3c26720375e4fd81ee8cbd6d58449d754f26ea61f1e4b2ac94b06ba8437e43fd51c7e201a4ff39b7fba480ba9848aff1efc5a8dc57818c9e6b3a26583fa32"
    },
    {
      "line": 188,
      "relation": "increases",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 94,
      "target": 51,
      "key": "5f9dc804794de2d9c17540f077ea205f6c231f63ccdb739a5d57a40add47001a91072cf2368f153569c6e05482ab5eb60f84dba373277219628cd8e6f772b9b3"
    },
    {
      "line": 227,
      "relation": "decreases",
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 108,
      "target": 60,
      "key": "3642081a9299f906f547588b05ffaaf73f3894c8ee842ee64c05c39260d1569f23ef529d0294e084ec40e9479056bed41c96585f7333aa9760e529f58224693c"
    },
    {
      "line": 228,
      "relation": "decreases",
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 108,
      "target": 57,
      "key": "4446dd7183a4a840f8606c6a7f7b2e0c4e078faff3a369840eab6b2017224cb3a95ac3c3d6728c75668f88d956ed842d33d267b9916306bbfecc53dfa7e2b9fa"
    },
    {
      "line": 229,
      "relation": "decreases",
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 108,
      "target": 52,
      "key": "d6e4bdf85f0c9af4988290f35e4ee2ca50675ed7ab6644f6b734387e78bbae5d9cb3cbf5934234fb248ff534852b9f03be5da5bb5e2f14a3d4f0705befc1a1d5"
    },
    {
      "line": 230,
      "relation": "decreases",
      "evidence": "The binding of all four SH3 domains tested (from Fyn, p85alpha, PLCgamma1, and the N-terminal SH3 of Grb2) was considerably decreased by phosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 108,
      "target": 56,
      "key": "107afda12ddc6b8f6012aae244e6b166af04b1c6c488cca6550f29c797e129d554a1936b01d34c73b64d2a7241de342af88f6c4897d73e4fd6f7fb7f18bd4b91"
    },
    {
      "line": 288,
      "relation": "negativeCorrelation",
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 108,
      "target": 158,
      "key": "3912e3e00c19cbdf11147fe1106e6ca921aae21478de1e4a8be078e4b61c03ce67a8de7b1be895fbaed2c6a9c0a88efe75475277391600394f7f459b37f07a4f"
    },
    {
      "line": 331,
      "relation": "positiveCorrelation",
      "evidence": "To test the effect of Hsp90 on tau phosphorylation, this protein was mixed with tau protein in the presence of GSK-3 and ATP. Figure 4 shows that tau phosphorylation increases in the presence of increased added amounts of Hsp90.",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 108,
      "target": 156,
      "key": "1dd853c4405b54cfdee2ca0462395323ff6c4a98b288a1575a34d485e4999564b0ead9370ddbf04eadc41ef86ec56e964f82e58f8a68fcdd10d149d5bf531670"
    },
    {
      "line": 354,
      "relation": "association",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 108,
      "target": 99,
      "key": "dbc23d108fd42ae2ef028d73a504694b255ae53315f5728af51f40b35a90a229b2b6a93036099e18fbd2611ce67834c8da65e85f9429775ff7fd1b07ee1532c5"
    },
    {
      "line": 357,
      "relation": "increases",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 108,
      "target": 55,
      "key": "fdf26b659e4e2008b27fd7fd933ce17109240bb705178be2145807eaee23689bc5369d1c2a43f2caa67d1c6bf89f8dba701158b0425002ff9a4419c390953a04"
    },
    {
      "line": 364,
      "relation": "increases",
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 108,
      "target": 17,
      "key": "f8e8a84ea3a5dff06e5996e9ac186a328c27e76277a8eb90e93d36f676e766f2ccda59721b1410d468f1b0371d3d68e6dfc185c48c38d26c2d6271feec68acf6"
    },
    {
      "line": 397,
      "relation": "positiveCorrelation",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 108,
      "target": 118,
      "key": "0ffd727ad2e79fe29e83feb86da3bcea5851aa538662ae0b2276f3e2137f7705dfd93648baad121743b72e0d9863a51741d88242a7c0abc8b47071c47d92b1f8"
    },
    {
      "line": 406,
      "relation": "isA",
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 108,
      "target": 62,
      "key": "601886b931e39a3e5a21005e4e2d1fc39a0e05b0eb7e8e0617ec967f5d0a10975822148100e5ed7d529ce6c22367a86c7aa1d3f8ad11823ead23cb0b1dbf2349"
    },
    {
      "line": 432,
      "relation": "negativeCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 108,
      "target": 85,
      "key": "aac5bc1f26827da492c090fa5df74e0dbc7dbc0250584680f3055bd8f0e8c42b804d07f0cf45c2610919c7e725040f731c662e05b2add9998ad26f769eca5220"
    },
    {
      "line": 175,
      "relation": "association",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 105,
      "target": 94,
      "key": "7bbc4a3e9817f4c47dd3b3f9aae0a14db2b54bf683109459c040ff13cc574c2c041852857bbc0cad1ee45944a16b6981614955db9a799e7db835b3c5039b80cb"
    },
    {
      "line": 176,
      "relation": "partOf",
      "evidence": "Furthermore, Tau binds Fyn both in neuronal and oligodendroglial cells (Brandt et al. 1995; Klein et al.2002), and Fyn phosphorylates Tau in neuronal cells (Lee et al. 2004). The main Fyn SH3 domain-binding PXXP motif (Pro, Lys, Ser, Pro) in adult rat Tau is at the residues 223-226 (Kosik et al. 1989; Lee et al. 1998).",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 105,
      "target": 103,
      "key": "715af4e6c23f09802e2b10a1b2c31c316c64e9898ba59f8128529a3ddbb7bf12da9b7365046c75d01ae424721659fa58dbb49857c1aa412e0b7a6d9044550c5c"
    },
    {
      "relation": "hasComponent",
      "source": 51,
      "target": 94,
      "key": "7f668e1b51e9b64c5b2f3654ecdd28fac8a76b632d5b6f80763e634b00cb79e44b000739415a7839213acb5eaf8b4135f93539a124c1414799a6f2ef4963e386"
    },
    {
      "relation": "hasComponent",
      "source": 51,
      "target": 103,
      "key": "da4d257ec5a50caea49561402b69b05d0f89ffc71d57b82de018494c7e3a748ea46d0c95ecdd5cde14992dd522e4f96d534de6a16ee87691457f52bdeb57bded"
    },
    {
      "line": 189,
      "relation": "positiveCorrelation",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 51,
      "target": 20,
      "key": "ce49aa4344f6c5baa528e668fa2061f8ec1115d9d4802f341d0d86b08984f97b48e776ed929c0974113f4c36ea956f003d61983f34df6f9c217eac01a8ab60fc"
    },
    {
      "line": 189,
      "relation": "positiveCorrelation",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 20,
      "target": 51,
      "key": "dcd2bc4fc21f723c2f273d5811a34739075b42483e948b6ab4cc836ceeb80ec7940b37da9a79d246795f8f3b235e536c89bc052b4a5da050901e2ba4ea654138"
    },
    {
      "line": 190,
      "relation": "association",
      "evidence": "Here we demonstrate that the Tau-Fyn interaction has a role in developmental myelination. CG-4 cells were stably transfected with control and experimental truncated Tau and transplanted in the brain and spinal cord of the md rats. In the brain, experimental cells have a severe defect in their ability to extend cellular processes and form myelin; in the spinal cord the cells extend cellular processes but the extent of myelination rostral and caudal to the injection site was decreased compared to control. Cultured experimental cells display shorter cellular process length. In addition experimental cells have Fyn largely in the cell body, whereas control cells distribute Fyn both in the cell body and the processes. Taken together these results demonstrate a direct effect of Tau in OLGs in in vivo myelination.",
      "citation": {
        "type": "PubMed",
        "reference": "18680553",
        "name": "Journal of neurochemistry",
        "title": "Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line.",
        "volume": "107",
        "pages": "351-60",
        "date": "2008-10-01",
        "first": "Belkadi A",
        "last": "LoPresti P",
        "authors": [
          "Belkadi A",
          "LoPresti P"
        ]
      },
      "annotations": {
        "Method": {
          "Confocal Microscopy": true,
          "Immunohistochemistry": true,
          "Imunofluorescence": true
        },
        "Cell_Line": {
          "CG-4": true
        },
        "Cell": {
          "oligodendrocyte": true
        }
      },
      "source": 20,
      "target": 103,
      "key": "cce74e42ec3ae9121c0969646a9730adbe10f581d08c29454d707187b5ecf7446f5e5edb009b2291f6eba05e23abdfdfddaad9900c51c46ee3ae9afdc7daf5aa"
    },
    {
      "line": 202,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 132,
      "target": 103,
      "key": "a775c5dff4548dff290c22bfe981c13c40058083dd28c0d5af878d82978ba0bcb5a180d444da51b4cefe4958a731c68f8c99aa5d9f8d6f47e11c85240bf46d42"
    },
    {
      "line": 203,
      "relation": "partOf",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 132,
      "target": 131,
      "key": "434a55d3b83c1b167758066d1238f72537ea146bf9e3dfe9a7c640e9db501485c6d8cebd55af6f8ce3e06609cdb0bb27473844d385e19dbd77c508b55d262731"
    },
    {
      "line": 204,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 132,
      "target": 142,
      "key": "3331a5cb3218171f6c4d019dbecbe1f930c758e4b30c253297122f9b173c3bb12b3507b65ba09a1c22c9ac13d6d292b0ba9b3760e8426babcbf88bd9acbfd09c"
    },
    {
      "relation": "hasVariant",
      "source": 131,
      "target": 132,
      "key": "6b4d5acb882994b47fb78d5a8873c4d47169521a1fa41f57e9d36ccc8f526adb705869d49c2c40a2a9d33e4737d608583d3975c6a8a1cb4164b2595e280c0619"
    },
    {
      "line": 205,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 131,
      "target": 60,
      "key": "9baad772e831c0e207ac0b3c94d3b6f56452a1e1029393cce6ab4d3ca49016911ff5be6770082dc714c06724966b7561c772f726481af5365393ca14332746a3"
    },
    {
      "line": 204,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 142,
      "target": 132,
      "key": "9cb0478777b40af852f53bc568638f482a5aac45154aa0697153d25a86cb57acf5c491469e396a0535e6fcb557f94335cac0f9bc6eacc839137803779f0a4950"
    },
    {
      "line": 209,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 142,
      "target": 126,
      "key": "e4bcda112b7c1664e430272cf27ccd94fb36efab03eb9df4c073d0a2f18380f06c12b5879239b8bf96adaa382fdd9cb0f95bcff46b95d4b7d6830a929541325b"
    },
    {
      "relation": "hasComponent",
      "source": 60,
      "target": 103,
      "key": "54b679f6dd7cf13fade50382870e7bf73e45facb6b6c7a9bd45e5ef763aece13f059866266a90b71555544e76e5ac1730671f1970f94308e2f02093d156d2adf"
    },
    {
      "relation": "hasComponent",
      "source": 60,
      "target": 131,
      "key": "a8612ff43df717e9e19f7b8d61614c01ed7cd29f534f4b15fcf330577ca9a508685ce0fa2965b969b2ec9a6e594e1972c1f92d5c22bc4da4de55999efe753b94"
    },
    {
      "line": 207,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 126,
      "target": 103,
      "key": "558ea344bc16b979eb084910030007c4bed4686ed60d5653ac9d83ad33f90feaa6fa6b38283d709e4b17993ed3091f962a13c681dd8bfe188cb62996844d4268"
    },
    {
      "line": 208,
      "relation": "partOf",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 126,
      "target": 125,
      "key": "38aad73e23f003d6c11d96cea9410a033e43d393d3b233d8f8a9a1d08f440993f996827932e9154901a2006d90b4fc21a5815f0afc3355839d6eee4c384df8af"
    },
    {
      "line": 209,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 126,
      "target": 142,
      "key": "25da0e824b6d7df432f8ae81b9270be3484e9316703c76f60433dc15c764076c91da8debfaf324f9ebda2308d035a053196f644ebc7f477a34e34002c695fd9d"
    },
    {
      "relation": "hasVariant",
      "source": 125,
      "target": 126,
      "key": "bf89c776836a768ebccd6182bc9a400a58197cd405fdf60d6e48dc93ab5116050c3c8cdbcb87d1dfe2d5f84bca612237d616831c6b67da3a1c05a5a568ea720e"
    },
    {
      "line": 211,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 125,
      "target": 57,
      "key": "07c29a185f6a37a344d9c888bd2074fc8462b09d07bb144568094dcc94ebad7dac0021aecd06de1b33b5adea5c77b1d72c34dabd4855b1406685adfbafcde896"
    },
    {
      "relation": "hasComponent",
      "source": 57,
      "target": 103,
      "key": "a07578ea5a63871634c2d90ceaf0e580b2611ee846fe7820046f5278728c86161c0b461268addf2af3a0711c153f508272a13d6ae7b4339e26924b9ede8074eb"
    },
    {
      "relation": "hasComponent",
      "source": 57,
      "target": 125,
      "key": "8976b2bf2b64d3f017c5d385eb23ee5b9f20d192d6f6e5c02d21a860fbf1266adf13ba8ebdaf28d1395e8ef6387e178abfc44440585ef7bf7da9e0f1f029dae5"
    },
    {
      "line": 212,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 96,
      "target": 103,
      "key": "abadee755926fb05dc10c48e76dfb0d56a748ff442f5ae362e38697e5d658ee6b129656f43f237b5f7f3f011b533c61e70cdf0a76dae50781c0807d1b8ec400a"
    },
    {
      "line": 214,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 96,
      "target": 52,
      "key": "15a5d50e18dc12aabe626d56471d2886d91adc9c03db5a7f0597636626fe54dc5da52045fce189c5255f34df4fb95cdf418bf2c50539bc81c4d8e0a91228182f"
    },
    {
      "line": 215,
      "relation": "partOf",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 96,
      "target": 95,
      "key": "23fc4e212d5b10be7d9dfdd6c98412bde90ceabfead5b17613549fdef200ede946324d3a92be0c566f756e7f35a44af070c9282992c152f8938d199ee6325a3c"
    },
    {
      "line": 216,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 96,
      "target": 137,
      "key": "41677b53b665223f8bd5fe5dda655ad3262f7e50eb84c83e7c0e55e2f49b9f0affd618bce826cf5cdeb02772ac5317574580511999f25dfd8cae8be103b6f699"
    },
    {
      "relation": "hasVariant",
      "source": 95,
      "target": 96,
      "key": "eeec4edebc4cf544334ca346225b9f940b7334f790ba045bc1bb8298e81e51dac9e50bb0933ded40840c02711e12d433d308ee5242f68398a490937353ab919f"
    },
    {
      "relation": "hasComponent",
      "source": 52,
      "target": 95,
      "key": "4e5fbf0b2ab1c9f10b5971cf47fce3dab694bf1197af20d4801a359b3ac5d51d36f8625737b78bcfbd2e8f0c0c575aa74bead6d8d9f96dbea8011184fb1e4bf8"
    },
    {
      "relation": "hasComponent",
      "source": 52,
      "target": 103,
      "key": "1b0670d84603f3f8a1fd1189be91df022fafed48b359f230b449dd5c35f3ba309cbe70517c001c619ef9d56a3029ffe386d2db5dd56318b856b3b5d81809f6f4"
    },
    {
      "line": 213,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 52,
      "target": 103,
      "key": "3c5c44778993f42d355f53455266c641df438f70c8640ad29dc19ef7c6b19b2950ede74f4f4e4aab06b5117f77a45d083971f8a6706229d82c32c133afe1b7fc"
    },
    {
      "line": 216,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 137,
      "target": 96,
      "key": "733ebca2951c6ea3f477dcb9e2795b8b65c5dbdab0ace3f61ec43207af154b179ed1cbcc176de47f22bca05a016f4526550e2d4d2489710c141b1f7bf388e669"
    },
    {
      "line": 219,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 137,
      "target": 121,
      "key": "119a756eb7a24566bd321fc2ec92df42c6a62e7ba06629bbaef6c5ac7615ce7e7bf7e216e4d07bb449b3e1128371d643a35cee19a2606b6af8cc30a5d3e379fa"
    },
    {
      "line": 217,
      "relation": "association",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 121,
      "target": 103,
      "key": "0b571cfe7a5df9a055500456df59784b8ca3175e9776fc66c46a06c9a0b3911274dea4db2a49ddd62647c271f3c74a7118d9906e9f2aa6cf709102ffd1b503de"
    },
    {
      "line": 218,
      "relation": "partOf",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 121,
      "target": 120,
      "key": "d6c1da6b69de97f679d4defd19406843df45e895fdc5d26b987b765739c00e2c919d8adf2345c4c56b693ca2614ee9e6350bb09679f9d7764bf6a1ab877bf22c"
    },
    {
      "line": 219,
      "relation": "equivalentTo",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 121,
      "target": 137,
      "key": "91e0e8de7ccf13578e099f286733d715cea3ff7730134380eafec259cb52f35087cb86dc967e999a47eb3333804efd6abf180c89f5e15a317c50f4e7e0813895"
    },
    {
      "relation": "hasVariant",
      "source": 120,
      "target": 121,
      "key": "889a44bc30a7381fcc213d5d282dd51940511f069661e4bd6f71ac6e9d807c30cbd9508c6ec1eaa00df8285fccdbfc9f6d9432700afa9a4ea9e0c5e11c336ac9"
    },
    {
      "line": 221,
      "relation": "isA",
      "evidence": "As shown in Fig. 2A, tau co-sedimented with SH3 domains of cSrc, PLCgamma1, the N-terminal SH3 domain of Grb2, and most effectively with the p85alpha regulatory subunit of phosphatidylinositol 3-kinase.",
      "citation": {
        "type": "PubMed",
        "reference": "18467332",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.",
        "volume": "283",
        "pages": "18177-86",
        "date": "2008-06-27",
        "first": "Reynolds CH",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Garwood CJ",
          "Hanger DP",
          "Kellie S",
          "Perera T",
          "Price C",
          "Reynolds CH",
          "Sheppard PW",
          "Varndell IM",
          "Wray S",
          "Yang A",
          "Zvelebil M"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Pull-down assay, GST": true,
          "Chromatography": true,
          "Western Blot": true,
          "Immunofluorescence Imaging": true
        }
      },
      "source": 120,
      "target": 56,
      "key": "6c0387f77fca1fdcd958d1113a7c6e43236e0c5d28ed304d26b5b1c77e278bce7803dc3fd9ac554c8d3f399bbfa6a36b6fe1b0101987b863de52b40ac0c8d212"
    },
    {
      "relation": "hasComponent",
      "source": 56,
      "target": 103,
      "key": "b13b0626ceabc4ffe087423087701bd5965c83875eb64d358bb5f0f326a49796469376e062316c627a59e26520230f53802f0b2b0f92b75e5e2b91ddc0a08d79"
    },
    {
      "relation": "hasComponent",
      "source": 56,
      "target": 120,
      "key": "5bc810164071c68c8a17ecbb6c78725247240c80965a5337d54e4ae0ae5d8466e80278eee5824f0da3f74feba776aa6228ef895bc38a4b98f278588c45f04ef3"
    },
    {
      "line": 242,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 102,
      "target": 25,
      "key": "0c3bd6325c9c38de758c630aaf0f5a96bc69bd4e2b0b0d2aa5b4bab0158eebd06c0c807cd6ddad5dafd03b4d531d0b31f075a3c8a3212735a55368a683aa3473"
    },
    {
      "line": 247,
      "relation": "isA",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 102,
      "target": 25,
      "key": "f0dcaaac976698cc939eeb981fb4e59ee9327349aa048410ef55aa2cc866102745edba8dbee3b906290f805c1d6373e0f5bb7a1a0244588b4d71fbbd4544bf19"
    },
    {
      "line": 245,
      "relation": "association",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 102,
      "target": 101,
      "key": "e7bc7ec09920686c622d323144dbdcb323496124554ca5dc0ff40d9731fbd7bfd58bd1a908f5cc760703e9c0b9cdbf8fad7088ba2d01829de8cb2b864b7247fd"
    },
    {
      "line": 242,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 25,
      "target": 102,
      "key": "5ee9bc18a9bc55afeb854ea14c2d6cc9a4ecf371e776bd0447df2b3268467a22d9a850f3e5b752a90c631a984ff99c7a2a485e000d566098f1a8ac7ece500bf2"
    },
    {
      "line": 243,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 25,
      "target": 101,
      "key": "54a74ead5e1d50127d75dd5ae8e1399b9cede5ef5ba782ed95eeb32c08aaf30ec8c87c28bdb4ec791d323e31103f1dfe500468ecf5fdf6a882d46cb9374ce228"
    },
    {
      "line": 249,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 25,
      "target": 19,
      "key": "17bad54fad8425c64760721aea370732d29ea83c1a8d5fcabde533ff304408f6533339528da323ecfc5c20258b51fc30c466b6c29d7aecb84dcaee3ff00899fb"
    },
    {
      "line": 243,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 101,
      "target": 25,
      "key": "b004139af84ab713f0bae11d252c801b945f3a12ec5b5da65d3f9505e75647d4f5a771641ef8d5b91300e9a907196a7c24be0907f9361b22aa767e07a4a9a609"
    },
    {
      "line": 244,
      "relation": "isA",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 101,
      "target": 25,
      "key": "d189eba6af0a093a319a04693668d2185a0dcb9b7782d1d55ab25e95f8d4b724aeffaabb5dd53dc8bd55894ef2e419d71c1fddf05973867e7bc79d0e5c881b11"
    },
    {
      "line": 245,
      "relation": "association",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 101,
      "target": 102,
      "key": "9103eb3f22699e19728919fd8f1100d4d47330f56da8af777c6ec07fcc9478bf64b8979c5f8431499fa7c82372ba55f58f0ae01775994237543504d03e9a983a"
    },
    {
      "line": 246,
      "relation": "isA",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 100,
      "target": 25,
      "key": "1f01150712dd8513b0527a2220565127aa1143d5053ca8af8fb4f8524a87644ef9b4a8b2be5ec1814b06d2aace5e37215e0f2292afe8c1cd83bebf73de1a5929"
    },
    {
      "line": 248,
      "relation": "association",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "source": 100,
      "target": 32,
      "key": "2778ddb48e57635b75a2eca04b1b6c4b3a9509ee9f1698ed27d07c434512dabbd73f75d4c81d67c59d2ab482221ec1e96de5a450f73ed210a3918595d1c41cc0"
    },
    {
      "line": 249,
      "relation": "positiveCorrelation",
      "evidence": "These include the scaffold protein JNK interacting protein (JIP) that is involved in the linkage of cargos to the kinesin-I motor complex via KLC (25, 28â33).This complex is formed by the kinesin heavy chain (KIF5; previously termed KHC), which interacts with microtubules, and kinesin light chain (KLC), which mediates cargo linkage. In addition, scaffolding proteins are involved such as the JIP1 that binds to KLC (21).",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 19,
      "target": 25,
      "key": "c4433765e27daf7ab45e8328c7adfc676f535b81b1d53c830832cfe2f4ee2fe18a5fd246f0c2767f8185fc4f89300b0129453cc703f19217936a4ea93315af9d"
    },
    {
      "line": 257,
      "relation": "association",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "source": 148,
      "target": 146,
      "key": "2e6b8c9b694f603328985367d2691de49601a7e30726e8bb5b6150aa6411938bccb5c04ca6226da2a83dce3428c134e5e8ea6e5724a188a314ada3e39c9cdfb1"
    },
    {
      "line": 258,
      "relation": "negativeCorrelation",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 148,
      "target": 146,
      "key": "e0e5e63a192351e997067b42259f70d3842585bf0c9f275b1c9e214e41d1608a59271e1cd3d61a3fc8f507ff9b8056c15c6108bcb68f2bfd7056e9f3b05243a9"
    },
    {
      "line": 259,
      "relation": "negativeCorrelation",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 148,
      "target": 145,
      "key": "54aaaa98ab07d37386a9327f89607d5743f95f1b4863c76e67b433658e0709c8afc7420c9a547823367ca3df38588ef99ba29dda1357a264f69c45f1a80ca693"
    },
    {
      "relation": "hasVariant",
      "source": 147,
      "target": 148,
      "key": "2c2ea9b1bf222f9bdc74a04eea4aea1ce45cab18586adb11e8c9889ab3c25edcd3db437e123224f5555bba399383b0c940ffbabee03881d8e5f45b8c2605a862"
    },
    {
      "line": 832,
      "relation": "negativeCorrelation",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "GOCC": {
          "membrane raft": true
        }
      },
      "source": 147,
      "target": 0,
      "key": "0a39004ef6c0e746c8d627d93f6bee42d31a9439c921b2bbd0b0d8701eda0653a47304304c142d9836fc8029124dace42fc6285427302a119c49e4492357a57e"
    },
    {
      "line": 257,
      "relation": "association",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "source": 146,
      "target": 148,
      "key": "8dddd43ac22aa24a588493ec15dbfecf7b232911312f7491092d725adea36cc06fc47438d69f5d5f040e797215e61f7aaf4800bae5bb4451f3c7a2f6824868ea"
    },
    {
      "line": 258,
      "relation": "negativeCorrelation",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 146,
      "target": 148,
      "key": "d57e9e5dedadfd789ecb657e2175ecafd92984760db6badf9ff25078c061136e7ae3b1ae1148768fa7dd5e69f1c3285fdfa8775eb427d78ef045094736fcac18"
    },
    {
      "line": 259,
      "relation": "negativeCorrelation",
      "evidence": "Thus, the lack of kinesin/JIP1 interaction occurs together with an aberrant Tau/JIP1 interaction in K3 brains.Taken together, our data reveal that hyperphosphorylated Tau competes with KLC for the interaction with JIP1.",
      "citation": {
        "type": "PubMed",
        "reference": "19491104",
        "name": "The Journal of biological chemistry",
        "title": "Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.",
        "volume": "284",
        "pages": "20909-16",
        "date": "2009-07-31",
        "first": "Ittner LM",
        "last": "GÃ¶tz J",
        "authors": [
          "GÃ¶tz J",
          "Ittner LM",
          "Ke YD"
        ]
      },
      "annotations": {
        "Method": {
          "Pull-down assay, His-tagged": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MouseStrain": {
          "K3 model with hyperphoshorylated tau resembling FTD": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 145,
      "target": 148,
      "key": "b6080282896efcb9d336625b4fb5eb2444c6a0078240da1d619bec5215438367472dd3e035169786cf1292676ee7404ac84b08b6d804ccb689d9caf873d6a4ad"
    },
    {
      "line": 271,
      "relation": "association",
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 34,
      "target": 78,
      "key": "ea35a221fd21e6211a911d148a86257c548ef57d95b59452b9e0762021b42bea4d5dc2a05d816c12f3e96483595136c839e663ea529b101729f1726304104efa"
    },
    {
      "line": 287,
      "relation": "increases",
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 34,
      "target": 158,
      "key": "1bbba8cd926212cb2d12393d209e80ad9b9ac9b6615bc9a16405dee73505f8a91a43650939de4603200b356bc6d7d2bf5780b061888db5456b03643cb2f59509"
    },
    {
      "line": 271,
      "relation": "association",
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 78,
      "target": 34,
      "key": "18fc0ea8fe94b53a152177d74ef83371a4919b83d954444dd907dcc534cd916de937d702327e13ad16b819f69522dcfaaa685c4acd95d5a3afb5a376a108afb1"
    },
    {
      "line": 272,
      "relation": "isA",
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 78,
      "target": 103,
      "key": "a6993cfe75e51d41a7045b71b298621195a6a7ec50af21bbcf790809889600f78f51ee3d8c4f9c41c5da43a21602781cf5d5c5d9f93d64a309dd9cfe64a74d3f"
    },
    {
      "line": 273,
      "relation": "positiveCorrelation",
      "evidence": "Using tau deletion mutants, we found that ABaC binds a domain on tau that is indistinguishable from its MT-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 78,
      "target": 32,
      "key": "785fdacace52ae875c9858d37cff5cdf67518b8d80196a822835378628d85d06eec564f3e359d5df4864341ba7ba2202db2a692e14af75d39e0f842638467497"
    },
    {
      "line": 305,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 78,
      "target": 98,
      "key": "4ec5ff5c84b599413a1fb98e59a4afbb596800e6702ec52190a7db16fe2cdacccfa6ccbce8438e1cd1ca44e82c3ed875ce93d40030b92576310103fec8e020fd"
    },
    {
      "line": 310,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 78,
      "target": 139,
      "key": "d403e171bde51cf6622dcb752b77768a9bca494ce0736c5ddd28d6cd5fef231c7c23a2539665c5cae9842c73340afeee6ca0b2fbf3445f6681ed08fff1471ff6"
    },
    {
      "line": 444,
      "relation": "association",
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "SDS-PAGE": true,
          "Immunoblotting": true,
          "RP HPLC": true
        }
      },
      "source": 78,
      "target": 73,
      "key": "a5f7a8b7445300b6c41973610288e9ca911f4e4a0f385f6106ea9a21a27a88c46b9c57e2d8d61f145ea78a62b417b439166027658d650bd822c0750bd497567c"
    },
    {
      "line": 278,
      "relation": "association",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 127,
      "target": 32,
      "key": "5702f33e4128f28b5ab98f3dcab7cb4ae7f3b03a6be4c82558595b70e74123264e139cb0a93ba89465189cc9df65af737d075f12ccf09f5259b5e723c87ffcc8"
    },
    {
      "line": 279,
      "relation": "increases",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 127,
      "target": 42,
      "key": "8c84cf279be19ebda27cc6919f4239bc2528e39849ad77fb408920275013ff71ffa53ed3c1cb09df33bde60e92182e4bedccc6126b26a559b433e80f0466f69f"
    },
    {
      "line": 280,
      "relation": "isA",
      "evidence": "ABaC binds directly to MTs through a site that encompasses its catalytic subunit and is distinct from its binding site for tau, and ABaC and tau bind to different domains on MTs.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 127,
      "target": 34,
      "key": "209e86be794a0f63ad1af8bf7c96f8ac3ff6839381734a92cfd42ad107840cb091bec39cefdffb25f48eaca0b566ffe3284b7c5dda9420eaf77a16989d65623a"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 32,
      "key": "c7bb9aef4b843b6cf18ac070692c7d91ee1efc57385e6635f9b0db88caeeaf0740a5546d416e92b53e34b7f6ffdba1379bf412ed5e91cf04f3ff2a398e97420e"
    },
    {
      "relation": "hasComponent",
      "source": 42,
      "target": 127,
      "key": "c2af685734cd4151464f037b1d0088cc345441d2cdd2b2ad22ad8239b78d6f6ee59b781ccc450ef1d9ff8217f3b108a06a6e754693779c06f66b4fbc1aad7513"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 32,
      "key": "933de09db312046444258c7ef1a70a76e181e7fc7b809190e2ddb71a64f041631f2d81dd438d877c3ac12653f1fadea686b58d39fdce696fc2a33b8246ece7ee"
    },
    {
      "relation": "hasComponent",
      "source": 41,
      "target": 103,
      "key": "b80672effa4718ee5d999a5353942c5ee612ecd1f7d33695c69ae4787017fd1ee1690d61b2c79ef26288bc60b005dc4348695c4783e43fe40eba263370084a9a"
    },
    {
      "relation": "hasReactant",
      "source": 158,
      "target": 108,
      "key": "d1641565b18def1b0f78ba11a137055e95b02b9e168251a1074efb0ee425abe6226897ee4f2235ec0dc1c85b92a1ae5cfaf3ff2e00f7a0dfc4b8e8f972612e6f"
    },
    {
      "line": 288,
      "relation": "negativeCorrelation",
      "evidence": "Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",
      "citation": {
        "type": "PubMed",
        "reference": "10464280",
        "name": "The Journal of biological chemistry",
        "title": "Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.",
        "volume": "274",
        "pages": "25490-8",
        "date": "1999-09-03",
        "first": "Sontag E",
        "last": "Bloom GS",
        "authors": [
          "Bloom GS",
          "Brandt R",
          "Kamibayashi C",
          "Kuret J",
          "Lee G",
          "Mumby MC",
          "Nunbhakdi-Craig V",
          "Sontag E",
          "White CL 3rd"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        },
        "Method": {
          "Dephosphorylation Assay, Colorimetric": true,
          "Enhanced Chemioluminescence visualization (ECL)": true,
          "Microtubule Co-Sedimentation Assay": true,
          "SDS-PAGE": true,
          "Western Blot": true
        }
      },
      "source": 158,
      "target": 108,
      "key": "290c140387c8d71ace7b766f9b796bc304d58c6f13c798ba166ec714ade7ffae6d7684df058c27c4145781c2ecaa1b3f473d874c7a657e8cf76aabd596b26c60"
    },
    {
      "relation": "hasProduct",
      "source": 158,
      "target": 3,
      "key": "6b0ec7db27b9e63e9db0e8b8a427f8864febf095549ec8fa6b4ffa160e466708f7f8c0ebb7f919f3aa7db22bc10b509b4eda3e030a972ae86c7c0b88f59407dc"
    },
    {
      "relation": "hasProduct",
      "source": 158,
      "target": 103,
      "key": "3b53c46e7188b7002728e1510246519f55cd48e3b2b11a4103f024c9fd3ef9d4bed40040f811fb6e4a303af83f205641ac071c92bbab135ae65785fcfa75c6cf"
    },
    {
      "line": 305,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 98,
      "target": 78,
      "key": "6e6f8ca7a5b55077dca08375f46614002c4324c39c10bfe538ecf9f6deecd9f674b6270f5162cfbff98a11a41e1ab27d4693ca42268aa004063a96cdd2e03abe"
    },
    {
      "line": 307,
      "relation": "negativeCorrelation",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 98,
      "target": 32,
      "key": "42bd413d357624bbcdcd6d909c61a3192e82a5cdcf5bedfc984efb18e1690b23c9d099d9c7b248359a7e28e5ef841ad97b9cd9116c78b7ecd11a4f182e3af9f0"
    },
    {
      "line": 309,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 138,
      "target": 32,
      "key": "1881c87f53f384cda24d0ab9a4409be5429c4578d9228bdd7ae59906c48be403829621d2e187ee23d7dccf5523449c9777ef0ad22b01bbbaadf9decca11ac670"
    },
    {
      "line": 310,
      "relation": "association",
      "evidence": "The location of the hsc70-binding site in the tau MTBR suggests that hsc70 cannot bind microtubule-associated tau. The location of the hsc70-binding site also suggests that hsc70 might compete with tubulin or microtubules for binding to tau. Our data implicating I308/V309 in tauâs binding to hsp70 similarly suggest that tau cannot bind simultaneously to hsp70 and microtubules. However, unlike hsc70, which does not associate directly with tubulin or microtubules (Gache et al. 2005), hsp70 binds microtubules, presumably through its N-terminus (Sanchez et al. 1994). This would allow hsp70 to simultaneously bind to tau through its C-terminal substrate-binding domain and to microtubules through its N-terminus.",
      "citation": {
        "type": "PubMed",
        "reference": "18500754",
        "name": "Journal of neuroscience research",
        "title": "Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.",
        "volume": "86",
        "pages": "2763-73",
        "date": "2008-09-01",
        "first": "Sarkar M",
        "last": "Lee G",
        "authors": [
          "Kuret J",
          "Lee G",
          "Sarkar M"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Pull-down assay, GST": true,
          "Western Blot": true,
          "Surface Plasmon Resonance": true,
          "Yeast Two-Hybrid Assay": true
        }
      },
      "source": 139,
      "target": 78,
      "key": "fbc2eae5418098ea7a38cffc60382157d6bc4f7ce63d6cad5441fd01626ab65fbda646b9f428d7cdf911e485a201c70253fc32f925466110b6db3431d9a6225e"
    },
    {
      "line": 322,
      "relation": "association",
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 156,
      "target": 77,
      "key": "3ed3c1e829bf79fecbfa89a0757bc222dac0cd4881e147f30bf4f3edd36c3f9babd2eea59dfe1188afa3d43d2abe57459f8010a4956f6ff500a180d8d7c02e92"
    },
    {
      "line": 324,
      "relation": "increases",
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 156,
      "target": 61,
      "key": "dfeef7f6a4fe4fb9247cd70d430c886d13f748666e668c5b7d11252235b2aa8be13acf2372aca53ac9b1f729d06eff6915e61acd7009270f75b5d619cde5b583"
    },
    {
      "line": 331,
      "relation": "positiveCorrelation",
      "evidence": "To test the effect of Hsp90 on tau phosphorylation, this protein was mixed with tau protein in the presence of GSK-3 and ATP. Figure 4 shows that tau phosphorylation increases in the presence of increased added amounts of Hsp90.",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 156,
      "target": 108,
      "key": "eb0f56fed75d745c95c288e7a6807cf3142d73276ef5290c55df6626aca654cd5bf8fe65fdc342580d07c4ba93ea63ca180f0b5b20f1157b2dbc23fb365b9f3d"
    },
    {
      "line": 338,
      "relation": "positiveCorrelation",
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 156,
      "target": 16,
      "key": "efe08aeddcb91a49f046b1d02279c27b803e2502a1f4e180aa74a56df055d9a53b5e36f0b44220d893ebd07ca0e1bd7a3bd51ce6a6b5ac6eb5d55682290012cd"
    },
    {
      "line": 568,
      "relation": "association",
      "evidence": "In addition to its peptidylâprolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        }
      },
      "source": 156,
      "target": 92,
      "key": "90e3e778e7b0402cc167c6d56664124cea133c8e259c43174ddb3329eb1ae3cea659e0aff223070e9605e9e7142f8eaf789c35e5e4f40ca8954b997f8e6b301a"
    },
    {
      "line": 623,
      "relation": "positiveCorrelation",
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 156,
      "target": 86,
      "key": "e11204889802d4a7c24e7242f7a5ec76ba5f28a65fe793a6554f3847366158767a3786b1189b20df834a334da7fa3cd4296377ca0ecb5926c41fdbe0807cb85f"
    },
    {
      "line": 644,
      "relation": "negativeCorrelation",
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 Î¼M 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 156,
      "target": 103,
      "key": "08fae75027134686ea7c3616c3d954ba5838b84693a300cccacd7092b48f0a4ee9731a56bb4d6f1fccd6011bd0878067c758ff572a737433cac5cd3760954590"
    },
    {
      "line": 322,
      "relation": "association",
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 77,
      "target": 156,
      "key": "86cc20dad77d8fa045cc98a66cc7a192230537aea8016490cbf363b41bf0b196308555b88126bd25aa8b3b1d38bbb49291ff8cae6e6b305a0e0c91f7a33d5356"
    },
    {
      "line": 323,
      "relation": "isA",
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 77,
      "target": 80,
      "key": "806b276b77adaaa4dfb7eef4e1f031a7b6644a7b45c4fadc78c0b836dc6a92dfd05c9468ffed9736030829a72bd59c8f1b17c55e30b91576bd4c7ab0177dbe82"
    },
    {
      "line": 325,
      "relation": "increases",
      "evidence": "This result suggests that the VQIVYK peptide plays a role in the interaction between Hsp90 and tau protein, a hypothesis which is also supported by the fact that a tau variant deleted for the peptide VQIVYK was unable to interact with Hsp90 under immunoprecipitation conditions (Fig. 2B).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 77,
      "target": 61,
      "key": "1072c83ef0d936eb2020b4274f17fe0b0830f2aa4cb02b2443c3d2c68647768017def66a794ac4acd815cb26b144f1fe2e7dacc4b332b8ea5125e35a39bfb824"
    },
    {
      "relation": "hasComponent",
      "source": 61,
      "target": 103,
      "key": "032b9449f44a9ac10b7b85310875908aedd2c997307c36932d56e98d31c8732d9f112b4ade61b000582086b5bbafb1033806de21939f3824c35d1064092f9475"
    },
    {
      "relation": "hasComponent",
      "source": 61,
      "target": 156,
      "key": "656350296c3f46c4966f90ac0f9475cd718ce1daae97d0de4d72d52835414f424885e357cf16a117f2166afe394c9a01b5fcbf1884de1d55a17533c652ef51fe"
    },
    {
      "line": 606,
      "relation": "positiveCorrelation",
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 61,
      "target": 93,
      "key": "3935f8b4bc14c68abf73f6ebe68555531b7029e4e67940ede690f0c801c23208c4c0b295bb2c129c835885a2829508624fd24c090471bb76bc90101970398c0c"
    },
    {
      "line": 338,
      "relation": "positiveCorrelation",
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 16,
      "target": 156,
      "key": "342ad55f713d2e21e5ca8d17212e0343b86f82ffb42afd1211ca76a22a78be95844a5dce58491fe8397a1f04bf7c0f40582cf69f829e1278550b3d108a04cdd6"
    },
    {
      "line": 339,
      "relation": "increases",
      "evidence": "Figure 5 shows the presence of fibrillar polymers when the Hsp90 was mixed with tau protein. These filaments are similar to tau aggregates assembled in the presence of quinones [19] such as juglone, used here as a positive control (Fig. 5C). No filaments were observed in control samples of tau2R alone (Fig. 5A) or Hsp90 alone (data not shown).",
      "citation": {
        "type": "PubMed",
        "reference": "19363271",
        "name": "Journal of Alzheimer's disease : JAD",
        "title": "Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.",
        "volume": "17",
        "pages": "319-25",
        "date": "2009-01-01",
        "first": "Tortosa E",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Lim F",
          "Moreno F",
          "Perez M",
          "Santa-Maria I",
          "Tortosa E"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Immunoprecipitation": true,
          "Dot Blot": true
        }
      },
      "source": 6,
      "target": 16,
      "key": "c82b875e9dc9f43207ae41526fae38db133063d45216a37bffdf3b75bda9f16728f5f4649e3f68eeabc2e0c1384b427d42153fd5aca83c8a84a5e43b8fb4b889"
    },
    {
      "line": 354,
      "relation": "association",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 99,
      "target": 108,
      "key": "91501fb65c5ed0d2fa57b29cadec7018160803eb7665b365155e7003e414b1d6589e5f17af3cd1b90bd4c87de0a163c6fe282d9ce9ee8ffa5233a1824c04ba94"
    },
    {
      "line": 365,
      "relation": "decreases",
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 99,
      "target": 108,
      "key": "c379008734c9ee36301de1cfbec0968136eb65f447b81a7c19e71cf5797436c4edb816a476cc2602a49314473c08df1603538b6f5639c5c410f5b04b43d3e0ec"
    },
    {
      "line": 355,
      "relation": "causesNoChange",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 99,
      "target": 103,
      "key": "235e3cbf8609162cf09194ff06ae33b1d26a94c2108eb9a2631c9567f90a49bdf0f379676d4cb091ca8dd5c91b6b9d342b4ef60c4af5870072037438ed717a37"
    },
    {
      "line": 356,
      "relation": "increases",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 99,
      "target": 55,
      "key": "3e407bdc81b6b5c097219341de5d6e80e413ea77f9011e7ef6aef6f80e15e21c5bd0d9217a03d2d97be3734b93629294cebd60ed31852bf7ddea76448688cfbc"
    },
    {
      "line": 366,
      "relation": "negativeCorrelation",
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 99,
      "target": 17,
      "key": "f96c69924f886371ecf10ab0e40f56efa494462f77be22b690f572c0518b6704b30f2a096637094e6a0bb59707e0c15efd598f51c5985afbf93927134c042fe8"
    },
    {
      "relation": "hasComponent",
      "source": 55,
      "target": 99,
      "key": "a5cfbc6fea09b92130351ab6f4ff94aea65d0894db4da2b25468dd3498b1415511e5e0c5bdec6a0181c7992d9e0ab6dc4e8c3039afb7f8729c7cb36048dc20c3"
    },
    {
      "relation": "hasComponent",
      "source": 55,
      "target": 108,
      "key": "8ea6c8b6cea6db487bddf1933a8b15258d2462521adf2efba56661c61431f89c7af8483be7ddb11e1534bab18a30169dc0f80da0b6ff65925fe9a4911023c43f"
    },
    {
      "line": 359,
      "relation": "increases",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 55,
      "target": 108,
      "key": "8a181dca80bf2592e77d48f4fc3f882a3934dcd6b3bfc188596f2df40a81b2ddafb73c4219c6a912090c76998928a6ed010f7d79d62a87e4a81571faaaa1f7c2"
    },
    {
      "line": 358,
      "relation": "increases",
      "evidence": "Here we show that heat shock protein 27 (Hsp27) preferentially binds pathological hyperphosphorylated tau and paired helical filaments tau directly but not non-phosphorylated tau. The formation of this complex altered the conformation of pathological hyperphosphorylated tau and reduced its concentration by facilitating its degradation and dephosphorylation.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 55,
      "target": 158,
      "key": "e849a2650d22d0d406016791e81e7d26027445abb4adcec5262aad1ad427ce462a46a78166b35ff4bba6ada03cc9643fbc62292f0fa3c43d3b1d13e8ccc8a3cf"
    },
    {
      "line": 366,
      "relation": "negativeCorrelation",
      "evidence": "Taken together, pathological hyperphosphorylated tau caused cell death, and Hsp27 attenuated the cell toxicity of pathological hyperphosphorylated tau.",
      "citation": {
        "type": "PubMed",
        "reference": "14963027",
        "name": "The Journal of biological chemistry",
        "title": "Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.",
        "volume": "279",
        "pages": "17957-62",
        "date": "2004-04-23",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Kosik KS",
          "Miura-Shimura Y",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "SDS-PAGE": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "HCN2A": true
        },
        "Anatomy": {
          "temporal cortex": true
        }
      },
      "source": 17,
      "target": 99,
      "key": "df0e1c96555c74092e8a9eab7d7dcb27cc4ec105e9f2a978ffe2061b8da0259427fa1b9fc6c7008c895a43fb33e5be8a1e90cea0188d2f4599110e4f0eaffc96"
    },
    {
      "line": 378,
      "relation": "positiveCorrelation",
      "evidence": "This result strongly suggested that the E2 conjugating enzyme for tau ubiquitination is UbcH5B.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 134,
      "target": 118,
      "key": "a699f18c7acef6482dd8a77645f77f2a0998ea108196cdfa3e089ce334ca0fe7e79bd374995257ee8fcd32b2e85de67ea67b0200c4c1571b5efb407e3d36f1be"
    },
    {
      "line": 404,
      "relation": "isA",
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 134,
      "target": 62,
      "key": "223be6e766a1dcb5f374ea68a13144599ff66c6cd9183b821e2f863caf45c6cae327580cb8f1f3f527b50b7846785200cb19ac358d53f2f22a8fcea7d8d3cc3e"
    },
    {
      "line": 378,
      "relation": "positiveCorrelation",
      "evidence": "This result strongly suggested that the E2 conjugating enzyme for tau ubiquitination is UbcH5B.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 118,
      "target": 134,
      "key": "490cb5c28797c79da84e9e0c978e5f9c81d41fd571d80236e1f61a8af2457899b423c01e45971d4533bbba0ee958a3e562186681c4b3a69b383cdcdc430b80ae"
    },
    {
      "line": 397,
      "relation": "positiveCorrelation",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 118,
      "target": 108,
      "key": "48a67657a6a581f991525b65b63fa638bbec4221fa364af36fcc1762e4e6dff5e739662728add2877198e27bc8974ca8c43538611d4a9e4879f1f58af4c70631"
    },
    {
      "line": 443,
      "relation": "increases",
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "SDS-PAGE": true,
          "Immunoblotting": true,
          "RP HPLC": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 118,
      "target": 103,
      "key": "8256bb83dbcbe30e37cad205c6de7b02da1a7f0afc107a51a9d51a67e2e22f818b9f2a384c97c34f933e299df86323c8f3624f9c6a4af234267eb86d90c7152c"
    },
    {
      "line": 393,
      "relation": "isA",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 110,
      "target": 108,
      "key": "aec0dc3de8508ef19b13f835d1b4679cb6571edf9c3ac9518eb84ccd0c8934c162bff46fa65cf4457b2a15244a8d8ac08d572333a7cfbc47967a75041bb68175"
    },
    {
      "line": 591,
      "relation": "isA",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 110,
      "target": 153,
      "key": "731f095cd488eb5c38184086b520c94f1d590fcce931da64f54aadb45e5ef1d1bb626be3c26477d35dc06236a6cadbdce027969cd1a247af5fad9250db2d2ba4"
    },
    {
      "line": 594,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 110,
      "target": 50,
      "key": "fb0b736797117809d6d2ae694747ec7b504aa8963b15525147d1a3fcda3dae8c01724b2ab757b49e64f63e8bf2ed9ec69cb18c9076635dc093f45b5a3d6c98c4"
    },
    {
      "line": 597,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 110,
      "target": 93,
      "key": "ef2cfe6eb959c26510850e0763cb40726d26cc6cd36d0074b480aac6208b8ef5998a5ca39b22b8453fae1f2517993f9bd2d368041980ee21604e9f6a0e00f5a5"
    },
    {
      "line": 632,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 110,
      "target": 86,
      "key": "b0d299651e6857b24365e9f3e8688d55a58755727cda14687de092e501d00d17034baff0a28185010d7c00df210e8023d73017858ed729a029139f6d72b719cc"
    },
    {
      "line": 394,
      "relation": "isA",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 115,
      "target": 108,
      "key": "e4866c9e2a49470a9dede75c8e33f3e828b7d03beb2813119857f85b97ff7cd3fff15e7ef42be01f17d827eb152e5df99e1f4cdd4a7bda76819647415e30961a"
    },
    {
      "line": 395,
      "relation": "isA",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 113,
      "target": 108,
      "key": "729a05db20fe1a68cccf207da70f02397d0fe969b6d088234e632fb56800ab53e293febb2edf8fcbd1f68d61fe66b5e51981559f704179c753e7ebc60c774c69"
    },
    {
      "line": 589,
      "relation": "isA",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 113,
      "target": 153,
      "key": "bbf45ba10c7fa01df406bfe929b01bff1b1f424a0d7a32bbda3d15469465485289bb0d39fe26cf49c6bcf7577a1947409dcf7882a95ac2bb54bbe627ac2637b4"
    },
    {
      "line": 592,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 113,
      "target": 50,
      "key": "ecb2d050aaccc88554cb28968b3c10ab08574e4e52a7d83378b5e0dea3cacdd924ccf08bda41ea2c945f6379764a8fe03080578c48dcd31c8e8554608e33ddc4"
    },
    {
      "line": 595,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 113,
      "target": 93,
      "key": "8bc1c679aaffd16efeb1e10c73292b8b9d36f763f9eeceacd84bf27d052de0c9c2044feabca50ef707f18d52c3151c53a98f950b41fb77a89e0a8006afad1676"
    },
    {
      "line": 633,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 113,
      "target": 86,
      "key": "04f5396d0282e495fad62ab6beb1d0c07a3b436c9a7789fc04ad7e57f67cd5a90a0ff80a1574d4e2d89d5ac2f0968489825c19b71acbac425a5cd66686c0c051"
    },
    {
      "line": 396,
      "relation": "isA",
      "evidence": "These data indicated that phosphorylation of PP2A dephosphorylation sites is an important recognition signal for ubiquitination. We used 200 Î¼g of amino-terminal His-tagged full-length recombinant human tau in an in vitro phosphorylation reaction with GSK-3Beta. When phosphorylated, the tau protein reacted on immunoblots with PHF1 (25, 26) and AT8 (24), indicating that at least sites Ser202, Thr205, Ser396, and Ser404 were phosphorylated. Following GSK-3Beta incubation, this tau served as an excellent substrate for in vitro ubiquitination using UbcH5B and the cofactor fraction from AD tau immunoprecipitates (Fig. 2a). This finding suggested that GSK-3Beta can place phosphates on tau that create recognition sites for an E3 Ub ligase.",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 114,
      "target": 108,
      "key": "84f4e527cd36927186505451a3a33e4d033f86ac8f4a43d2049f5422b32a88b9bbfa6de8bb8bee44553c925a711c75f98c3faeccd6be2298d624dbca679e7909"
    },
    {
      "line": 634,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 114,
      "target": 86,
      "key": "ef124475e6498bbbb2f43007093262257eeee9a19319d256bdec3ecf3efc78d340ddc293b97989e9e6d4912045a1d34c18ba99e67729426343666e9a56134141"
    },
    {
      "relation": "hasComponent",
      "source": 62,
      "target": 108,
      "key": "ccf586eab03e1ce2fa604e78823a8b515729caf8bac4d94ccf73c07be2e8d519d0a1af24adde8a303623bfdc3c08b6f640ca41f3e63bb7cdd8f2914e85a7945a"
    },
    {
      "relation": "hasComponent",
      "source": 62,
      "target": 133,
      "key": "627a72a06e1cfda73906570e7cb9fa18e62e42251ae2d4f5feefb2eefcb7c9587ba3b4ef167eeae77c1ed268936b7332c4df62d11bc6bab8a6f028603a58e478"
    },
    {
      "relation": "hasComponent",
      "source": 62,
      "target": 134,
      "key": "af6367cc08493df5b74bac391bd9ef853c500e66579649b8a82cd4806e2d77b5bb09a0502d41541c6ad1cf6168ca3a12b3d5019576d3cc3c639d593159e43505"
    },
    {
      "line": 407,
      "relation": "directlyIncreases",
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 62,
      "target": 118,
      "key": "43de0603d6885662d9b67393205724804152d075b9e579c21afb270e6af8eef6746e4522c84ed9cbe8edb660ccc6c907d97817ab0df35bed7be1c91fbd49f34b"
    },
    {
      "line": 405,
      "relation": "isA",
      "evidence": "These data suggest a model by which phosphorylated tau is bound to a chaperone and the complex is recognized by the E3 Ub ligase CHIP. We further examined whether recombinant GST-CHIP ubiquitinates phosphorylated tau in vitro in the presence of UbcH5B and Hsc70. Ubiquitination of phosphorylated tau was detected as high molecular weight bands by immunoblotting with 5E2 in the presence of UbcH5B and Hsc70 (Fig. 2e).",
      "citation": {
        "type": "PubMed",
        "reference": "14612456",
        "name": "The Journal of biological chemistry",
        "title": "CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.",
        "volume": "279",
        "pages": "4869-76",
        "date": "2004-02-06",
        "first": "Shimura H",
        "last": "Kosik KS",
        "authors": [
          "Gygi SP",
          "Kosik KS",
          "Schwartz D",
          "Shimura H"
        ]
      },
      "annotations": {
        "Method": {
          "Deglycosylation Assay": true,
          "SDS-PAGE": true,
          "Immunocytochemistry": true,
          "Ubiquitination Assay": true,
          "Dephosphorylation Assay": true,
          "Phosphorylation Assay": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 133,
      "target": 62,
      "key": "b42e98e6ddb78e38a11bf958ae51213d1c36925a5c2c29e09c44305d97bae886202371966628295385570951b1f5d22b261e6dbb342e7bfe42ad925fcffbe5e1"
    },
    {
      "line": 423,
      "relation": "isA",
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 133,
      "target": 46,
      "key": "757fe8c56ad3f9695c0b637df93dce78516680de02edfa31eceb433d7ae849ce663282cb21cb2d2edbd8be02fadbd6636140c4257162eef8f01c17c178af8589"
    },
    {
      "line": 421,
      "relation": "isA",
      "evidence": "BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 85,
      "target": 46,
      "key": "1af54e4da78cfa0a02727b152dcc91c64a069a9d5bbae6770c63e229e605ba5465bc3f515a464ad6ad06411917fe9e1d12e47dc7aacba2420077584809dec043"
    },
    {
      "line": 427,
      "relation": "positiveCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 85,
      "target": 103,
      "key": "f32d1fe30ddc9251ac3355a9a1cd83194d5db4e6ef2f8200e24239cd76e39a4ee52f81bd447d0d7a25fd61fa35ce1c64942a10462928928100d3b13ec8c6358f"
    },
    {
      "line": 430,
      "relation": "decreases",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 85,
      "target": 103,
      "key": "2bbefd3a65d068fa66cd69090591f5dcf70fd92fe76a393844a6abea9f5b58bc45e747faea783eedc35eda25a5cce8103be688a8ab84ca85d6b065896b966c2e"
    },
    {
      "line": 431,
      "relation": "negativeCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 85,
      "target": 30,
      "key": "a979fc46716c7715b5c68454f143ca44f8095be2df09e6106131041ddc85f89c84ecf5910953c0713812d92af681a052a06fa183424aacb366c08faaa1406c86"
    },
    {
      "line": 432,
      "relation": "negativeCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 85,
      "target": 108,
      "key": "99125755aa5ed06a0d8d8a416954f5b21ddef484658da6d111d0965d411933824dc6e34a2dbe1c120a6d79c8ab1c8309ed63c469e371efbf2287657f1d616a6f"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 85,
      "key": "5ec77843d2520808a43d6e8cc8950b02544706fa1813139809d7f1b337880d5feb3f181257ae1938d2dd0c966d94e83b7c53f5fc7a2dcd275c6e59feec981c1a"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 103,
      "key": "49e065329f00d41f4ffa7a8f872f7c8bae1679776fb0b44f38ef008e9ee0c39519a76cb22e02154aa74b4bc7b876a33dbe2054bcd8412af5e18991a049cdb25f"
    },
    {
      "relation": "hasComponent",
      "source": 46,
      "target": 133,
      "key": "04fe3dc1ab16d862d102912df9c5001fe35791c7f28edafb0375973206de6fb034a2cff19def9bd82da37fdebf8d1ff3e91fca977b60809990b4332c8dbc1753"
    },
    {
      "line": 428,
      "relation": "increases",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 30,
      "target": 103,
      "key": "5448d1828790cff72da099ca9ff417a4bd2d3ef7b59d3d6b3c0b4a8ca87c767359718cf52b59920c80f48839b53937dd2c854431ef3fa641d5fe1716e523b473"
    },
    {
      "line": 429,
      "relation": "isA",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 30,
      "target": 30,
      "key": "698334d3e6b89eaceb293e561588ad318a7473873c183a3420c21784a00039307104eaadcce8d4ecbbe837b2c987200a79b200a5c50f330e3e3a2ba139969294"
    },
    {
      "line": 431,
      "relation": "negativeCorrelation",
      "evidence": "We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein.RNA-me- diated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein.",
      "citation": {
        "type": "PubMed",
        "reference": "17954934",
        "name": "The Journal of biological chemistry",
        "title": "BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein.",
        "volume": "282",
        "pages": "37276-84",
        "date": "2007-12-21",
        "first": "Elliott E",
        "last": "Ginzburg I",
        "authors": [
          "Elliott E",
          "Ginzburg I",
          "Tsvetkov P"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Degradation Assay, 20S Proteasomal": true,
          "Western Blot": true,
          "Immunoprecipitation": true,
          "Immunohistochemistry": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 30,
      "target": 85,
      "key": "69762c63e21ecdb85d98a57cccd1c287689d4e608bebb9556a14b9a968d2d04f8a1366c03262faff3f02c3ce0397f2a2680f44d108e0102f6f55d90594679f76"
    },
    {
      "line": 444,
      "relation": "association",
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "SDS-PAGE": true,
          "Immunoblotting": true,
          "RP HPLC": true
        }
      },
      "source": 73,
      "target": 78,
      "key": "2a207f85069ecc09fb74d4bcd28ff89ed49b15d7e85383b831fbd44b8dc04e8adc5c54f15ae87a6c06e3896948956a6019d0df6d29f22c549b27d62ed35e5455"
    },
    {
      "line": 445,
      "relation": "directlyIncreases",
      "evidence": "The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "SDS-PAGE": true,
          "Immunoblotting": true,
          "RP HPLC": true
        }
      },
      "source": 73,
      "target": 118,
      "key": "6a8b5f12aa68a828774c5afa66190bfeb80644910fb8a9018df2de2878ef1ab6ba32d9059cf52bb6dad9b3bb81cff8e27087af8aab66a2f10ec3ec44df8d0068"
    },
    {
      "line": 455,
      "relation": "association",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 141,
      "target": 89,
      "key": "621d2d2582f653ac90b220081e83753d2aae451d7a00b9b6e9d645d8d7c727e0e5418b12af9f9bfdcafa46be64d0e192a12dd843d394fc35b6c7475c7104686c"
    },
    {
      "line": 456,
      "relation": "partOf",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 141,
      "target": 103,
      "key": "1aefdbb791d4d545596cb2dcba7ce5a2e7c1c2b64450fad4cdd1a408d9747eb26772476018270dec017217edfb60222599d69c35d25fedcf22fdb939547bbc2f"
    },
    {
      "line": 789,
      "relation": "isA",
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Electron Microscopy, Immunological": true,
          "Immunofluorescence": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "source": 141,
      "target": 103,
      "key": "24ba85aad591a2268257c8321a1c6e156363db440b284911cc1a9559f362acd6c879fc2d142581075c0c33fa31fe0e0fbc7f038f602a1f51b98fd2000b22f37d"
    },
    {
      "line": 788,
      "relation": "decreases",
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Electron Microscopy, Immunological": true,
          "Immunofluorescence": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "source": 141,
      "target": 18,
      "key": "b3bb7e7ce570d9d7028fcf5a9928e4c55e7091f721aadef2f84c7fb5dd9dce526d981528e499ca1ef68068e7fd0d2ef3518fa3d3cc3e21e596c6177979950ab1"
    },
    {
      "line": 790,
      "relation": "negativeCorrelation",
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Electron Microscopy, Immunological": true,
          "Immunofluorescence": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 141,
      "target": 28,
      "key": "a86ffe4b40d1ea0f34ddbe7d0e2defcbfd551ef2e198e4613797b30dec3d8c6381f75c444c3d6996e5e8cf1b7810cda1e723d93654eef908aab497fa6c5adeba"
    },
    {
      "line": 455,
      "relation": "association",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 89,
      "target": 141,
      "key": "bfb6ef7d90714b7ffd218cc4a3e315ec1ca00ce4a7b19029c219d1c0c635e97999954ebae268bd784c700d88dafa61a8ce0ce489ffb01d8f2ca0fbe04210fb2f"
    },
    {
      "line": 458,
      "relation": "isA",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 89,
      "target": 48,
      "key": "c379976c58666059540b548e7b05c048330ef2b496aabcae8f7e68f4ee2f64a8293e2be86a88db445bbd2e8ad926704858969a5b15ac671e945d25d7d35344b0"
    },
    {
      "line": 459,
      "relation": "isA",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 89,
      "target": 136,
      "key": "26a2883328b293ee95a9aa2d4635ee3c6c9a96d139848d0d3875f4c25881cdf671fed1d59ccefcc6afadd3d4415acbe8cb685b90b458b0f9b24e871029fd95a1"
    },
    {
      "relation": "hasComponent",
      "source": 48,
      "target": 89,
      "key": "529326b8b60ff3c43a5889f67afef2b20f3959c3bc170093488a0835927cf55e40c6801803f5ac9e99f251f2911bf083a4c7678d11eac34e3a87240f1d552eb9"
    },
    {
      "relation": "hasComponent",
      "source": 48,
      "target": 103,
      "key": "22ac37997458db53684e67d68c8f9457507ff256c54cd07c2ca34ab3b0d719697a659f6160ef599cbf5cf2002bbd0b649fa2142c969684f312705e8362e0b440"
    },
    {
      "line": 460,
      "relation": "isA",
      "evidence": "We show here for the first time that the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex. The sequences of tau encoded by exons 1 and 4, which lie at the tip of the N-terminal projection domain, interact with the C-terminal region of p150.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "source": 48,
      "target": 136,
      "key": "ab2b23ac79c7899123ee7f4f78873b68c6f247d4303aa8d3b250b5ad58227cabb95a1b7a9884de2e8edbe4b97c0e2d7f34930f319b05b3205c348a1c76401232"
    },
    {
      "line": 474,
      "relation": "negativeCorrelation",
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10090": true
        },
        "Anatomy": {
          "ganglionic layer of retina": true
        }
      },
      "source": 48,
      "target": 69,
      "key": "f96d91e278772dbe400bc83987b695f296c4bae37ee8fa0bda3b57f842abcdd22199a88caa9e8143b5cfab4b129ad30419da967e4386aa5f97bd6ad2944b4130"
    },
    {
      "line": 466,
      "relation": "positiveCorrelation",
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 136,
      "target": 39,
      "key": "e4088e34c9c9512898d627a9c3fd01699ebfc761975c83c33f35dabc8c2de91d2d4d9daa27b071d292d8fae839a39a8a6460df6155d111f72f9d9faf8f6ea5e4"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 12,
      "key": "d772767695a6dbd10fd84f04ac3fec7b00bef68664221e4d66f11a455606a6a07fcf4abb905f851f773b9999f19dfdfb2eb8a2cfa7e1ca64e2f653fe088a95fd"
    },
    {
      "relation": "hasComponent",
      "source": 39,
      "target": 136,
      "key": "c09ea0c3c2cebdfd303b2c1a9dd3291a033098ba09f38d4ff6fae203caa174f56b4761379d440e90caa7043afd49037322d47c04dd1ace362160e8bb3cccc297"
    },
    {
      "line": 466,
      "relation": "positiveCorrelation",
      "evidence": "Tau and dynactin show extensive colocalization, and the attachment of the dynactin complex to microtubules is enhanced by tau.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 39,
      "target": 136,
      "key": "ee5b0d7dc4aa4f468aa93ffd5f63e37f2490bee66d71314f46318b5e2b779f7fe25c9d996cc4e10718e1d33c5e844041ab41014a0c6ec13d5f647612c05d7eb2"
    },
    {
      "line": 473,
      "relation": "positiveCorrelation",
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10090": true
        },
        "Anatomy": {
          "ganglionic layer of retina": true
        }
      },
      "source": 69,
      "target": 157,
      "key": "fd4f676f2e31c9a03b267bcac194698d6e06770739f5a6b29520ddbbf0300fd353dc11b7c194c8a88400cefc8afb1377750d949d8d525f267a532f4bad279dc0"
    },
    {
      "line": 474,
      "relation": "negativeCorrelation",
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10090": true
        },
        "Anatomy": {
          "ganglionic layer of retina": true
        }
      },
      "source": 69,
      "target": 48,
      "key": "8e0022c7bd7111bff5f2865dd05a02adfac3ce200eca4d8bdfdeb9ddc35375c9422f708719cce13fc1ff117eecf52e0653c0804457efa8a5d0e49358eb47f32e"
    },
    {
      "line": 473,
      "relation": "positiveCorrelation",
      "evidence": "Mutations of a conserved arginine residue in the Nterminus of tau, found in patients with FTDP-17, affect its binding to dynactin, which is abnormally distributed in the retinal ganglion cell axons of transgenic mice expressing human tau with a mutation in the microtubule-binding domain.",
      "citation": {
        "type": "PubMed",
        "reference": "8391280",
        "name": "Neuron",
        "title": "Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.",
        "volume": "10",
        "pages": "1151-60",
        "date": "1993-06-01",
        "first": "Morishima-Kawashima M",
        "last": "Ihara Y",
        "authors": [
          "Hasegawa M",
          "Ihara Y",
          "Morishima-Kawashima M",
          "Suzuki M",
          "Takio K",
          "Titani K"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Electron Microscopy": true,
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Pull-down Assay, His-tagged": true,
          "Pull-down Assay, GST": true
        },
        "Species": {
          "10090": true
        },
        "Anatomy": {
          "ganglionic layer of retina": true
        }
      },
      "source": 157,
      "target": 69,
      "key": "0d65659b3bd41bb1e6c14e9569cf49ad76951c8134e515ee59db3e2b422b234bd106c129c7959a433f1db3a27691753049d3daf4b275d3698c87dab98fba7588"
    },
    {
      "line": 489,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 152,
      "target": 65,
      "key": "222ec579aa6836193e31afb775d430b14a4ab9ca7369bd40f8e9561f7955a87e5f37e255e1de39a22fdc5a0c0c35224d79d30fc6279b7648b1b6483e9eca2e6d"
    },
    {
      "line": 491,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 152,
      "target": 66,
      "key": "6fd055247070df737dd9e693d96397e416fb5639f8e0719c4b6c97e5c83dcadf96b6c93d2348406de4bd592010a6ade2fa3eeab8d200c7a3dc827aa4de089268"
    },
    {
      "relation": "hasVariant",
      "source": 152,
      "target": 153,
      "key": "13dfd5e324e943b5b15969ee80cc94c2ee476ba98038149d2d3eea748cda06d59bc0296a07e95ac18a414ec8c83ff561354f04122550f1c3479a8907fea110a6"
    },
    {
      "line": 550,
      "relation": "increases",
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 152,
      "target": 15,
      "key": "2423da41506d3879558a10962c404b74b258eaea4a3b1edc4bc0c8dcc457c0c6501b577d037c3801cbbd3ae41ca4019faee876af76566c5460d22df4a5ef17d1"
    },
    {
      "line": 560,
      "relation": "increases",
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 152,
      "target": 18,
      "key": "84d8974e80162cb8f6f16306ae9d0c3ad345fb878eaf85f5a9fa11f09b8d208fd5c8656e723f603ac6631d1e297c287f8056e6305587dbe5cebb92243b9a12ce"
    },
    {
      "relation": "hasComponent",
      "source": 65,
      "target": 150,
      "key": "b9e15525f691fe46a47620174aeb03b51ecdfc8da21b5be7930ac9cbcf82d2498bdc8da506b58365a61aa70674979ca6ad76d678f562d09bc3e7a77313b9ecec"
    },
    {
      "relation": "hasComponent",
      "source": 65,
      "target": 152,
      "key": "871daca88ad51ed5a3a5e265221e051ace8a8ca5925dffed0c40e6f58d00ac7a236ac2d661843f0fd7157038853532d9d7bd4ea09ac05c30e63bbfe629c7428d"
    },
    {
      "line": 490,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 150,
      "target": 65,
      "key": "c44bdc17b820b2881dd3995f545013dec67b7cf4b14907f8915e11d8a56e28b501b24fe0ab706e70208e1b12ba064b554bb2485b7d6ee455c88bae1514a93605"
    },
    {
      "line": 493,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 150,
      "target": 140,
      "key": "42acdb67b97d398b1cc216b1bf973d8cf1fd9006e23741b753f4ac8f061e9208fe7826ac1838172d8ec444b99581e2f07f352e7d03f207445ef0b870bed6a537"
    },
    {
      "relation": "hasComponent",
      "source": 66,
      "target": 151,
      "key": "7ba999532ad9ed704ffb0abaa6e8caa5fe168b3b807934fde8c59270d34a50d18bbcbe19ce94719c088cf526ea98fd95458b62136521d9ee97563b6be59d88d4"
    },
    {
      "relation": "hasComponent",
      "source": 66,
      "target": 152,
      "key": "1729050b78e655ae6deaa97f64a24a032194bb3b366188ff8c187041b5b6b6ba8d47861bf961a4f1e2176375614612aa1955cd8be057e02b8917e2ba4d84cbcd"
    },
    {
      "line": 492,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 151,
      "target": 66,
      "key": "325a819f5bf05babfb9b7c22097b4de36bf9a07a193727c8022b1a892a7150a079d5eef7d16da32b95420e7edf651e21f07c14ca5db698be9f9289702d879441"
    },
    {
      "line": 494,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 151,
      "target": 140,
      "key": "a0ffb67f3e53eb0705f35c934d1028ab06843a163d393a2b951945dd305fe9c227d69a82ed2f8e670502e0537542fd0c41edc47313ecea8c55606dfae1f8e3bd"
    },
    {
      "line": 496,
      "relation": "association",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 140,
      "target": 154,
      "key": "f595423ea574a148493b99efb37c196c0e050d38ba654aed3951b542dbe7cd3adf60d56a7733b6cf83c27c5460adfcf7b94b0133570bf6dcb15a52155ad62043"
    },
    {
      "line": 495,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 154,
      "target": 43,
      "key": "1686e2daf36a220e5d2843bbe214797d7c47c4a52d66b58b9cb82a9c50a0a6bc82b8e7a3f1984be0fdf5bf974f24281bfd35c68a18828874b3000934e2085736"
    },
    {
      "line": 496,
      "relation": "association",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 154,
      "target": 140,
      "key": "7b1815421e1749a1638dccfbb48ac3b19be575bbb6fbaa3a3d56ae6971970ab4e5762d34bedbd5646eb98f2849dce182d1e07ccfb1b6ce14564b622b1a4b9de2"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 70,
      "key": "6b074553fe2042b7473274c9caa452d8530c3614e9a40f87703ab9e417c7e9e831edfd32823c5d8405d1c55e323e87e7193305587919467b4ca5152b0410a67d"
    },
    {
      "relation": "hasComponent",
      "source": 43,
      "target": 154,
      "key": "f0d7642e8377a2e29e851dc7759c7eb80502bc6064bea16bf7a69e520bd9e844578b91be633f6c237d57613facfee9f3e8e8a7b6b3ca8fddaaa0ae901419b125"
    },
    {
      "line": 497,
      "relation": "isA",
      "evidence": "By immunoprecipitation, we also found that tau and alpha-synuclein are each associated, either directly or indirectly with complexes containing the fast anterograde motor kinesin-1, and alpha-synuclein is also present in a complex with the fast retrograde motor dynein.In this study, we observed marked differences in the relative associations of tau and alpha-synuclein directly with molecular motors because tau interacts with a kinesin-1 complex binding to KLC1 and KLC2, whereas alpha-synuclein did not bind to either KLC1 or KLC2 under our experimental conditions.",
      "citation": {
        "type": "PubMed",
        "reference": "16176937",
        "name": "Journal of cell science",
        "title": "Molecular motors implicated in the axonal transport of tau and alpha-synuclein.",
        "volume": "118",
        "pages": "4645-54",
        "date": "2005-10-15",
        "first": "Utton MA",
        "last": "Hanger DP",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Hill JE",
          "Noble WJ",
          "Utton MA"
        ]
      },
      "annotations": {
        "Species": {
          "10116": true
        },
        "Method": {
          "Immunoprecipitation": true,
          "Pull-down Assay, GST": true,
          "Immunofluorescence": true
        },
        "Anatomy": {
          "brain": true
        }
      },
      "source": 70,
      "target": 43,
      "key": "3a6f5cbc2d06ab840eeedbfe18bbd027eacd64778e2fde0f453981e845915df3917c83564dfb40bd46477c799574181d7ecc82fc89808b44e01fa6d5efdbe274"
    },
    {
      "line": 513,
      "relation": "association",
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in theWWdomain, resulting in a loss of the phosphoserine-binding activity13. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 123,
      "target": 117,
      "key": "d46a5a1521deb861317d8351ee73a997b48ac9c9003102b6d8592194fb2b7754dd9443a85d4f0065c2d72ea65ed48cd94a35f98dfaba337201ba435b70d8efd8"
    },
    {
      "line": 514,
      "relation": "positiveCorrelation",
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in theWWdomain, resulting in a loss of the phosphoserine-binding activity13. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 123,
      "target": 63,
      "key": "55c59e129229cb97d54a04b8b888cbd6e86e7e3340a18aeb926f56a1ed422570b0954a826987bc70ea5921488193b5ee4b8e2d55814f11d98a49e55928f49c11"
    },
    {
      "relation": "hasVariant",
      "source": 122,
      "target": 123,
      "key": "e2b86b50c50c5167f9202b353bc80447c85ca1c163585db8ec7a0772c58a4347b330ebfb5fa22e6791bb84d648eeb3bad1316047dfcdd947e0d60619bb6e101c"
    },
    {
      "relation": "hasVariant",
      "source": 122,
      "target": 124,
      "key": "c1f0768b3dc6328bf755a26b56d711681bc6d31c05de4d764013e6f7a14d5ab9eb74ac6d130bf2486f1a465e7e7483729fc5d0009d6fadc882f3ba71f24e0a48"
    },
    {
      "line": 513,
      "relation": "association",
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in theWWdomain, resulting in a loss of the phosphoserine-binding activity13. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 117,
      "target": 123,
      "key": "7d46fe40dadcdf33e1503b5c7f4a846354df52d9dd78ab04302dddb1b24b813eecf3306ed614b7388df9f89e2e4b8a5e8f6584ff9d084f489fb80ec74087b45b"
    },
    {
      "line": 530,
      "relation": "negativeCorrelation",
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 117,
      "target": 103,
      "key": "3a96b14fa3907562b028cd5c85a489f3fe0061ac616ed425a06d7f6eb71b831ee7e1535e66b258d8b6a1ae665b92389b131af84f86295d903bfa82e67bdc26c0"
    },
    {
      "line": 630,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 117,
      "target": 86,
      "key": "77b23c857ce571188bd0f74725ae867bfce490880f0b1ac4b51d1d9ff09c15e7ad5af623820a511148c05b3415c5b1a1ec05d521fc0db781448cae941db0d4d1"
    },
    {
      "relation": "hasComponent",
      "source": 63,
      "target": 117,
      "key": "df42210588c8f0e38df091924843c8147e18793cfd3463d9ca6789c22587d9c564f67f3e8c89c05d4d42a6ee52ce28226a1788c2704eb9c32a6c67a4e96a36fc"
    },
    {
      "relation": "hasComponent",
      "source": 63,
      "target": 123,
      "key": "1133f2e24ee47620ab09c6528097bf93c21f23d34bbb1105142d2c788497a74fe66a3f54026645554eb76430c6f9feedf265076a67d8dd8baa4672636ce640a9"
    },
    {
      "line": 514,
      "relation": "positiveCorrelation",
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in theWWdomain, resulting in a loss of the phosphoserine-binding activity13. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 63,
      "target": 123,
      "key": "fb9444402a3cc69a3fa714ef49ad593f8d819c85ea3273892ac066ffda401262ae737db139747f5ba37f091fbe453f026431e38c367067c56814839d38bb8754"
    },
    {
      "line": 521,
      "relation": "association",
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 63,
      "target": 26,
      "key": "670a83019ff4d5c42cb6ab06b68fd20a174f4f1106dc2e20da85abb8ef9395dbdad1b7f54f06286dcbf20fa730faa8869ea7c0d144eba7ef72c6ad3e63ec35c2"
    },
    {
      "line": 531,
      "relation": "increases",
      "evidence": "To examine whether Pin1 affects the ability of pTau to bind microtubules, we generated pTau in vitro using purified Cdc2 (refs 17, 18), and determined its ability to bind Taxol-stabilized microtubules with or without Pin1. Although Cdc2 phosphorylation disrupted the ability of tau to bind microtubules; the binding was fully restored by preincubation with Pin1 (Fig. 5a). Furthermore, Pin1 was detected in the fraction of tau-bound microtubules (Fig. 5a). However, no Pin1 was detected in the microtubule fraction if pTau was not added (Fig. 5a), indicating that Pin1 does not bind microtubules directly. Thus, Pin1 binds pTau and restores its ability to bind microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 63,
      "target": 103,
      "key": "7e723f8b3674881989d748983cce7da58a342ac5243cf4dbc23bae538fd0b526b72cb366011b47cda69a8121fe84279e7d5fdf372120abd36b8e1b086e94da80"
    },
    {
      "line": 515,
      "relation": "decreases",
      "evidence": "In contrast, no binding was observed between Pin1 and the nonphosphorylated tau (Fig. 4a), demonstrating that T231 phosphorylation is required for Pin1 binding of tau. To determine whether the WW domain of Pin1 is responsible for binding, the mutant Pin1Y23A was used, which contains a single alanine substitution at the critical Tyr 23 in theWWdomain, resulting in a loss of the phosphoserine-binding activity13. Pin1Y23A showed much less binding to pT231 peptide (Table 1). The residual binding might be due to binding of the pT231 peptide to the much lower affinity isomerase domain of Pin113. These results indicate that the WW domain mediates Pin1 binding to the pT231 sequence of tau.",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 124,
      "target": 123,
      "key": "857215050326bf833b86fe7215aa38161e5bbee2230c86e7d40020f46e491deeb794bada912da11aa0d208a333cd638b5bf63d179dda6c66462bf70dad061b9e"
    },
    {
      "line": 520,
      "relation": "increases",
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 87,
      "target": 117,
      "key": "65cd36e61fdfdca12bcba300ab335f776d2ceac0541b2658ddb903da431ac634f866bd09136623c998c1e50c08b690586b3f40b962703b1841a24aaef960fdfc"
    },
    {
      "line": 522,
      "relation": "positiveCorrelation",
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 87,
      "target": 26,
      "key": "a4284bf35f6a2983f1a931b0c5762941a1b89cd68fc004a4f0040cc7ce2b8bb1247504b391860c3c795e0de7295da7325a2350e56f8c49933b39e2497426746d"
    },
    {
      "line": 521,
      "relation": "association",
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 26,
      "target": 63,
      "key": "9e05159af6457e2d0bc0959ba0171cd765c552f2ded6909fea69d0e6012c60150bfb52727283e5ee5f278c4eda16db087ca53d826eee6b5113f671a6f813d5d3"
    },
    {
      "line": 522,
      "relation": "positiveCorrelation",
      "evidence": "This result confirms previous findings that T231 is an important Cdc2 phosphorylation site in tau, and is also consistent with Pin1 binding mitotically pTau (Fig. 1a) and being sequestered on to PHFs in AD brains, where Cdc2 is upregulated (Fig. 3).",
      "citation": {
        "type": "PubMed",
        "reference": "10391244",
        "name": "Nature",
        "title": "The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.",
        "volume": "399",
        "pages": "784-8",
        "date": "1999-06-24",
        "first": "Lu PJ",
        "last": "Lu KP",
        "authors": [
          "Davies P",
          "Lu KP",
          "Lu PJ",
          "Wulf G",
          "Zhou XZ"
        ]
      },
      "annotations": {
        "Method": {
          "Immunocytochemistry": true,
          "Pull-down Assay, His-tagged": true,
          "Microtubule-binding Assay": true,
          "Pull-down Assay, GST": true,
          "ELISA": true
        }
      },
      "source": 26,
      "target": 87,
      "key": "d7bb9de18601fdf28b70526430c3b73ba2e9ef89f651e5e307825ba30be2babcea18d934c55cc79552409be9f4b8e8f62d910e9ea266372cd50a7e08af01f594"
    },
    {
      "line": 737,
      "relation": "positiveCorrelation",
      "evidence": "Recent studies of an individual with Parkinsonâs disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread -syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant -syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "source": 26,
      "target": 68,
      "key": "4cf0012c9d48013f8f708853867d1665c1e6ef377a28a5c3b0d8ebe7b2b0299d39a2543a99054aec434db47add6de6040fe6688b7a21df20d52c9216d0122cbd"
    },
    {
      "line": 544,
      "relation": "positiveCorrelation",
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "source": 149,
      "target": 153,
      "key": "18b4ec53d3aa4d785991a66712ec557ee458aa0ac394387e11dbdd95113f2fde00cabb63e968e3c256352a405fa12050771d603d635754f2b66f83e74653c191"
    },
    {
      "line": 545,
      "relation": "isA",
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "source": 149,
      "target": 64,
      "key": "6d2a35b3f20a3912693981e3f474494ccb00ac929a42d32caae36c702731d48832027cdaee39f739ed9a484725d0a2e0f4b1559bac8bbdad9c456b0cb35b997c"
    },
    {
      "line": 549,
      "relation": "decreases",
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 149,
      "target": 152,
      "key": "05a98415c03be85121c064925a352ed8a61bb85171bdb9dd8bdeea6447852a17bcd9ad3305ef9598066cbdfa8166f9b4e8f56f62f73681a7a2c69b8ac689b4a2"
    },
    {
      "line": 561,
      "relation": "negativeCorrelation",
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "source": 149,
      "target": 18,
      "key": "7866808ceb29bdbe5d2659f8e93e853a14d3a8d028385b7d22d75e69760c36f37d66ec4391bac9eb9a6bd142dee1571db74497f8369b285f03aa588fc8e9741a"
    },
    {
      "line": 544,
      "relation": "positiveCorrelation",
      "evidence": "Thus, Tau and FKBP52 form a complex in rat brain. These findings indicate a direct interaction between FKBP52 and Tau. As shown in Fig. 3B, the amount of FKBP52 recruited by Tau depends on its phosphorylation state.In any case, these results underline the importance of Tau phosphorylation for its binding to FKBP52.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "source": 153,
      "target": 149,
      "key": "289d154ce70c1e5d21b4064422f11e6b6bab87ec83397488d3c8d2a3e003422f39cd7ec84214ae827dd91850f2a182b72ef93c23548e27b7121bcb154bdaa488"
    },
    {
      "relation": "hasComponent",
      "source": 64,
      "target": 149,
      "key": "4a00ec94414065b075bdf56b2136a4908ca7f3eb3b5316e3538c29ba6866e3e445ea3052cfafa51e611891ecde05dc835facc288da45c9a3207cc53904ac17ad"
    },
    {
      "relation": "hasComponent",
      "source": 64,
      "target": 153,
      "key": "a219c95d3057e777246f6c3e16a37cb38e0d3318dc9174186f843b00e7a8c5113cac5fa079e659b7b07c719fabf68464fda0f89b0e83ccd2dcf90705cf7f19f4"
    },
    {
      "line": 551,
      "relation": "positiveCorrelation",
      "evidence": "We concluded that FKBP52 inhibits the promotion of microtubule assembly by Tau.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        }
      },
      "source": 15,
      "target": 32,
      "key": "21bbdab38eb19ddd40d7afeb3f5a828b99e033f2877e4e94b10ad7aa7cec52521df07e04f4f73ad3a618c722a2a68c9b36a4e2a226cfc982bcfd923f271ce350"
    },
    {
      "line": 561,
      "relation": "negativeCorrelation",
      "evidence": "Because one role of Tau is to stimulate neurite outgrowth (12), we investigated the consequence of FKBP52 overexpression on neurite length in both PC12 and H7C2 cells. The inhibition of neurite outgrowth resulting from FKBP52 overexpression is in agreement with our previous report showing that the loss of FKBP52 in PC12 cells results in the formation of neurite extensions (9). The FKBP52 effect on neurite length could be explained by the binding of Tau to FKBP52, removing Tau from microtubules.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        },
        "Species": {
          "10116": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "source": 18,
      "target": 149,
      "key": "cb593638c110d9eb77e17adf8f0fa2f5a49a6c02217ef4b553b2210e9bf8615e53f8f1e3a22a6e66de46252d5d5ebe090fabc815433117c155372125e3f4280c"
    },
    {
      "line": 568,
      "relation": "association",
      "evidence": "In addition to its peptidylâprolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        }
      },
      "source": 92,
      "target": 156,
      "key": "60fcc65b11c5bfb14f0fee159a69ead770eb0fb67247546f6912f6184abaa6b7aa34ee5d403595e3df72ed28bc657a23e765b80ec169c82fc4730d7a1a192e23"
    },
    {
      "line": 569,
      "relation": "isA",
      "evidence": "In addition to its peptidylâprolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        }
      },
      "source": 92,
      "target": 91,
      "key": "9d85d039593b950c6fa8da85b27517f3668797d6c950c64919e73404740854dd2519587b679c1447861c69457d6f9a4966e02ce4a94bbeab06e476f3df145f7b"
    },
    {
      "line": 570,
      "relation": "isA",
      "evidence": "In addition to its peptidylâprolyl isomerase activity, FKBP52 serves as a molecular chaperone. This activity depends on its tetratricopeptide repeat domain (27) to which the molecular chaperone HSP90 and other proteins bind.",
      "citation": {
        "type": "PubMed",
        "reference": "20133804",
        "name": "Proceedings of the National Academy of Sciences of the United States of America",
        "title": "A role for FKBP52 in Tau protein function.",
        "volume": "107",
        "pages": "2658-63",
        "date": "2010-02-09",
        "first": "Chambraud B",
        "last": "Baulieu EE",
        "authors": [
          "Baulieu EE",
          "Chambraud B",
          "Dounane O",
          "Giustiniani J",
          "Goedert M",
          "Sardin E",
          "Schumacher M"
        ]
      },
      "annotations": {
        "Method": {
          "Dot blot": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GST": true,
          "Co-Immunoprecipitation": true
        }
      },
      "source": 92,
      "target": 49,
      "key": "4a0394acd55bf22bb71d4983a949c64d090a0f856d349ba9dc7197aa8120f6c7ded9d0c78f4afa1de3eb97dd5d1ad590ecd606ebdea76e947f0862f4688e1f6c"
    },
    {
      "relation": "hasVariant",
      "source": 91,
      "target": 92,
      "key": "5bee8009e048a74bea0fc1652a100e9f3b6cf6863a4089a4bee6edb7a80b15a9ae043ccdbffb66b4c060805f8a4b1ec854df1a2aa291e71cb0719c5f4788433c"
    },
    {
      "relation": "hasComponent",
      "source": 49,
      "target": 91,
      "key": "7eec87628a9b77c26e3740ce0c0df51e6c576e1653c3865c7965052092bfb0dec81c159c50afe16a80c5075a3373f9bd4ecedf4a683dffe2c7e85882c91fcb0e"
    },
    {
      "relation": "hasComponent",
      "source": 49,
      "target": 156,
      "key": "1be77dd920b0561de15a270f93d4f7ee00f25817b565a8f48b3939f7d572c2c3ebd606bcd44c66eae70a592de20fe79c84700114f80de89440d3c4e2be4596f8"
    },
    {
      "line": 586,
      "relation": "increases",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 103,
      "key": "32dccdaf53b0fab332e4581aaeb68dd0341a81663162ab208522cb8e5a855b8abc1c4c5045e712097d033f646c3f6f93bab3e5705058022aaead77785cde1155"
    },
    {
      "line": 587,
      "relation": "isA",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 50,
      "key": "2994dd8be86d43b59b84418825595c5d333816b6767bb7c9259a77beee8a739ed0d767306832795279336ebd7af88b97b83d3556cafa58741ccbc7e8a7b348c8"
    },
    {
      "line": 595,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 113,
      "key": "6ea2f2a92695e6faa0832294192f9287089ed34c822e27772d53b9ce0363ee56d92709230c9dbb7d1a7eda3cf9fb129ac1d97873b46da3a7e46da3ec511081d9"
    },
    {
      "line": 596,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 109,
      "key": "026baabf3bbc0d93e9996bcbdec38525c54a382c5594af59b4670b8a9aa89e1221808cfc28d75f28bbb733520e0179de5d5b02e222a75b6c46e148923b4a1d25"
    },
    {
      "line": 597,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 110,
      "key": "ccdfcded8bf96af2882d482e915fcdd2cd458a00ed4c9c37b1511ba4eb7a14f1b25dd8dccb5f0fcb6a451f86e4c7924156973f0d9ca1162595a5a2858f421c75"
    },
    {
      "line": 605,
      "relation": "negativeCorrelation",
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 45,
      "key": "9915cd64b65a3aab90385a1a987a8dc83cdb58a6ed84a88c60e519fa11685ce28ddefd414f725bce373fa17e15eabf841e5d62f9adac1ca48e57420fa54613c9"
    },
    {
      "line": 606,
      "relation": "positiveCorrelation",
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 61,
      "key": "08fbf322113ec2c30eff4ef2242b5a973cd73ea4f5940b8b1e561732583bab189a828d711e230132e8ce05a94c9d97898b012be58c6c4aade6877bb219d7e445"
    },
    {
      "line": 607,
      "relation": "decreases",
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 58,
      "key": "308c00f0b6bc1065a1184c965e965bec29fb4fc5404554f30fa2fbbac9024028a3f09fe3d1161bad912a3f8d5a434f0902ab7ba6cc3634f5812df583b9f29a34"
    },
    {
      "line": 613,
      "relation": "increases",
      "evidence": "Fluorescent imaging of these extracts revealed that wildtype FKBP51 promoted microtubule polymerization relative to extracts treated with buffer only (Fig 7A and S2). Conversely, neither mutant F130A FKBP51 nor FKBP52 stimulated microtubule formation.",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 93,
      "target": 15,
      "key": "7220925de658372683a56d418f40850543448f53a292e2cd35a22abe4325fe1f0a076d6660697849cc9a139d080c9f83cbe92b791c2bcbcbc1975dc0961bd607"
    },
    {
      "relation": "hasComponent",
      "source": 50,
      "target": 93,
      "key": "751cc2dface2921a035edc432b6ff2a513c5fcd0d182cc7b1ac204d30578b72c88cb45c728d9ef69b391714c1ca5931f75debcc42c3dd635bfcb0a61d76d2caf"
    },
    {
      "relation": "hasComponent",
      "source": 50,
      "target": 103,
      "key": "78e0ecd13102ba0b90fb1a41250aa795bede51517dafff80a580d99bd5b6516dee6fbf5c074adbbd28d8a2e2336d57d096b066fc70d84e7ea929c34f911d14c7"
    },
    {
      "line": 592,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 50,
      "target": 113,
      "key": "11c2db509de7c9017ee075a55caafd4e3ef662739e05683d8dfeeaebedd6aeee5e8a0b3b7493610f37a3fb656605f4ef44b74ad90c03942046bfc1c2d6b7b871"
    },
    {
      "line": 593,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 50,
      "target": 109,
      "key": "9a86e0b7e8b929aaa580d7102c2669e18c9fdc605095ff987dc3084d7ef6382f434703041dd9fa838977bbbb488e8994810c453c9ec34c6d6b993fb3cb6858af"
    },
    {
      "line": 594,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 50,
      "target": 110,
      "key": "7b0b22eb577709082ab0ccd39608064a9da708b0cb466bb30d70ec65ce301a9bd61bf06b6ecaf5b57fd97c32844da8640c57b13256cc683e303e3a6583bcf3ee"
    },
    {
      "line": 590,
      "relation": "isA",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 109,
      "target": 153,
      "key": "bf6f1c17d2adc09859a7cf48e3d6acfd0a23fc9e4c0b28753d85961acbf581826d28a5c39795ac8f3c8d046e1fcff848037a3926a1600f718424ab5f63f71e7c"
    },
    {
      "line": 593,
      "relation": "association",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 109,
      "target": 50,
      "key": "6ff61a9c4db99768b6fd8d844200b3576f73816f40e4237eab30417bd22c0f2a39bcde21f5531d477e95b870709813ad6e9b431b60205bc7cd39bf50d3d6d171"
    },
    {
      "line": 596,
      "relation": "positiveCorrelation",
      "evidence": "We found that FKBP51 indeed could interact with tau from both AD patients and control cases (Fig. 3D), further suggesting a functionally relevant relationship between FKBP51 and tau. We then investigated whether FKBP51 would preferentially interact with phosphorylated tau species. We increased the number of samples per group (4 for AD and 4 for normal) and again co-immunoprecipitated FKBP51. After gel electrophoresis, immunoblotting showed increased association of pS396 and pS199-S202 tau species with FKBP51 in AD tissue (Fig S1). Indeed, we found that FKBP51 over-expression increased phospho- and total tau levels (by 80%) in HeLa cells stably expressing normal human tau, while FKBP52 over-expression had no affect (Fig.4A). These experiments were repeated multiple times and Student t-test of these replicates demonstrated that FKBP51 significantly increased total tau levels (p= 0.0104).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 109,
      "target": 93,
      "key": "acc22a1994d04ef803fa3f581b0dd2028eb5acf6880d8d1034fac4d50e95598b8fbd3d39f1296edd94e89d5f19ce55d7d7cb261e413f5e91b39ea0d66863c953"
    },
    {
      "line": 631,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 109,
      "target": 86,
      "key": "cd847569cea6079d71f9b9ffe383067c8241282392c0e6d439b7af66f639e7f489e0ef3a9655f1648c5a117e103b8a552184fba4c8a5fe050115ec28870e421b"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 82,
      "key": "8825b169e95be3c771eda55172b245c80fc1892235d56c48776f6e69fbb3f4dca0ebafa7c1d8164d754794d9989738ba444a9f239f89d63c6aa599ab7024264a"
    },
    {
      "relation": "hasComponent",
      "source": 45,
      "target": 103,
      "key": "e9a42630ab686ea6cd9a4a2ac2928ea1cef7a8eccc152b5bc91c37602e2b3984f699df97ff3a37ac2946309ff0ae74a2633862f74594f71ab73fbadfe09e1fff"
    },
    {
      "line": 605,
      "relation": "negativeCorrelation",
      "evidence": "We then investigated what effect over-expression or knockdown of FKBP51 might have on the interaction of tau with other Hsp90 cochaperones that comprise a mature Hsp90 complex. Surprisingly, we found that FKBP51 over-expression decreased the endogenous association of another Hsp90 pro-folding cochaperone, Aha1, with tau despite increasing Hsp90 binding (Fig. 4C). Endogenous p23 binding to tau however was not detected. Conversely, knockdown of FKBP51 with siRNA increased the association of endogenous Aha1 with tau despite decreasing the number of Hsp90 tau complexes. Moreover, endogenous p23 binding to tau was only detectable when FKBP51 was knocked down (Fig. 4C).",
      "citation": {
        "type": "PubMed",
        "reference": "20071522",
        "name": "The Journal of neuroscience : the official journal of the Society for Neuroscience",
        "title": "The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.",
        "volume": "30",
        "pages": "591-9",
        "date": "2010-01-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Blair LJ",
          "Borysov SI",
          "Buchner J",
          "Cox MB",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "O'Leary JC 3rd",
          "Schmid AB",
          "Shults CL"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatography, Ni-NTA-Sepharose": true,
          "RNA Interference, siRNA": true,
          "Co-Immunoprecipitation": true,
          "Chymotrypsin Assay": true,
          "Protease-coupled Assay": true,
          "Microtubule polzmerization Assay": true,
          "Immunohistochemistry": true,
          "Chromatography, Gel filtration": true,
          "Immunofluorescence": true
        }
      },
      "source": 45,
      "target": 93,
      "key": "203cc2a76801298a8ee4344642390e720ba7d4b72bd4185fcb86b171bd534f866dd862aa89d03e8763169a1f4157bbc3a2865bf0dfcba3f525eab8f25689fd17"
    },
    {
      "relation": "hasComponent",
      "source": 58,
      "target": 103,
      "key": "3b1a71032e6e158eed362f39f4353746887231cbadd79063a6de99ec5431d97229f1890356c405433bbd6a4f0ba9cd779491444ef07159a485c0ee7f844a09e5"
    },
    {
      "relation": "hasComponent",
      "source": 58,
      "target": 128,
      "key": "aa831c0d2a532e7efaed01169c2b7deb013c265de9a5e9463e3b5fc7e3cb2301c5bfd47a14a921e0d26f8a644dbc97fd2da4c2e2148f6158a07c60305d33be90"
    },
    {
      "line": 623,
      "relation": "positiveCorrelation",
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 86,
      "target": 156,
      "key": "44f938caa67669b18e7b08636976340527a7574ff437e25b83323d5a511622fd8d24416a2dd6a363999d131b14efcfa6c1715328848991a0e2234e3e1ac2cd59"
    },
    {
      "line": 624,
      "relation": "isA",
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 47,
      "key": "411e0157a03986e5f0e32cd6407859dfa1dbf283e80dd9276dd717af7278aac67b1308177532b9610fe64e8b3f636d1c45486127fd4a7eea75ba68b7de75fc62"
    },
    {
      "line": 630,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 117,
      "key": "d271d3592416c842ad0ef9acbd865daff1f10aa195785798575320ce9f06e076810b20b49ed5ea0ed80b3bd51c509d9533391aec580d961e5b171fadfdf9317e"
    },
    {
      "line": 631,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 109,
      "key": "3422a1c4caa2cb8071f0db85e4a818d4241098c9c4dd8d5c7fc0d70b551fe62309e704cc82b98cf59de5fab87dfd0b621770647b4b69a2c63fdded21380a17d1"
    },
    {
      "line": 632,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 110,
      "key": "84053cb1fae3d7c1722923a4baea3a3cd7920e2920862e5b29823423e9470eafd792d271ffe0786daec26c4ebe7a0e820fc4e4e5895f2940f4db1a06456441a7"
    },
    {
      "line": 633,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 113,
      "key": "690491c61b91c802bd03449bc1d3c94c2665542f76c5a44b54477282490b0db29942136efdc99a91b2c0e768b9b551246a5b0f0cfd808a47431655ac33636d37"
    },
    {
      "line": 634,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 114,
      "key": "f5ae2ba0892dab4656926ed0aa5879287014e2613f048ce18e16c17594d5e7a263140ec48ec47b640c6682aa84a6ce110f7af55746e8d5c9460d0cda2d28fbb0"
    },
    {
      "line": 635,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 111,
      "key": "c5926f8765339ee4c61b755ab84a0dfd4344a04bcb61d73ebe6e91d282e143a72db115d180528d9385f6486411238a9b2f0adbd8d6c098210fa998424fee494f"
    },
    {
      "line": 636,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 112,
      "key": "e66ff33d7b78b5cd0a977b581dde870bdb960769f3d63530847b37ba2875bffe9c0a3d6bfd7ab82d1eb3e32bdddff14fc49bb9d99c2f3e6ccac8bc1785bbf3a0"
    },
    {
      "line": 645,
      "relation": "decreases",
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 Î¼M 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "object": {
        "modifier": "Degradation"
      },
      "source": 86,
      "target": 103,
      "key": "c4ba974dc8f45047bd3d624dae020640d25b5aef0bcf3b4e993e65d3ee60197d7faea91b2c9dc0610bf2913e125f8a89ab93ca4a065893d4c780e37a046d5043"
    },
    {
      "line": 651,
      "relation": "positiveCorrelation",
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 86,
      "target": 88,
      "key": "658d93e6178b4749382f45ddcac4c9e02e2ba25e75bbeaba1df622be99ef9d67066186565ba2d66f82d3a45009fb3518769b2170c6803ac0a91c75cbb30c1287"
    },
    {
      "line": 652,
      "relation": "causesNoChange",
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 97,
      "key": "ae2028d90108c2c11a942da1ff607d4e9b34b72ba6061060db35e4d484444a41fffd879a384b815048274a594de3b5a82470bb0eb36a2c4202eda81819060e2d"
    },
    {
      "line": 653,
      "relation": "causesNoChange",
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 86,
      "target": 119,
      "key": "2117e17b99319ec9b7e3252c0900e0ec4b0d31b58a0d8e8049579835bb39e142f383712f91a1849fdc654bd926b3b8e69cceac9b11c07f565be02478eecd8f27"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 86,
      "key": "f9854420a8dca22d16a217984236d64f3993971107108b13439d6ecde59b844e81a9b7ae9faabeb7adb0dc4bc491ab8b93a438b4d921aaa3e6bc8aba584b06e4"
    },
    {
      "relation": "hasComponent",
      "source": 47,
      "target": 156,
      "key": "a923c523a54bd5fc622a0055ab6eb701d9af1d29a378d968d299515e6359a8991a6a6f09357b5e3832b2e72f4b40817789773963b65c103bd554c8e7031897cb"
    },
    {
      "line": 625,
      "relation": "positiveCorrelation",
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "object": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 47,
      "target": 83,
      "key": "2745da56bf649780ff477073fdd2b4c92324be9a0e50d9af0b68e7ae804a6f0d34bd7d1685f37f07f7879e624ebca40ede1dbda7ec2198ca17ae4f1c9eb1923a"
    },
    {
      "line": 625,
      "relation": "positiveCorrelation",
      "evidence": "This coordination of kinase triage decisions by Hsp90 requires the co-chaperone Cdc37 (cell division cycle protein 37). The Hsp90/Cdc37 machine is essential for the maturation of a number of kinases, including Akt",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "subject": {
        "modifier": "Activity",
        "effect": {
          "name": "kin",
          "namespace": "bel"
        }
      },
      "source": 83,
      "target": 47,
      "key": "aa274096a7b05e3d51e3bd008ce874776f423575a0f18286f7c4744c0e370c6e3f2a184f5515185accbd012b18731602fdf53e7dcfecba977042649fdc9d1a37"
    },
    {
      "line": 635,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 111,
      "target": 86,
      "key": "e939f96641b0d13c4e566f57894fcbb564f6efce17da16a12a2f8326cdc46890e4f5e94fdc319445571c546b24d3b2c4b564c0c1d304c7d11e740745a18c33f4"
    },
    {
      "line": 636,
      "relation": "positiveCorrelation",
      "evidence": "Quantification of the Western blot showed that Cdc37 knockdown reduced phospho-Thr-231, phospho-Ser-199/Ser-202, phospho-Ser-396/Ser-404, and phospho-Ser-262/Ser-356 tau.",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "source": 112,
      "target": 86,
      "key": "45adeea9285acb82d47d3ab023f6646b3b306dbdf509e9c79b524c8b0b4afbcbc3afb5f6e8a3215daf7bc480bc10d795bf77f7063f56616b683dcd5608ae9dc7"
    },
    {
      "line": 643,
      "relation": "decreases",
      "evidence": "Previous work showed that Hsp90 inhibition with 17-AAG reduced phospho-tau levels in vivo (16, 23). We speculated that Cdc37 might modulate Hsp90 inhibitor efficacy for phosphotau. M17 cells were transfected with Cdc37 siRNA and then treated with 1 Î¼M 17-AAG for 24 h. Indeed, reducing Cdc37 synergized with Hsp90 inhibition to reduce tau levels more potently than either condition alone (Fig. 6A).",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 156,
      "key": "cd5a07ec1e943c140498b018d5aa08c92cdbe0422cd4a953e613f35e90eac668c7b384a3fe111cdab2e399d681dab9a4d3d9c8d0f1bb4888e675615fe7442727"
    },
    {
      "line": 651,
      "relation": "positiveCorrelation",
      "evidence": "Western blot analysis for a panel of tau kinases showed that only the levels of endogenous Cdk5 and Akt were significantly reduced by Cdc37 siRNA; the levels of GSK3-Beta and Mark2 (microtubule affinity regulating kinase 2) were largely unchanged",
      "citation": {
        "type": "PubMed",
        "reference": "21367866",
        "name": "The Journal of biological chemistry",
        "title": "The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.",
        "volume": "286",
        "pages": "16976-83",
        "date": "2011-05-13",
        "first": "Jinwal UK",
        "last": "Dickey CA",
        "authors": [
          "Abisambra JF",
          "Dickey CA",
          "Jin Y",
          "Jinwal UK",
          "Johnson AG",
          "Jones JR",
          "Koren J 3rd",
          "Lawson LY",
          "Li Q",
          "O'Leary JC 3rd",
          "Trotter JH",
          "Vestal GD",
          "Weeber EJ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Immunocytochemistry": true,
          "RNA Interference, siRNA": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 88,
      "target": 86,
      "key": "370ad1bf7571d330cf6d9916c986fd7df65e375b0be22fa40787f82d879a1fc492f449b347ded3a68a5284b6307c085048f97306f31c969391bf69d5513d0ee5"
    },
    {
      "line": 664,
      "relation": "association",
      "evidence": "The present studies show that the calcium-binding protein calmodulin interacts with a tubulin binding site on tau defined by the second repetitive sequence",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "source": 71,
      "target": 79,
      "key": "db1dd4f35d2d11c41b2c4714a555cd9fd70f5a61d8c7a1af41734fbc1e73ca1ba4ce9f8de8f4f6c0441428614cb75624390b21dce70c065304c6457da050f0a9"
    },
    {
      "line": 672,
      "relation": "increases",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 71,
      "target": 35,
      "key": "81971907faf7d94658e541fae5682d1ba7b439a7d2c23e79d757a5d7e37231a601fd18189886720b2af36173fb8473bcc120862e7a2015aea77e04126d472bf0"
    },
    {
      "line": 673,
      "relation": "decreases",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 71,
      "target": 15,
      "key": "78742bd1d5495ab32c4aea6b1047b8f9e606888692ba123459c790ae0b13cc45a6ab171ca07cb33dc00adf49388c22667c0152b3723b88a0ca4f4e166b0eb6de"
    },
    {
      "line": 664,
      "relation": "association",
      "evidence": "The present studies show that the calcium-binding protein calmodulin interacts with a tubulin binding site on tau defined by the second repetitive sequence",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "source": 79,
      "target": 71,
      "key": "c563276a2870e729b50fdff3fde5a50ab4f6a71d4a8f3d9c867f260d521c68326bad2f05c2f76ec2ee065c676a3ecb5ce5f09c348fe4596c264917c3c32aabb1"
    },
    {
      "line": 671,
      "relation": "increases",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 71,
      "key": "3f3f0044f1bb5ee50aaa7f44381d13420bf80d177d5598f5ac4847cc269a8163fb8cc0fb8bdcf6b0ffadf6f0464f8f4866561e5712237dbcad900678e16d2028"
    },
    {
      "line": 694,
      "relation": "increases",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 1,
      "target": 129,
      "key": "844189a32de52e8da7cd30fc5ba04a56af52a33a8e0ca7df76995791fa18d4f05d8ef787c0b9115ea39dce18028c5a3cf2212a084fc2326917bc9d2a75d00979"
    },
    {
      "relation": "hasComponent",
      "source": 35,
      "target": 1,
      "key": "07028dcdd2ae6afa50d4555ced0afab3f1bc87ff4c7f573e32a60eec40392f6015135d2c3247316d66e382e6639ef2407ee41ca5e9acf2e63abb124b9834d74b"
    },
    {
      "relation": "hasComponent",
      "source": 35,
      "target": 71,
      "key": "9bf43fd878d49a2bbe15e7aab82fc57439527a3878309d1629f93d2201c1cd7eac74b9dea1d82056804675dc67ec7e7e1b5b046e8031e424ca839c1f256a7241"
    },
    {
      "line": 676,
      "relation": "isA",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "source": 35,
      "target": 36,
      "key": "a95abf1d4401cd20d30aedfa1db5ebb9a611a857747f0835f5d72dfeed37c2fa7f2051fd2529b086dd095009b9ec367c48cd9e101e9abc200a71533701715c39"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 71,
      "key": "4370f4ce3547cdcf3710babe9e83b1a2556abd889f6c0c53d323a9929752a9cf9fc235863f8a2567727c2c91c8e856761047f51d8623af871859bb78c6edfe01"
    },
    {
      "relation": "hasComponent",
      "source": 44,
      "target": 103,
      "key": "1f9c71c76e9cac0ad82c5d163c1d135786eec2c5a565949a38662630be9378c5471bca4c117c467863fcb7256bb565d158bcbba3553d4b26b803c150996f4d8a"
    },
    {
      "line": 675,
      "relation": "isA",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "source": 44,
      "target": 36,
      "key": "973155911060d10dd8373863421d24c5c2e50911304fe72e914f07fab76f7486a29dec592b00ee86043d41d5fe50d8030506aa611eb7aedb3d3fb51e8530e4bb"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 1,
      "key": "2b5bfc1b0088c829d9b80af991adad8c35af34a7b13693f99dc8f50d387ed371d8b01d00a5037afb853b4ac7a2989afabe92bd45f5a4ee2f0dcf8dbf32110e22"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 71,
      "key": "c0a842bb697f7deed63772b57bb83a30739bb05a5cbcdfef134b31b4d0f6289b837412e45a061538f68edd6cf234a11df82e92dc106531cdb453b3b834b21111"
    },
    {
      "relation": "hasComponent",
      "source": 36,
      "target": 103,
      "key": "4906da465d9aca042cdd73e7ab1dd3f7bbe49a273adf5c4c2c470865748f7db21f50bfee669f7aeaac19774b64a22ac7906675d679217546916451237aa15f0e"
    },
    {
      "line": 677,
      "relation": "negativeCorrelation",
      "evidence": "These findings provide new insights into the regulation of microtubule assembly, since Ca2+/calmodulin inhibition of tubulin polymerization into microtubules could be mediated by the direct binding of calmodulin to tau, thus preventing the interaction of this latter protein with tubulin.",
      "citation": {
        "type": "PubMed",
        "reference": "2123288",
        "name": "Molecular and cellular biochemistry",
        "title": "Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.",
        "volume": "97",
        "pages": "35-41",
        "date": "1990-09-03",
        "first": "Padilla R",
        "last": "Avila J",
        "authors": [
          "Avila J",
          "Maccioni RB",
          "Padilla R"
        ]
      },
      "annotations": {
        "TauIsoform": {
          "Isoform F (441 aa)": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 36,
      "target": 103,
      "key": "5051b65560c2257cde3dc62d183293c16f551a7aae03ddff26e4c2c20dfb0e8a7dccd9f4cdf4b2c01a6b7553d632df2ac1034f88c0de1f63311d8ed9bf7d4409"
    },
    {
      "line": 693,
      "relation": "association",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "source": 129,
      "target": 103,
      "key": "4bff4be0072b59d2e9425b70fb60bb7994ec26939c9493a2ca6a87a764753f4b8f847543ac11528a162ce6831c8b29a818600f3acc5e40a5701445fb2e9d47b5"
    },
    {
      "line": 695,
      "relation": "isA",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "source": 129,
      "target": 59,
      "key": "b4f7ca4fa248dd32235cceaa1399e56e59531847410b531a97c918c2b6749b5044d99ff9766b34a4d6b5d2227d207296158d6f0ff435672a482773a505ed603e"
    },
    {
      "line": 699,
      "relation": "decreases",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 129,
      "target": 155,
      "key": "09f2df4f63e891812b76c10bb39dc7eee04fada71929898c11ceef78871b70083d40bc822db6a4c3c82d4b37096a229cc803239102af5bf5a87501a5aa8cd580"
    },
    {
      "line": 724,
      "relation": "increases",
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3Î² phosphorylation and Î²-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 129,
      "target": 81,
      "key": "9bbb60ee0350a707e70f2823669264e92b4f1fc1b02e343d54b1ec11a63250a7a33729348073d4fe4e2d8d823efbec5c219eb0dbbf477021d34c9dbb0858d6fa"
    },
    {
      "line": 726,
      "relation": "increases",
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3Î² phosphorylation and Î²-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "source": 129,
      "target": 72,
      "key": "77c75650eb02e43213c9c5e284423e8f363d0bd54a17fa2f969245e2e508c47b46069289d08ef95b7dec66275a0a15183f052d723b74765bb543f4d79d7597e3"
    },
    {
      "relation": "hasComponent",
      "source": 59,
      "target": 103,
      "key": "85839472101be94f478dee3fd0b101c3946ef3111abf096178f775195a687df0d65d0ec4a74eb764a38858f28aa0e535550a2b6382ef7df701f82e615c0119ce"
    },
    {
      "relation": "hasComponent",
      "source": 59,
      "target": 129,
      "key": "41af0133074b2e22b0559121d119f1e5152fb0d61a80af2f8585c304bdbb6fdf8da2397d8976d223fdfef5788fe904769a156454175aca733660a72e31debc0b"
    },
    {
      "line": 698,
      "relation": "decreases",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 59,
      "target": 155,
      "key": "eee259b498ea501eea1525ee151c87898626051d075dca364e27492638aa7d1726946ad201dabfb11277d0f172039131d1777324bf1e0aeb67a64a5adffa1edc"
    },
    {
      "line": 697,
      "relation": "increases",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 155,
      "target": 108,
      "key": "108056bbd0dc88d4f76a7771e905c7e3db5b37d08ccfa002ca35d059466a4f379fea41ef14b37eeb303bb9e6db9d0c464b8b670571638c9253a3226fb28ab923"
    },
    {
      "line": 700,
      "relation": "increases",
      "evidence": "We here confirmed the interaction of SlOOb with tau through affinity chromatography and crosslinking and demonstrated that such an interaction also inhibited mode I phosphorylation by a Ca2+/CaM-dependent kinase. Increasing Ca2+c oncentration to the 100 Î¼M range potentiated the SlOOb effect. Therefore, although Ca2+-independent interactions may occur between SlOOb and protein tau, it is the Ca2+ form of SlOOb that has significant affinity for protein tau. In any case, Znz+ and Ca2+ both appear to be capabble of inducing a conformation in SlOOb that promotes its binding to target proteinins, including tau.",
      "citation": {
        "type": "PubMed",
        "reference": "2833519",
        "name": "The Journal of biological chemistry",
        "title": "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II.",
        "volume": "263",
        "pages": "5876-83",
        "date": "1988-04-25",
        "first": "Baudier J",
        "last": "Cole RD",
        "authors": [
          "Baudier J",
          "Cole RD"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Chromatography, FPLC": true,
          "Chromatography, Affinity": true,
          "Phosphorylation Assay": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 5,
      "target": 129,
      "key": "30f2567d9800afe673c72901ac6935ae95b90d102397a4c09ed478d73107165e483d272680f9633266b3878a7a544a6707f01394d695559cbf212947ae97942d"
    },
    {
      "line": 707,
      "relation": "negativeCorrelation",
      "evidence": "In general, GSK-3Î² phosphorylation is inhibited through the canonical Wnt signalling pathway [5]. Wnt, binding to frizzled receptor, recruits dishevelled protein, which in turn antagonizes GSK-3Î² activity.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 13,
      "target": 97,
      "key": "760f3d55e27af15d7d4a30f0103c1b157061d3f2bec07991e46d6d01d27399d58bd472627b2838f61f32e36e31ea3e04217a822bac83c11273199434c3fc6f42"
    },
    {
      "line": 712,
      "relation": "increases",
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3Î² activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to AÎ², and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "source": 14,
      "target": 90,
      "key": "8ceab7e4eac90baef90f9fc3f64f455c2df8c37b1fc6bf579b317afa8a9035a3a3861ffe74334478e1d56be38382a81e5d1bb4621f3d19be4ebea745215cb07f"
    },
    {
      "line": 713,
      "relation": "increases",
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3Î² activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to AÎ², and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 90,
      "target": 97,
      "key": "92fd1b19c912531c7017bd26207f1d5b4c3b8da7ecabe0ffec2bfc039aea10a244f00ee0669f381dca4df934cc9d1c12b155fd35c64d2a18db9d66f139157b9f"
    },
    {
      "line": 714,
      "relation": "decreases",
      "evidence": "For example, ongoing inflammation can trigger various cell stress-response pathways, including overexpression of the secreted glycoprotein Dickopff-1 (DKK-1). DKK-1 up-regulates GSK-3Î² activity, promotes tau hyper-phosphorylation, NFT formation and neuronal degeneration. Thus, DKK-1 inhibits Wnt signalling in a manner similar to AÎ², and thereby fosters a self-sustaining feedback loop resulting in cellular injury",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "source": 90,
      "target": 13,
      "key": "42b455028023ca4050f5570e5f7159d243a304fcdbf1bbaca94c1d843371e220474445acc1886ee56abd2776e4787c348098b7045be3b0387764f2351a29e215"
    },
    {
      "line": 725,
      "relation": "positiveCorrelation",
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3Î² phosphorylation and Î²-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 81,
      "target": 72,
      "key": "cbb3a6b9efd40fee909e42f084e597b877522668d3844f1944309c1e995eebe4c6a85098e42d033569872f47f40298a5920b6b72496f8186014444a1463c7e1f"
    },
    {
      "line": 725,
      "relation": "positiveCorrelation",
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3Î² phosphorylation and Î²-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 72,
      "target": 81,
      "key": "feaba23fcd095fc29df18978211a5e58f0bce8f9afaeb9bcb56e432b86b9eb132ab4b26728ca4fc1471684ab0a44f1381f151c20b79a72dfacbd28c5a1aca140"
    },
    {
      "line": 727,
      "relation": "increases",
      "evidence": "Utilizing Western blot, electrophoretic mobility shift assay, supershift and reverse transcriptase-polymerase chain reaction techniques, it has been demonstrated that micromolar S100B concentrations stimulate c-Jun N-terminal kinase (JNK) phosphorylation through the receptor for advanced glycation ending products, and subsequently activate nuclear AP-1/cJun transcription, in cultured human neural stem cells. In addition, as revealed by Western blot, small interfering RNA and immunofluorescence analysis, S100B-induced JNK activation increased expression of Dickopff-1 that, in turn, promoted glycogen synthase kinase 3Î² phosphorylation and Î²-catenin degradation, causing canonical Wnt pathway disruption and tau protein hyperphosphorylation. These findings propose a previously unrecognized link between S100B and tau hyperphosphorylation, suggesting S100B can contribute to NFT formation in AD and in all other conditions in which neuroinflammation may have a crucial role.",
      "citation": {
        "type": "PubMed",
        "reference": "18494933",
        "name": "Journal of cellular and molecular medicine",
        "title": "S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells.",
        "volume": "12",
        "pages": "914-27",
        "date": "2008-06-01",
        "first": "Esposito G",
        "last": "Steardo L",
        "authors": [
          "De Filippis D",
          "Esposito G",
          "Iuvone T",
          "Lu J",
          "Savani C",
          "Scuderi C",
          "Sheen V",
          "Steardo L",
          "Steardo L Jr"
        ]
      },
      "source": 72,
      "target": 90,
      "key": "4aba6b071b964f43c5db8a08bfdd4bb6476a1649c48b225e490e263931ae22a10018a90e40fa73dc9fc0d155b57ad7420896fb96fefe62a9d1680cab8ad7e30c"
    },
    {
      "line": 737,
      "relation": "positiveCorrelation",
      "evidence": "Recent studies of an individual with Parkinsonâs disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread -syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant -syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "source": 68,
      "target": 26,
      "key": "a321e6004953e166c48375d876249d039d607ac98ee462b5497e051452b12a3205f3b0ed82b824801b4c99926b7e48bba99f11db3a05c7ba3876038f2082b0f8"
    },
    {
      "line": 738,
      "relation": "positiveCorrelation",
      "evidence": "Recent studies of an individual with Parkinsonâs disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread -syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant -syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "source": 68,
      "target": 23,
      "key": "0b711fbacdb572275c6a7899ad745afc1ab2718279b7173da112a6b57d5b7bcd6950f3a7e69a9664279d6654757309e55a444e355718fb609b3ae588028ad8f2"
    },
    {
      "line": 738,
      "relation": "positiveCorrelation",
      "evidence": "Recent studies of an individual with Parkinsonâs disease (IX-47) of the Contursi kindred with the rare A53T alpha-synuclein mutation revealed widespread -syn and tau inclusions (15). Post-mortem examination of another affected member (IX-51) of this kindred also demonstrated abundant -syn and tau inclusions(figs. S1 and S2). Thus, a pathogenic mutation in alpha-synuclein that is known to increase the propensity of alpha-synuclein to fibrillize (8, 9) also promotes formation of tau inclusions in humans.",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "source": 23,
      "target": 68,
      "key": "4e217510ee602dd95806096a515e2e35ce46df3947c3d389b9ee3846d09fd79f91f701da103bd01da7587ceb2b3314f6de1cb3fba6ae358ccda275adde75c3e2"
    },
    {
      "relation": "hasComponent",
      "source": 67,
      "target": 103,
      "key": "206b8537cd04fc4eb89faa3e37f9ce42300eef55c090f23b799b57daf4db35f3f2d59c52365ef9ae1150527ba9ee1d044eb9c9b4360636b50ac87c789c8d58ab"
    },
    {
      "relation": "hasComponent",
      "source": 67,
      "target": 130,
      "key": "34f80828a92ae2511e080994299ea51a504c809b879379f1ff49adab1dff16f4d50b5573e743f696641af9b5b178b051a0f82e31141b36bb405834c98298485c"
    },
    {
      "line": 746,
      "relation": "increases",
      "evidence": "We also observed that tau and alpha-synuclein synergistically promote and propagate each otherâs polymerization into fibrils",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Electron Microscopy, Immunological": true
        }
      },
      "source": 67,
      "target": 26,
      "key": "7c1bf80aa235917fa0b563edeeb350449346a5488414ba98112639babcf69ac639928771a69336e802047f1aef827de351a685c69f4a210420fd035e8d9b423c"
    },
    {
      "line": 747,
      "relation": "increases",
      "evidence": "We also observed that tau and alpha-synuclein synergistically promote and propagate each otherâs polymerization into fibrils",
      "citation": {
        "type": "PubMed",
        "reference": "12714745",
        "name": "Science (New York, N.Y.)",
        "title": "Initiation and synergistic fibrillization of tau and alpha-synuclein.",
        "volume": "300",
        "pages": "636-40",
        "date": "2003-04-25",
        "first": "Giasson BI",
        "last": "Lee VM",
        "authors": [
          "Forman MS",
          "Giasson BI",
          "Golbe LI",
          "Graves CL",
          "Higuchi M",
          "Kotzbauer PT",
          "Lee VM",
          "Trojanowski JQ"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "Electron Microscopy, Immunological": true
        }
      },
      "source": 67,
      "target": 23,
      "key": "e42b45d58e5144c6d35cf9eb51ac02ad8ec8d7697ee9cc10eef88aec79a2c539b31513b6abcb81469ba2a58b6a802307dd8ea5548633edc6957d9a5168dee4b2"
    },
    {
      "line": 763,
      "relation": "isA",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 135,
      "target": 54,
      "key": "1937611761c4cf16ce7e4e4832fe90c2843df0eb1f1130c02660151075515d1be5c9be6e08401a4439419bf5ed3ab5e6a2b6f3833fade59dac9d9c8d1c3857fc"
    },
    {
      "line": 764,
      "relation": "association",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 135,
      "target": 103,
      "key": "a2a09a29610c3ac564db321a03cefb5ece7350f43255c4297b1851fe879700478bf7b5b0f2c9c1411cfd20b71d8b106e2743acbf0cbefe25648e41b9ecd94372"
    },
    {
      "line": 765,
      "relation": "association",
      "evidence": "These observations suggested that 14-3-3zeta may be bound to GSK3Beta and/or tau within brain microtubules and may be a component of tau phosphorylation complex.Therefore, 14-3-3 must be the central molecule that holds tau and GSK3Beta within the complex. Indeed, FLAG-tau co-immunoprecipitated with HA-GSK3Beta from cells overexpressing FLAG-tau and HA-GSK3Beta only when these cells also overexpressed Xpress-14-3-3zeta (Fig. 6A, lanes 8 and 9), indicating that GSK3Beta associates with tau only in the presence of 14-3-3zeta. As discussed above, 14-3-3zeta binds to tau (36) and GSK3Beta (Fig. 5) directly. Taken together, these observations indicated that 14-3-3zeta connects GSK3Beta to tau in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "source": 135,
      "target": 97,
      "key": "e46f3fa9d93879073c40a427af96a9a2ebed1fa48f74a991a0ab26b105ffdc42a5a68d45c3e5d5fbbd8eaecea47732b8c9f0529de279c763b5fe880054e42b27"
    },
    {
      "line": 775,
      "relation": "increases",
      "evidence": "In cells that were co-transfected with fixed amounts of FLAG-tau and HA-GSK3Beta but different amounts of Xpress-14-3-3zeta, FLAG-tau phosphorylation increased progressively with the increase in the amount of Xpress-14-3-3zeta (lanes 7â9). This increase was evident not only by an increased immunoreactivity against all tau phosphorylation-sensitive antibodies tested but also by a retarded mobility of FLAG-tau on the SDS gel, a characteristic feature of hyperphosphorylated tau (2, 3). Thus, 14-3-3zeta profoundly stimulated GSK3Beta-catalyzed tau phosphorylation in vivo.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "SDS-PAGE": true,
          "Co-Immunoprecipitation": true,
          "Immunoprecipitation": true,
          "Chromatography, FPLC": true,
          "Pull-down Assay, GST": true
        },
        "CellLine": {
          "HEK293": true
        },
        "Cell_Line": {
          "COS7": true
        }
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 135,
      "target": 97,
      "key": "e2e0089dcac41a89f5aaa8d2b9a9cced27cdac21d81aac9ed40fa6c6c5eb017ca819c70803f58ae3c524ed6a0f295a64222be378933307e5e0c55817e1801e80"
    },
    {
      "relation": "hasComponent",
      "source": 54,
      "target": 97,
      "key": "62d5acfa00fd4339b9a4a472d6205d77c94cf65552fbb63f6c1cd3faa0d2b9c568943fbf20fde58966e880d8d5bae69ca6fb948fbaa56e527459759c06e78264"
    },
    {
      "relation": "hasComponent",
      "source": 54,
      "target": 103,
      "key": "1e30f3e7ef8f96cde1f039272f406628d3e9c7ff4b8ad5ebb04002dff545f1cebba0ae2884618553066d52ecc7e246b73fb2bee07c3180a8c2834313603ddb65"
    },
    {
      "relation": "hasComponent",
      "source": 54,
      "target": 135,
      "key": "edfc75a8c68308049e0a76e2806abd7fab4636e412f0b02baf621133443c229e22e8dff136332fe579a9ef79a55806536e4f14721e835ada7137733bf7a05592"
    },
    {
      "line": 790,
      "relation": "negativeCorrelation",
      "evidence": "The results suggest that the amino-terminal fragment suppresses neurite outgrowth by competing for plasma membrane binding.",
      "citation": {
        "type": "PubMed",
        "reference": "12551948",
        "name": "The Journal of biological chemistry",
        "title": "14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.",
        "volume": "278",
        "pages": "12722-8",
        "date": "2003-04-11",
        "first": "Agarwal-Mawal A",
        "last": "Paudel HK",
        "authors": [
          "Agarwal-Mawal A",
          "Cafferty PW",
          "Han D",
          "Lin R",
          "Paudel HK",
          "Qureshi HY",
          "Yuan Z"
        ]
      },
      "annotations": {
        "Method": {
          "Immunoprecipitation": true,
          "Immunoblotting": true,
          "Electron Microscopy, Immunological": true,
          "Immunofluorescence": true
        },
        "CellLine": {
          "PC12": true
        }
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 28,
      "target": 141,
      "key": "12bd4118e065d58e4744a78c40c838dd39c18da1c56e20b744a0d3c5bb359537c9c79efd449ccd531a07642917219dc823acbbf214df27acfb594a4380c8f574"
    },
    {
      "line": 800,
      "relation": "decreases",
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40â65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "source": 75,
      "target": 115,
      "key": "a0cbc225cc12669d917f54ca94e03e2c63d1d9a1a53fa38a84b0f34452efdf59ece5808a5fb1ce6579aaf5807c3d9ea1279525a7b24540c8eefe9560101a8120"
    },
    {
      "line": 801,
      "relation": "decreases",
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40â65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "source": 75,
      "target": 116,
      "key": "a61688cc8256384637d6879eb2972c0961846fd400704ec2a208bf7b370cd3da881ac52102938aac8e20d0153b6e6d430e6b075df254b60f9ec0084765a21396"
    },
    {
      "line": 802,
      "relation": "decreases",
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40â65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "source": 75,
      "target": 113,
      "key": "dda54b057f735421f370e34b88a3eee190a3bab6f69ef88ebd03c29df1a39c76c0cd5f66cc3918b94235086b602b5bc68b1907be02e0bbfd33ff6cac83b2a666"
    },
    {
      "line": 803,
      "relation": "decreases",
      "evidence": "The quantification of all immunoreactive bands revealed that the R406W mutation exhibits a decreased phosphorylation at T205, T212, and the PHF1 epitope (S396/S404; reductions of 40â65%) as compared with wt tau, whereas other sites were not affected or only slightly affected (T181, S199, S214, and S262).",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        }
      },
      "source": 75,
      "target": 114,
      "key": "1e9a2563d0d5b3399a2a18fccc738096e97007826c8d135cd630395d55e4560ae6e4b9154cf357de5fc59c0e69fb12fe0bcf99240c12642a3c5050b9585d245f"
    },
    {
      "line": 814,
      "relation": "decreases",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 75,
      "target": 38,
      "key": "95a3555362561ea60d0b95476176042756e4f18f369e540176658221cf98cc36c605d6ad0d589f22dedc3dc4e53411717f09eb8f9bb66b14011b93461580a2dc"
    },
    {
      "line": 809,
      "relation": "association",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 84,
      "target": 103,
      "key": "1289d5b925fb8f8981140f28826828878ae94a14dc919aebc289e4dbac78f0987e22513e0e6370e7034f183b9842d897eb4c45271421baeb24f79bb5be1436ff"
    },
    {
      "line": 810,
      "relation": "association",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 84,
      "target": 11,
      "key": "720c70cbbbaec5ba907854855875211fa5a010b20d7fc9933d6ac7944f89f4c245216f6acf6de37d269a232193cab1e0fab54068fb96a6b931e41e1ad207456b"
    },
    {
      "line": 811,
      "relation": "isA",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 84,
      "target": 38,
      "key": "2adb64b555c97f28dbe72300fce3cf1099353080744ac92604752d2975e6374e632d953b31dd39b6d22d903256b93156b2ce2f1d3b9128e34b1f76e5c338fea3"
    },
    {
      "line": 810,
      "relation": "association",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 11,
      "target": 84,
      "key": "9d4b6683ed4734ebbde808d7f5a43f92280c49e36e63bb7da60d177626178bab8d25a02b09f58ccc39c070c1725166c9b08e96df9fd4fd7b124ddb0faff71615"
    },
    {
      "line": 813,
      "relation": "isA",
      "evidence": "The data suggest that tauâs membrane association causes retention of tau in the tip of neurites, which is compromised by the R406W mutation. Also, after BAPTA treatment, the difference in the retention of wt tau and R406W tau was abolished (Fig. 9 D), which again suggests that tau trapping is caused by an interaction with AnxA2 at the membrane.",
      "citation": {
        "type": "PubMed",
        "reference": "21339331",
        "name": "The Journal of cell biology",
        "title": "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner.",
        "volume": "192",
        "pages": "647-61",
        "date": "2011-02-21",
        "first": "Gauthier-Kemper A",
        "last": "Brandt R",
        "authors": [
          "Brandt R",
          "Drewes G",
          "Gauthier-Kemper A",
          "Gerke V",
          "Golovyashkina N",
          "Heinisch JJ",
          "SebÃ¶-Lemke Z",
          "Weissmann C"
        ]
      },
      "annotations": {
        "Method": {
          "Mass Spectrometry": true,
          "Immunocytochemistry": true,
          "Pull-down Assay, GFP": true,
          "Confocal Microscopy, Laser Scanning": true,
          "RNA Interference, shRNA": true,
          "Tandem Affinity Purification, TAP": true
        },
        "GOCC": {
          "neuron projection": true
        }
      },
      "source": 11,
      "target": 38,
      "key": "82c5327b04eec02d021ede7dad3621ef6aa65c2fc1e803f5cce2a34d065fb70c0a4d9198adf697154ec2ef8ceed9ef10a5a42b9691d491c433f6cc53faea041f"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 11,
      "key": "81c328f0535b271e63558203fbc51abcbae479aebad6d0d56af0740e45a55860397bf4163d25750b69eaa33dd33c2945b720512a17deca948dd47fb5e313850b"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 84,
      "key": "037bc7d6690ecd750ec9bba6b016beb537109f81702b0f60aae05e6168b6993f38f413da16eb0e7a1fd7b1d476aefb8ef24e4fb4ffcd45ec7994efbd8ed71f26"
    },
    {
      "relation": "hasComponent",
      "source": 38,
      "target": 103,
      "key": "d91f42308a005f137832a2297cc813c2a786698f2f0d7f3b3b037abfc1eb38c9dcf88fc5e97584ab71da6e03c657434dba74e955ab1e8f27e8cb640c97bf3a36"
    },
    {
      "line": 827,
      "relation": "increases",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "membrane raft"
          }
        }
      },
      "source": 8,
      "target": 143,
      "key": "2ea8129d9459c42171120c6b9d6c43ee7f6664a26ca5da0e881a111e940d207ec146bdf81b4993b9f5fb4a98f2c8c2bc0aa01ce57e7d23fa4500cf1c6440b6ca"
    },
    {
      "line": 828,
      "relation": "increases",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "membrane raft"
          }
        }
      },
      "source": 8,
      "target": 147,
      "key": "d50e2ede5f7af2290c53795d7ab5c6d10b2a1b905cb976578458b646229e8b75c291daa67f81a2abe6cd4c89c7a1676bd3f95459a46749ab59d9099dfd080051"
    },
    {
      "relation": "hasVariant",
      "source": 143,
      "target": 144,
      "key": "1560cf51a7028c6b17b1439b2d47db814e910d8f73fc8736a9121e24575f7942879b15c962069c1da6acb8fea2dbb4aed801baeaa99475fa86430ecea5041773"
    },
    {
      "line": 833,
      "relation": "negativeCorrelation",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "GOCC": {
          "membrane raft": true
        }
      },
      "source": 143,
      "target": 0,
      "key": "405d394478d9ea8cfa1a1b127a9ce6852bbd40fc80aab7e249b13285de4e19661fc49cbb90618e553128eda58e6a6c511c5af746d080601186420924ee955a0e"
    },
    {
      "line": 835,
      "relation": "regulates",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "membrane raft"
          }
        }
      },
      "source": 143,
      "target": 147,
      "key": "ae1b455fe38e14283ce81ed70f2d82291c6ecb32302291af01573d38adcdaa6a7bcef520847197b10baeae6127fbc830f92accaf6fb5ba638b971bb0d6106008"
    },
    {
      "line": 829,
      "relation": "decreases",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "source": 0,
      "target": 144,
      "key": "31fdeba0dacfd8850980095a3108fc235b47d01b240af22fe00498050beb11e88dfedbdc7e87dbd26a0720b24f71d1124051df2b74984011e3ee96e036c1d0a5"
    },
    {
      "line": 832,
      "relation": "negativeCorrelation",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "GOCC": {
          "membrane raft": true
        }
      },
      "source": 0,
      "target": 147,
      "key": "af699208bb8de57258d77a080a98c664e766b5dcf2139c6b7e77874c9c194d9b969c1456fa77599e606f56f38ef3b6e84fb7f61711f8127f3cb73c30992e37e5"
    },
    {
      "line": 833,
      "relation": "negativeCorrelation",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "GOCC": {
          "membrane raft": true
        }
      },
      "source": 0,
      "target": 143,
      "key": "b4b1504d1bd50768a17fd01903a7ffad5abc811fa6a18922763f6da12d7b738d29087d9a922bf82f11b89625e2b910cee95fea9d8d74a3e2942fc7abf47044dc"
    },
    {
      "line": 830,
      "relation": "increases",
      "evidence": "A rapid but transient increase was found in the amount of fyn detected in DRMs on ADDL exposure for 2 min that was partially reduced after 10 min exposure. Mirroring the movement of fyn into the DRM, tau content of DRMs increased in response to ADDLs. To further test a putative association between fyn and tau levels in DRMs, we treated cells with 2-bromopalmitate, an inhibitor of protein palmitoylation, which is required for fynâs localization in DRMs. This treatment resulted in a progressive reduction in both fyn and tau in DRMs, demonstrating that the association of tau with DRMs may be directly regulated by fyn (Supplemental Fig. 2).",
      "citation": {
        "type": "PubMed",
        "reference": "18096814",
        "name": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology",
        "title": "Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.",
        "volume": "22",
        "pages": "1552-9",
        "date": "2008-05-01",
        "first": "Williamson R",
        "last": "Anderton BH",
        "authors": [
          "Anderton BH",
          "Hanger DP",
          "Usardi A",
          "Williamson R"
        ]
      },
      "annotations": {
        "Method": {
          "Western Blot": true,
          "LDH Assay": true,
          "Immunofluorescence": true
        },
        "Species": {
          "10090": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "membrane raft"
          }
        }
      },
      "source": 144,
      "target": 143,
      "key": "24af20863536073eed752c5cb4485daf119294aa4f2ec638a0a40c4c3788bf5351a09c1b40fcdb452f11cffc5ac309c3718f62b51e5b5649a9c866f82e5d31d8"
    },
    {
      "line": 850,
      "relation": "increases",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Chromatin Immunoprecipitation": true
        }
      },
      "source": 21,
      "target": 37,
      "key": "c19893ff5fb168a7a010329b3fc5664690d3f3fa1183cf71467f4bab218d97c7406dca34818dad95864da1f277c0ee52ffb194f81cb43816dfdcca2519a83147"
    },
    {
      "line": 857,
      "relation": "increases",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "nucleus"
          }
        }
      },
      "source": 21,
      "target": 103,
      "key": "d6950f865de2594c172c36bcfabb8ffbe1933586530265bfb1afac17d7883ca7e1ed9bc0125133a05cef566b6296391a348dff8611cb26a001ea44f7df23f223"
    },
    {
      "line": 858,
      "relation": "negativeCorrelation",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 21,
      "target": 103,
      "key": "134adf9fda2b940eaf44c8f71077054f60990caa1211335f595eb3bde68625168e7b3c04c0de3ded7a119a6e64c2e18a795e5ed92138fba90a28bdaee8f95529"
    },
    {
      "line": 859,
      "relation": "decreases",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 21,
      "target": 2,
      "key": "19cc6c501e66fc5b9aadf5d0222ccd7d03532958d4a658e1733fe8c23081ad05772a6886781235999d2b130a5386fcfd2cf801747a74955e6b16785fad4db8e0"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 2,
      "key": "30fe859728c9ee48201b4e07856fc38fc6db064b5e21eb8f4adea9c9efd9d25f704e54adeaec8ed313e35982e77c81251b712abbfd0e6f411b6124e95b6460ef"
    },
    {
      "relation": "hasComponent",
      "source": 37,
      "target": 103,
      "key": "bd1e95be3e5eb25398ad823489cd401d429708d7f7fc480b64640a65abca6d983198353c1879b12f939c691ce64d68033b9e5ab76e0860d326d749855fd1b9ad"
    },
    {
      "line": 853,
      "relation": "association",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 2,
      "target": 103,
      "key": "c2d11a8b057e1a1b339381c0507182ff27bdc73ffa33f0d00289b99054a23f61f99eb18115a6f8d33ec036e9680db0fd38afa1fca0747a64ac3f1200b9a201f7"
    },
    {
      "line": 855,
      "relation": "isA",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "source": 2,
      "target": 37,
      "key": "da6a16d4aaa90aadab8cd747624907700f277a9e4e66bee35cde879eb30022fbae18330c30bc08fd6469bd49411413d24f03e774c5d8faa4cc4afda6adf97d15"
    },
    {
      "line": 856,
      "relation": "increases",
      "evidence": "In this work, we demonstrate that acute oxidative stress and mild heat stress (HS) induce the accumulation of dephosphorylated Tau in neuronal nuclei. Using chromatin immunoprecipitation assays, we demonstrate that the capacity of endogenous Tau to interact with neuronal DNA increased following HS. Comet assays performed on both wildtype and Tau-deficient neuronal cultures showed that Tau fully protected neuronal genomic DNA against HS-induced damage. Interestingly, HS-induced DNA damage observed in Tau-deficient cells was completely rescued after the overexpression of human Tau targeted to the nucleus.",
      "citation": {
        "type": "PubMed",
        "reference": "21131359",
        "name": "The Journal of biological chemistry",
        "title": "Nuclear tau, a key player in neuronal DNA protection.",
        "volume": "286",
        "pages": "4566-75",
        "date": "2011-02-11",
        "first": "Sultan A",
        "last": "Galas MC",
        "authors": [
          "Bonnefoy E",
          "BuÃ©e L",
          "BÃ©gard S",
          "Colin M",
          "Galas MC",
          "Humez S",
          "Loyens A",
          "Mansuroglu Z",
          "Marzin D",
          "Nesslany F",
          "Sergeant N",
          "Sultan A",
          "Talahari S",
          "Violet M"
        ]
      },
      "annotations": {
        "Method": {
          "Non-denaturing Fast Halo Assay": true,
          "LDH Assay": true,
          "Comet Assay": true,
          "Electron Microscopy": true,
          "Immunofluorescence": true
        }
      },
      "object": {
        "modifier": "Translocation",
        "effect": {
          "fromLoc": {
            "namespace": "GO",
            "name": "cytoplasm"
          },
          "toLoc": {
            "namespace": "GO",
            "name": "nucleus"
          }
        }
      },
      "source": 22,
      "target": 103,
      "key": "000f28af6b3439353b4d97e79a51370d79e1d43933aefb454d046c10e811adce258d159c1915990a012ed46aa4aa3325d3efb02f8bfe98f99073cfda1432f9c0"
    },
    {
      "line": 871,
      "relation": "increases",
      "evidence": "As noticed earler, it is difficult to obtain PHFs from constructs containing domains outside the repeats or the second repeat, at least under conditions where assembly is driven by high ionic strength and high protein concentration [5,26]. This would suggest that some non-repeat domains of tau prevent PHF formation. The same tendency is observed here again, but low we find that the inhibition can be easily overcome by RNA in most cases. Since dimers are building blocks of PHFs, the extra repeat (no. 2) effectively acted as a PHF inhibitor [22]. However, this inhibition can be overcome by tRNA.",
      "citation": {
        "type": "PubMed",
        "reference": "8985176",
        "name": "FEBS letters",
        "title": "RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments.",
        "volume": "399",
        "pages": "344-9",
        "date": "1996-12-16",
        "first": "Kampers T",
        "last": "Mandelkow E",
        "authors": [
          "Biernat J",
          "Friedhoff P",
          "Kampers T",
          "Mandelkow E",
          "Mandelkow EM"
        ]
      },
      "annotations": {
        "Method": {
          "Electron Microscopy": true
        }
      },
      "source": 4,
      "target": 16,
      "key": "fd141c9ab31b414cd48a6c6d7046cf280e23cde7b33b828b5612be84f413b78702ad67acfc77e05962f732f30b0ca259e0042aa50aab0646110bc519e97f1a26"
    }
  ]
}